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ABSTRACT 
Reactive oxygen species (ROS) and especially hydrogen peroxide (H2O2) 
have been implicated in a multitude of cellular events ranging from pathogen 
eradication to finely tuned intracellular signal transduction under normal and 
pathological conditions. In some organs, such as thyroid gland, or in tissue 
injuries their expression is naturally high and requires special measures to keep 
it under control. Extracellular superoxide dismutase (SOD3) is an antioxidative 
enzyme, which converts superoxide into H2O2 thus reducing the harmful ROS 
burden of injured tissues. Recently, a more versatile role for SOD3 as an anti-
inflammatory and signal modulating agent has begun to emerge. We studied 
the mechanism of action of SOD3 in tissue injury recovery and whether it has a 
role in the thyroid gland physiology and pathophysiology, which untill now 
have remained uncharacterized. 
We performed an adenovirally mediated gene transfer of SOD3 into rat hind 
limb and mouse peritoneum to assess its effect on tissue recovery and 
leukocyte migration. Our rat hind limb ischemia model provided an acute 
ischemic injury to study the effects of therapeutic molecules on the initiation of 
inflammation. A mouse peritonitis model allowed a more specific analysis of 
the infiltrating inflammatory cell subtypes. We also determined the expression 
of SOD3 and its influence on thyrocyte function from rat and human thyroid 
tissues and cell lines. 
SOD3 gene transfer markedly reduced the inflammatory cell accumulation 
into the rat hind limbs and the mouse peritonea as well as improved rat muscle 
tissue recovery. Interestingly, SOD3 seemed to have a pronounced effect on 
the macrophage population. Activation of the Ras-mitogen activated protein 
kinase (MAPK) pathway was upregulated whereas the expression of several 
inflammatory cytokines and cell adhesion molecules was downregulated. The 
SOD3 expression analysis and signal transduction studies on thyroid revealed 
high thyrotropin mediated SOD3 expression in normal rat thyroid and even 
higher in hyperproliferative goitrous tissue. Accordingly, silencing of SOD3 by 
small interfering RNA reduced thyrocyte proliferation. However, thyroid 
cancer tissue from human patients and rat thyroid cancer cell lines had 
significantly lower SOD3 expression. 
These studies describe a novel role for SOD3 in cell proliferation in injured 
tissue and in the thyroid gland physiology. Additionally, they elucidate the 
anti-inflammatory mechanism of SOD3. Thus, SOD3 could have therapeutic 
value in treatment of ischemic injuries, and in assessment of the degree of 
malignancy in thyroid hyperproliferative disorders. 
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1 INTRODUCTION 
1.1. Hydrogen peroxide and other reactive oxygen species 
Hydrogen peroxide (H2O2) is one of the reactive oxygen species (ROS) 
which is characterized by their high reactivity with numerous intra- and 
extracellular molecules. In redox balance the reactions of ROS for instance 
with reactive nitrogen species, such as nitric oxide (NO•), creates elaborate 
network where altering the expression of one component usually has a 
significant effect on the others. Some common oxygen and nitrogen radical 
species and reactive sulfur groups are presented in Table 1. O2•
-
 and H2O2 are 
involved in a multitude of signaling events, their over production can cause 
tissue damage, and they can act as precursors for other ROS such as 
peroxynitrite (ONOO-) and OH•.  Accumulating knowledge of ROS has 
revealed a dual role for them as important signal tranduction molecules in the 
traditional immune responses and in cellular damage. 
Table 1. Radical species and reactive groups. 
Reactive oxygen species   
O2•
- 
 superoxide radical 
OH•  hydroxyl radical 
H2O2  hydrogen peroxide 
HOCl   hypochlorous acid 
Reactive nitrogen species   
NO•   nitric oxide 
ONOO-   peroxynitrite 
Reactive sulfur groups   
R-S-   thiolate anion 
R-SH  sulfhydryl (thiol) 
R-SOH  sulfenic acid 
R-S-S-R   disulfide   
 
 
1.1.1. H2O2 concentration and oxidative stress 
H2O2 is produced as a side-product of normal metabolism in e.g. 
mitochondria or peroxisomes, and scavenged quickly by antioxidative enzymes 
which maintain the normal reduction-oxidation (redox) balance of the cells. 
The intracellular H2O2 concentrations remain at a relatively similar level in 
mammalian cells ranging from 0.001 µM to a maximum of 0.5-0.7 µM in some 
cytotoxic immune cells (Oshino et al. 1973; reviewed by Chance et al. 1979). 
The optimal concentration varies strongly according to the cell type and the 
metabolic activity level of the cells. Actively proliferating and transformed 
R=organic 
group. 
13 
cells have been shown to produce more H2O2 as compared to cells in G0-phase 
(Pani et al. 2000; Duval et al. 2003; Policastro et al. 2004). Consequently, the 
variable H2O2 concentrations, whether applied to tissue culture or generated 
endogenously, have a distinct biological effect on vertebrate cells (reviewed by 
Burdon 1995; reviewed by Stone and Yang 2006).  
Extracellular H2O2 concentrations vary greatly according to the environment 
of the cell but, in general, there is a 7 to 10-fold difference between cell interior 
and exterior (Antunes and Cadenas 2000; Makino et al. 2004; Figure 1). Thus, 
the level of H2O2 under physiological conditions is usually in the range of 0.01-
7 µM outside the cells. Alterations in the environment are rapidly reflected in 
the intracellular levels since H2O2 can diffuse across the plasma membrane, 
and additionally the cells are actively maintaining this gradient (reviewed by 
Chance et al. 1979; Makino et al. 2004). The phenomenon can be utilized in 
exposing the cell culture to H2O2 in order to reach a desired intracellular H2O2 
concentration for research purposes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excess H2O2 and other ROS production result in oxidative stress, 
proceeding from mild to severe according to the level of oxidation in the cell 
interior. Redox balance of the cells is altered during oxidative stress, and 
Figure 1. Effect of applied H2O2 concentration on cellular responses. A 10-fold 
difference quickly develops between cell exterior and interior after application of H2O2. Low 
H2O2 concentrations (0.1-7µM extracellular) stimulate cell proliferation. Higher 
concentrations (20-200µM) induce growth arrest but a later adaptation may occur allowing 
the cell to proliferate again. Concentrations exceeding 10 µM result in increasing cell death 
rate. The outcome of H2O2 application depends considerably on the cell type and culture 
conditions. (Modified from the review by Stone and Yang, 2006) 
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normally leads to growth arrest and eventually to apoptosis (reviewed by 
Davies 1999; reviewed by Stone and Yang 2006; Figure 1). Oxidative stress is 
often associated with ischemia-reperfusion injuries and various inflammatory 
or metabolic diseases as well as with dysregulation of ROS generating and 
scavenging systems which are caused by genetic mutations in antioxidant 
enzymes or their regulators. For instance, hyperthyroidism, various cancers and 
cardiovascular injuries are known to involve excessive ROS production 
(reviewed by Ferrari 1995; reviewed by Venditti and Di Meo 2006; reviewed 
by Valko et al. 2006). 
Mild stress caused by 10-200 µM extracellular H2O2 depending on the cell 
type, increases the activation of various peroxidases. Interestingly, it has been 
shown that mild stress can actually prime the cells for later more severe stress 
and enhance their survival by altering the cell metabolism and respiration 
(Wiese et al. 1995; reviewed by Davies 1999). More severe stress will deplete 
the cytosolic glutathione reductant pool and inhibit the peroxidases themselves 
thus impairing the antioxidant system of the cell (reviewed by Stone and Yang 
2006). Consequently, this leads to more severe alteration of the redox balance 
and eventual activation of the apoptosis pathways (reviewed by Davies 1999; 
Figure 1). 
1.1.2. ROS generating and scavenging systems 
Cells, tissues and organisms are constantly exposed to chemical, physical, 
and environmental stress factors as well as microbial pathogens that induce 
expression of cytokines, growth factors, integrins, and hormones in order to 
maintain tissue homeostasis. Many of these agents stimulate the activity of 
ROS generating enzymes, the large family of various oxidases.  In mammals 
the main radical generators, NADPH oxidases (Nox), produce superoxide 
which is then dismutated by superoxide dismutases (SOD) into H2O2 that is 
further neutralized into oxygen and water by e.g. catalase. Therefore SOD 
enzymes act in the first line in reducing oxidative stress. 
1.1.2.1. H2O2 generators 
Presently seven NADPH oxidases have been identified in human cells: 
Nox1, Nox2, Nox3, Nox4, Nox5, and two dual function Nox enzymes Duox1 
and Duox2 (reviewed by Lambeth 2004). The functional enzyme is a complex 
formed by a catalytic subunit together several associated regulatory subunits 
and proteins as well as Ca2
+
 which is needed by Nox5 and the Duox enzymes. 
The components reside in the cytosol in resting cells but upon activation, often 
phosphorylation by various kinases or binding to phosphatidylinositols, they 
translocate to the plasma membrane (reviewed by Geiszt 2006; Bissonnette et 
al. 2008). Nox enzymes are expressed throughout the body in numerous tissues 
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such as epithelia, gastrointestinal tract, inner ear, kidneys, vascular tissues, and 
in professional phagocytes (reviewed by Geiszt 2006). Activated phagocytic 
leukocytes, monocyte/macrophages and neutrophils, produce toxic amounts of 
Nox2 derived O2•
-
 as the primary defense mechanism against invading 
pathogens in a process called oxidative burst (Cross and Segal 2004; Quinn and 
Gauss 2004). In the vasculature, Nox1, Nox2 and Nox4 have been found to 
mediate various important O2•
-
 dependent signaling events related to e.g. 
endothelial cell proliferation and migration (Abid et al. 2000; Van Buul et al. 
2005), cytokine production and endothelial permeability (Ali et al. 1999; Chen 
et al. 2004), and cell adhesion molecule expression to aid leukocyte 
transmigration (Fan et al. 2002; Chen et al. 2003). Nox enzymes are 
upregulated by a variety of growth factors, inflammatory cytokines and 
environmental factors such as hypoxia and shear stress (reviewed by Pani et al. 
2001; reviewed by Li and Shah 2004). 
Of particular interest in thyroid are the Duox (aka thyroid peroxidase, 
ThOX) enzymes which provide the H2O2 for thyroid hormone synthesis. The 
immature forms of Duox enzymes are post-translationally glycosylated at the 
endoplasmic reticulum before exportation of the mature enzymes with the help 
of DuoxA maturation factors (De Deken et al. 2000; De Deken et al. 2002; 
Grasberger and Refetoff 2006; Grasberger et al. 2007). However, majority of 
the enzyme remains stored in inactive form inside the cell and is matured and 
transported to the plasma membrane only when the thyrocytes are stimulated 
by thyroid stimulating hormone (TSH) (De Deken et al. 2002).  
Mammalian superoxide dismutases 1, 2 and 3 convert the O2•
-
 molecule into 
H2O2 using Cu and Zn or Mn cofactors at their catalytic sites. SOD1 (CuZn-
SOD) and SOD2 (Mn-SOD) are expressed in a wide variety of cells but differ 
in their subcellular locations. SOD1 is found in the cytoplasm, nuclear 
compartments, and lysosomes, whereas SOD2 is restricted to mitochondria 
(Weisiger and Fridovich 1973; Geller and Winge 1982; Fridovich 1986; Chang 
et al. 1988). SOD3 is an extracellular isoform of the family with extensive 
homology to SOD1 including the CuZn core (Marklund 1984). The principal 
function of the SOD enzymes is the removal of O2•
-
 in various conditions such 
as ischemia/reperfusion injuries, inflammation, or exposure to radiation, and 
thus attenuate damage to cellular macromolecules (Petrone et al. 1980; Wong 
1995; Jones et al. 2003; Kim et al. 2007a).  
Extracellular SOD3 is the most recently characterized SOD isoenzyme. It is 
expressed widely in vivo with highest expression in vascular smooth muscle 
cells, thyroid gland, aorta, lungs, epididymis, and kidney (Marklund 1984; 
Perry et al. 1993; Stralin et al. 1995). Additionally, skeletal muscles, heart, 
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liver, brain, and spleen show some SOD3 expression (Folz et al. 1997) 
suggesting a role in oxygen regulation in tissues susceptible to oxidative stress. 
However, based on the studies with SOD3 knockout mice which have a normal 
phenotype until exposed to oxidative stress (Carlsson et al. 1995; van Deel et 
al. 2008) suggest that in normal conditions SOD3 has a minor role which 
comes more prominent when the tissue redox balance is challenged. SOD3 is 
not freely diffusible but after secretion it attaches to extracellular matrix and 
cell surfaces through its binding sites for heparan sulphate, collagen and fibulin 
5 (Nguyen et al. 2004; Petersen et al. 2004; Antonyuk et al. 2009). Thus, it is 
confined to the proximity of cell surface Nox enzymes and its substrate O2•
-
. 
Bound SOD3 is most effective in eradicating the unwanted O2•
-
as shown by 
studies where defective binding to extracellular matrix allows collagen 
proteolysis and higher tissue O2•
-
 expression (Petersen et al. 2004; Nguyen et 
al. 2004). 
Numerous studies have established a role for SOD3 as an anti-inflammatory 
antioxidant which can markedly attenuate tissue damage. Absence of SOD3 in 
knockout mice increased O2•
-
 mediated damage and inflammatory injury after 
ischemia/reperfusion in brain or skeletal muscle and in arthritis (Sheng et al. 
1999; Ross et al. 2004; Park et al. 2005). In contrast, gene transfer of SOD3 or 
overexpression in transgenic animals improves tissue recovery significantly in 
e.g. myocardium, vasculature, lungs, skin or liver (Laukkanen et al. 2001; Li et 
al. 2001; Durand et al. 2005; Rabbani et al. 2005; Ha et al. 2006). Possible 
mechanisms in addition to direct removal of excess O2•
-
 have been suggested 
such as inhibition of leukocyte migration, and vascular tone regulation by 
simultaneous activation with nitric oxide synthase to reduce toxic ONOO- 
formation and thus increasing the availability of NO (Brady et al. 1997; Bowler 
et al. 2004; Na et al. 2007).  
Interestingly, the expression of SOD3 shows variable pattern in different 
circumstances. In acute coronary ischemia patients the endogenous SOD3 
expression was rapidly increased (Horiuchi et al. 2004), whereas in chronic 
cardiac disease as well as in systemic inflammation its expression and activity 
was downregulated (Landmesser et al. 2000; Tasaki et al. 2006; Ueda et al. 
2008). This could be partly explained by the variable regulatory effect of 
inflammatory cytokines and growth factors on SOD3 expression: interferon 
(IFN)-γ, interleukins (IL-) 1α and 4, NO, and angiotensin II all promote SOD3 
expression but tumor necrosis factor (TNF) α, and fibroblast, epidermal, and 
platelet derived growth factors (FGF, EGF and PDGF, respectively) reduce it 
(Stralin and Marklund 2000; reviewed by Zelko et al. 2002).  
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1.1.2.2. H2O2 scavengers 
Hydroperoxidases comprise a large family of antioxidant enzymes involved 
in scavenging H2O2 and ONOO-. The most prominent mammalian members 
are peroxiredoxins (Prx), glutathione peroxidases (GPx), and catalase. Prx and 
GPx are more readily oxidized than catalase and act therefore mainly at 
physiological H2O2 concentrations whereas catalase remains functional at 
higher ROS concentrations occurring at its site of action in the lysosomes. 
Prx enzymes exist in mammals as six isoforms divided into three subgroups 
with some variation in intracellular expression sites (reviewed by Rhee et al. 
2005a). In their active sites all Prxs contain one or two essential Cys residues 
with a thiolate anion or a thiol group that is successively oxidized and reduced 
by H2O2 and thiols, respectively, during the catalytic cycle (see Table 1. for 
different oxidation states of the thiol group; reviewed by Rhee et al. 2005a). 
The mechanism involves hyperoxidation of the Cys residues which allows a 
local increase in H2O2 during signal transduction. Therefore Prx are recently 
suggested to have an important role in signal transduction modulation 
(reviewed by Fourquet et al. 2008).  
The second large group of H2O2 scavengers are the GPx enzymes which 
differ from Prx by containing a selenocystein amino acid instead of normal Cys 
at their active site (reviewed by Papp et al. 2007). Otherwise their mode of 
action and catalytic cycle resembles that of Prx enzymes with reversible 
oxidation of selenium (instead of sulfur). In humans there are altogether seven 
GPx enzymes, although two of them have the conventional Cys residue 
(reviewed by Papp et al. 2007). They seem to have only a minor role in normal 
physiology, but instead constitute the primary antioxidant defense system of 
the body as they are more resistant to higher ROS levels than the Prx enzymes 
(reviewed by Papp et al. 2007; reviewed by Fourquet et al. 2008). 
Catalase is one of the first antioxidant enzymes found. The majority of the 
mammalian catalase is in the peroxisomes even though minor expression can 
also be found in the mitochondria (Salvi et al. 2007). Catalase, which uses two 
molecules of H2O2 to generate water and molecular oxygen, is an efficient 
enzyme with very high enzymatic rate (reviewed by Kirkman and Gaetani 
2007). Interestingly, deficiencies in catalase function or expression do not 
affect the normal phenotype and overexpression may even protect the tissues 
from oxidative damage but the absence of the enzyme becomes problematic 
when the tissue oxygen balance is compromised (Ho et al. 2004; Schriner et al. 
2005). Catalase can inhibit cell proliferation by removing the growth 
promoting H2O2 signal and thus influences the regulation of cell growth 
(Policastro et al. 2004). 
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1.1.3. H2O2 in cell signaling 
Nearly two decades ago it was hypothesized that oxygen radicals could act 
as second messengers as it became apparent that their generation was 
upregulated by proinflammatory cytokines TNF-α and IL-1, and that they 
activate the important stress-related transcription factor nuclear factor (NF) κB 
(reviewed by Schreck and Baeuerle 1991). More recently, especially H2O2 
signaling has gained attention as it seems to be involved in great majority of 
autocrine and paracrine signaling pathways, both in normal physiology and in 
pathological conditions. Characteristic to this function is that at the global 
cellular level H2O2 concentration remains at low physiological level whereas 
the local rise in H2O2 concentration occurs at the site of stimulated receptor. 
The local generation of H2O2 is under strict regulation to avoid excess 
oxidative stress (reviewed by Rhee et al. 2005b).  
Hydrogen peroxide has many features which render it a suitable signaling 
molecule. It is generated rapidly, it is relatively long-lasting compared to for 
instance superoxide or nitric oxide, and since it is not electrically charged it can 
diffuse long distances and cross lipid membranes (reviewed by Cai 2005). 
Additionally, H2O2 is capable of inducing its own expression thus amplifying 
the initial signal utilizing e.g. the mitochondria and cellular oxidases (reviewed 
by Cai 2005). However, this kind of continuous H2O2 production contributes to 
the development of oxidative stress in the surrounding tissues and further to 
e.g. vascular diseases and arthritis (Bauerova and Bezek 1999; reviewed by Cai 
2005). 
A general scheme of the signal transduction events involving ROS and 
leading to gene transcription has been proposed almost for 20 years ago 
(Schreck and Baeuerle 1991; Devary et al. 1993; Anderson et al. 1994). First, 
the extracellular stimulus, a cytokine, ROS, chemical compound or radiation, 
induces a common pathway leading to protein tyrosine phosphorylation. These 
phosphorylated factors then induce the activation of transcription factors, the 
most well-characterized of which is probably NFκB. Consequent changes in 
gene expression pattern eventually produce the specific cellular response to the 
stimulus in question. However, the detailed molecular mechanisms have been 
gradually discovered during the following years. Kamata et al. (2000) have 
suggested that several mechanisms become simultaneously activated to 
facilitate signal transduction e.g. oxidative protein tyrosine phosphatase (PTP) 
inhibition and intracellular ROS signal generation. Additionally, H2O2 can 
interfere signaling by oxidating important second messengers such as NFκB 
and diacyl glycerol (DAG) (Takekoshi et al. 1995; reviewed by Kabe et al. 
2005). 
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Several growth factors (EGF, PDGF, vascular endothelial growth factor or 
VEGF), cytokines (tumor growth factor-β, TNF-α, interleukins), and G-protein 
coupled receptors (GPCR), and also biomechanical forces such as shear stress 
have been found downstream H2O2 signaling (reviewed by Thannickal and 
Fanburg 2000; reviewed by Stone and Collins 2002; reviewed by Rhee et al. 
2003; reviewed by Li and Shah 2004). Additionally, various external stress 
factors such as UV light and hypoxia induce H2O2 signal generation (Masaki et 
al. 1995; Sato et al. 2005).  
Nox or Duox activation occurs relatively early in ROS dependent signaling 
pathways as the regulatory subunits are recruited to the plasmamembrane e.g. 
through activated receptor binding scaffold proteins IQGAP1 (IQ motif 
containing GTPase activating protein) and TRAF (TNFα receptor associated 
factor), or through direct binding to the cytosolic domain of the receptor (Ikeda 
et al. 2005; Li et al. 2005; Li et al. 2006). Alternatively, the catalytic subunit 
itself may bind the receptor, e.g. the C-terminal region of Nox4 interacts with 
activated TLR (Toll-like receptor) 4 in vascular endothelial cells (Park et al. 
2006). As stated above, the Nox enzymes then generate O2•
-
 in a highly local 
manner which then either promotes directly or after conversion to H2O2 the 
signal transduction (reviewed by Ushio-Fukai 2006a). 
1.1.3.1. Mechanisms of H2O2 mediated signal transduction 
A well-studied mechanism for H2O2 regulation in signal transduction is 
based on the reversible oxidative inactivation of PTP and Prx enzymes by rapid 
increase in local H2O2 (Meng et al. 2002; Woo et al. 2003; reviewed by Rhee et 
al. 2005bh2o2; Salmeen and Barford 2005;  Figure 2). PTPs inhibit the signal 
transduction of numerous protein tyrosine kinases by dephosphorylating their 
tyrosine residues (reviewed by Chiarugi 2005) whereas Prx enzymes remove 
excessive cytosolic H2O2 to nontoxic concentration (reviewed by Fourquet et 
al. 2008). All PTPs and Prx enzymes contain a Cys residue which at neutral pH 
is in thiolate anion form (Chae et al. 1994). It is readily oxidized by H2O2 and 
other oxidants into sulfhydryl and further sulfenic acid (see Table 1. for the 
oxidation states of sulfur) which inactivate the active site Cys and thus inhibit 
the enzyme (Denu and Tanner 1998). Inhibition of Prx results in prolonged 
H2O2 survival that in turn enables the inhibition of PTP and phosphorylation of 
the target signaling kinases (reviewed by Rhee et al. 2005b). Thus, the net  
increase in phosphorylated signaling proteins triggers the downstream 
signaling events. After removal of the original stimulus the amount of H2O2 
decreases as the oxidation processes consume it, and the Prx and PTP enzymes 
are reactivated (reviewed by Rhee et al. 2005b).  
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Another efficient mechanism of H2O2 to modulate signaling cascades is the 
activation of redox-sensitive transcription factors such as NF-κB, activating 
protein (AP-) 1 and p53 which are associated with a multitude of physiological 
and pathological functions (Abate et al. 1990; Anderson et al. 1994; Rainwater 
et al. 1995; reviewed by Thannickal and Fanburg 2000). NF-κB is an important 
factor in immune response and inflammation related gene expression. In the 
basal state it is inactivated by the inhibitor of κB (IκB) which in turn is 
subjected to degradation by multiple co-operating mechanisms, leading to NF-
κB release, nuclear translocation, and DNA binding (reviewed by Kabe et al. 
2005). H2O2 and O2•
-
 participate in NF-κB regulation through receptor 
mediated Nox activation enhancing the c-jun NH2-terminal kinase (JNK) 
activity that promotes IκB removal (reviewed by Kabe et al. 2005). It has also 
been suggested that the Prx enzymes, especially the cytosolic isoforms, have an 
active role in H2O2 signal regulation through modulation of intracellular H2O2 
concentration and NFκB activation after e.g. growth factor or TNF-α 
stimulation (Jin et al. 1997; Kang et al. 1998). AP-1 is a Fos/Jun or Jun/Jun 
dimer whose Cys containing conserved regions have been suggested to mediate 
the redox sensitive regulation of DNA binding through reversible oxidation 
(Abate et al. 1990). A similar Cys-dependent mechanism has been found to 
regulate the tumor suppressor p53 activity (Rainwater et al. 1995). 
Exogenous H2O2 is usually indicative of oxidative stress in cell cultures and 
within organisms under pathological conditions. Stress level of H2O2 can affect 
Figure 2. H2O2 signaling. Several factors can stimulate the H2O2 dependent signal 
transduction through RTKs. RTK activates gene transcription but is constantly inhibited by 
PTP mediated dephosphorylation. However, RTK also activates Nox and SOD resulting in 
increased local H2O2 concentration. H2O2 induces oxidative inactivation of Prx and PTP 
preventing its own removal and RTK inactivation, respectively. Thus, the signal intensity and 
duration are increased, and lead to enhanced gene expression and a change in cellular 
functions. In some cell types Nox may have direct influence on the transcription factors. 
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the outcome of other signaling pathways by e.g. promoting p38 mitogen 
activated protein kinase (MAPK) activation but leaving extracellular signal 
regulated kinase (Erk) pathway intact after stimulation with the same growth 
factors leading to increased cell death (Zhang and Jope 1999b). H2O2 can also 
modulate cell growth and other events by inducing activation of cell surface 
receptor tyrosine kinases and their downstream kinases. For instance, EGF 
receptor has been found to become phosphorylated and to activate the 
Ras/MAPK pathway in a dose-dependent manner when the cells are exposed to 
H2O2 in vitro (Rao 1996; Kamata et al. 2000). Similarly, H2O2 incubation can 
activate PDGF receptor through PTP inhibition (Kappert et al. 2006).  
1.1.4. H2O2 in ischemia and inflammation 
Inflammation is the primary response of the tissues to injury, trauma or 
excessive stretching as well as to many pathological conditions ranging from 
cardiac disease to obesity (reviewed by Lambeth et al. 2008). Local hypoxia 
often develops in the tissue as blood circulation is hindered or the vessels are 
broken by e.g. blood clot or injury. Consequently, potentially harmful 
metabolites begin to accumulate and tissue cells become deprived of nutrients. 
Mitochondrial dysfunction is the main source of ROS in inflammation 
stimulating the cell to release inflammatory factors and to adapt to the new 
conditions (reviewed by Li and Shah 2004). 
Acute inflammation, which develops immediately after the injury has 
occurred, is characterized by accumulation of fluid and inflammatory cells 
such as neutrophils and monocytes attracted to the site by chemokines. When 
the stimulus is removed the inflammation soon resolves. However, a controlled 
inflammatory reaction is necessary to launch the healing process. If the 
stimulus persists the inflammation becomes chronic as in e.g. tuberculosis, 
arthritis, and in many autoimmune disorders such as in thyroiditis. In chronic 
inflammation the persisting stimulus keeps attracting the inflammatory cells by 
inducing continuous production of inflammatory chemokines and cytokines 
from the tissue and previously infiltrated professional phagocytes. The 
neutrophils and macrophages get trapped at the site of inflammation where 
they continue to remove cell debris but also to produce ROS thus exacerbating 
the tissue damage and actually preventing the healing process. 
Vascular endothelium has a major role in the inflammatory reaction due to 
its strategic location between the injured tissue and blood-borne leukocytes. 
Endothelial activation is a complex phenomenon occurring in response to a 
multitude of stimuli, and it is necessary to attract the leukocytes to the site 
where they then eradicate the pathogens and clear the necrotic tissue so that the 
healing process may begin (reviewed by Lum and Roebuck 2001; reviewed by 
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Alom-Ruiz et al. 2008). Hypoxic conditions launch the expression of a set of 
redox regulated signaling molecules e.g. prolyl hydroxylase domain-containing 
protein (PHD), hypoxia inducible factor (HIF), factor inhibiting HIF (FIH), and 
NFκB in tissues (reviewed by Fraisl et al. 2009). Inflammatory cytokines can 
also mediate hypoxia-independent HIF activation (Hellwig-Burgel et al. 1999; 
Gorlach et al. 2001). Among others, Nox enzymes have been shown to be 
upstream regulators of HIF in vascular smooth muscle cells (Gorlach et al. 
2001). HIF controls many downstream cascades which modulate the cellular 
metabolism, initiate anaerobic respiration and angiogenesis as well as enhance 
macrophage and neutrophil activity and survival (reviewed by Frede et al. 
2007; reviewed by Fraisl et al. 2009).  
TNF-α, IFN-γ, interleukins 1 and 6, and VEGF are the most common 
mediators of inflammatory reactions (reviewed by Roy et al. 2008). These 
factors frequently activate Nox enzymes and utilize H2O2 signaling to further 
promote endothelial activation, subsequent cell adhesion molecule expression 
and cytoskeletal rearrangements in endothelial cells to facilitate leukocyte 
migration and angiogenesis (Chen et al. 2003; Wu et al. 2003; Park et al. 2006; 
reviewed by Roy et al. 2008). VEGF and endothelial Nox enzymes also drive 
the angiogenic process to restore the blood supply (reviewed by Ushio-Fukai 
2006b). The most relevant adhesion molecules expressed by activated 
endothelial cells at the inflammation site are the immunoglobulin-family 
members intercellular, vascular and platelet/endothelial cell adhesion 
molecules (ICAM, VCAM, and PECAM, respectively), and P-, L- and E-
selectins (reviewed by Salmi and Jalkanen 2005; reviewed by Galkina and Ley 
2007). Activated leukocytes express ligands for these adhesion molecules and 
are thus able to attach and transmigrate through the rearranged endothelium 
into the tissues in a strictly regulated multistep process called extravasation or 
diapedesis (reviewed by Salmi and Jalkanen 2005; reviewed by Zarbock and 
Ley 2009; Figure 3). 
Neutrophils and monocyte/macrophages appear in the tissues within few 
minutes to few hours from the first stimulus guided by hypoxia, cytokine 
induced macrophage inhibitory protein (MIP-2), and monocyte chemotactic 
protein (MCP-1) chemokine expression (Lakshminarayanan et al. 2001; Chen 
et al. 2004; reviewed by Bosco et al. 2008). The initial reaction of these 
phagocytes is oxidative burst, a massive and rapid production of O2•
-
 secreted 
to the extracellular space or into phagosomes in order to destroy the invading 
pathogens (Babior et al. 2002; Quinn and Gauss 2004; Cross and Segal 2004). 
The primary phagocytic enzyme responsible for O2•
-
 generation is the Nox2 
(reviewed by Morel et al. 1991; Babior et al. 2002). However, other oxidases, 
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mainly myeloperoxidase, are also involved that produce more reactive ROS 
with wider scale of target molecules such as OH• and HOCl using O2•
-
 and 
H2O2 as precursors (reviewed by Leusen et al. 1996; Quinn and Gauss 2004; 
Cathcart 2004; reviewed by Lambeth 2004). However, an interesting 
alternative antimicrobial mechanism in neutrophils has been suggested in 
which Nox2 activation drives uptake of K+ that then induces activation of 
phagosome proteases thus contributing significantly to microbial killing 
(Reeves et al. 2002). The neutrophils and macrophages themselves express 
various antioxidant enzymes which allow them to stay functional at the site of 
oxidative burst (Yoshioka et al. 2006; Rakkola et al. 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The healing process has not yet been thoroughly elucidated due to the vast 
number of players and interactions in the process. Inflammatory cells, 
especially macrophages, have been proposed to induce healing in muscle tissue 
since they can activate the satellite cells (muscle cell precursors), remove 
necrotic tissue, and influence muscle cell differentiation and proliferation 
(reviewed by Tidball 2005). They are also involved in angiogenesis through 
cytokine stimulated VEGF expression (Xiong et al. 1998; Ramanathan et al. 
2003). However, neutrophils do not seem to have such a distinct effect and are 
therefore more detrimental to the tissue integrity (reviewed by Tidball 2005). 
Also restoration of NO availability by removing excess O2•
-
 could contribute to 
Figure 3. Leukocyte migration. Blood-borne leukocytes enter the tissues by transmigrating 
through the vascular wall guided by activated endothelium and chemokines. First they are 
captured and start rolling on endothelial selectins which slow them down. Chemokines 
activate the firm adhesion phase and the cells are arrested by cell adhesion molecules 
(CAMs) thus enabling the formation of suitable bonds between the leukocytes and the 
endothelium. The activated leukocytes are then able to crawl into the vascular wall and 
finally through it by para- or transcellular migration. (Modified from the review by Ley et al. 
2007) 
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healing by dilating the blood vessels and thus increasing the blood supply 
(Wilson and Kapoor 1993; Hirai et al. 1994; Hickner et al. 1997; Thomas et al. 
1998). Additionally, NO has been found to be a negative regulator of 
inflammation in muscle tissue. In several in vitro and in vivo studies it has been 
shown to e.g. inhibit Nox enzymes, the expression of cell adhesion molecules, 
and to increase inflammatory cell apoptosis (reviewed by Tidball 2005). 
Recently, it has been shown that IFN-γ can also suppress VEGF and, thus, 
promote resolution of inflammation (Ray and Fox 2007). 
Inflammation is characterized by massive apoptotic and necrotic cell death 
due to the high oxidative stress and consequent damage to DNA, proteins, and 
lipids. Additionally, macrophages and other inflicted cells produce high 
amounts of proapoptotic TNF-α (reviewed by Wajant et al. 2003). Currently, 
the mode of cell death is thought to be determined by various factors such as 
duration and severity of oxidative stress, cell types and ROS involved, and the 
particular signaling pathways activated (Gardner et al. 1997; Troyano et al. 
2003; Dunning et al. 2009). The main death receptors mediating both apoptosis 
and necrosis are the TNF receptor (TNFR)1 and CD95 (Fas/Apo1) but the role 
of ROS in their direct activation remains controversial (reviewed by Shen and 
Pervaiz 2006). TNFR1 recruits the MAPK JNK pathway to increase 
mitochondrial ROS generation and inhibits NFκB regulated pro-survival gene 
transcription, thus initiating the death signaling cascade (reviewed by Shen and 
Pervaiz 2006).  
In chronic inflammation the ROS production is continuous and affects the 
inflicted tissues substantially. ROS have been implicated in oxidative damage 
to DNA, lipids, proteins and other cellular and tissue molecules which may 
alter their properties and render them active or inactive, and thus affect the 
cellular metabolism and signaling events (reviewed by Valko et al. 2006). 
Persistent ROS expression induces chromatin mutations (Konat 2003) that 
often precede malignant transformation and lead to tumorigenesis when tumor 
suppressors such as p53 are inactivated or oncogenes such as Ras small 
GTPase become constitutively active (reviewed by Sun and Oberley 1996; 
reviewed by Vachtenheim 1997). 
1.2. Thyroid physiology 
1.2.1. Structure and function of the thyroid gland 
The thyroid gland situates in front of the neck anterior to the trachea and is 
the largest endocrine gland of the human body. The thyroid gland consists of 
two pear-shaped lobes connected by an isthmus, weighing approximately 10-20 
grams in adults depending on the body weight, age and iodine intake. It is an 
important regulator of development and growth on cellular and organismal 
25 
level. Additionally, it regulates multiple homeostatic functions in the body 
exerting its effect through the hormones triiodothyronine (T3), and 
tetraiodothyronine, or thyroxine, (T4). Its endocrinological function is 
dependent on the available iodine, mainly acquired from food and drink, since 
it is the crucial component of the hormones. Additionally, behind the thyroid 
gland there are two pairs of parathyroid glands which produce parathyroid 
hormone participating in the blood calcium ion and phosphate balance. The 
thyroid gland, and sometimes also the parathyroid glands, is enveloped in a 
capsule consisting of connective tissue.  
At microscopic scale the thyroid gland has a follicular structure (Figure 4A). 
The follicular lumen contains colloid in which the main component is 
thyroglobulin (Tg), a protein used for storage and synthesis of the thyroid 
hormones. The follicles are lined by a single layer of follicular cells that are 
cuboidal epithelial cells of endodermal origin. They are responsible for the 
thyroid hormone production in response to thyroid stimulating hormone (TSH) 
by retaining the TSH receptor (TSH-R) and the necessary enzyme machinery. 
Follicular cells have numerous microvilli projecting into the lumen to increase 
the surface area available for hormone metabolism. Each follicle is surrounded 
by a basement membrane and connective tissue where are the parafollicular 
cells, or C cells, that produce calcitonin and thus regulate the calcium ion 
content of blood in cooperation with the parathyroid glands. Extensive 
capillary vasculature in the connective tissue provides surface area for the 
exchange of hormones, iodine, nutrients and oxygen.  
The thyroid gland traps and concentrates iodine, synthesizes and stores the 
hormones, and releases them upon stimulation thus regulating the overall 
metabolic rate of the body. The thyroid gland function is mainly regulated by 
the hypothalamus which secretes TRH (thyrotropin-releasing hormone) and the 
anterior pituitary gland which secrete TSH causing increased thyroid gland 
activity (reviewed by Chiamolera and Wondisford 2009). These glands are, in 
turn, under finely tuned negative feedback regulation by T3 (reviewed by 
Chiamolera and Wondisford 2009; Figure 4A). However, other parts of the 
brain can also generate TRH in response to e.g. temperature and nutritional 
status (reviewed by Chiamolera and Wondisford 2009). Secondly, the thyroid 
gland is capable of autoregulation in response to available iodine so that low I- 
concentration stimulates thyroid function and an excess will inhibit its function 
(reviewed by Dumont et al. 1992). Finally, B lymphocyte-derived stimulating 
or blocking autoantibodies for the TSH-R can influence thyroid function in 
many disorders (reviewed by Dumont et al. 1992).  
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1.2.2. Thyroid hormone synthesis 
Thyroid hormone synthesis takes place in the follicular lumen on the apical 
surface of the follicular cells upon TSH stimulation (Strum and Karnovsky 
1970; Tice and Wollman 1974; Ofverholm and Ericson 1984; Figure 4B). The 
location is optimal as the hormone can be readily stored in the lumen 
immediately after synthesis, and since the cell interior is protected from H2O2 
produced in large amounts. Song and colleagues (Song et al. 2007) suggest the 
existence of a thyroxisome consisting of thyroid peroxidase (TPO) and Duox2, 
described as the iodination complex acting on the thyrocyte apical membrane. 
Figure 4. Thyroid gland structure and physiology. The negative feedback system of 
thyroid hormones and thyroid structure are presented in (A). Hypothalamus secretes TSH 
releasing hormone (TRH) which induces thyroid stimulating hormone (TSH) secretion from 
the anterior pituitary. TSH stimulates thyroid hormone synthesis in the follicular cells (Fc) 
lining the follicle lumen (Lu) filled with colloid. Connective tissue (Co) surrounds each 
follicle. Thyroid hormone T3 from the thyroid gland inhibits hypothalamic TRH secretion 
thus decreasing its own production. Overview of thyroid hormone synthesis is presented in 
(B). a) TSH activates the TSH receptor (-R) on follicular cell basolateral membrane. b) TSH 
controls thyroid specific gene expression and enhances iodine intake. c) Iodide is imported 
from the blood stream by Na/I+ symporter (NIS) and then transported across the apical 
membrane by pendrin and apical I+ transporters (AIT). d) Iodide organification and 
iodotyrosine (MIT, DIT) coupling by thyroid peroxidase (TPO) and dual oxidase (Duox) take 
place at the apical membrane. Iodotyrosines remain bound to thyroglobulin (Tg) and are 
stored in the lumen as colloid. e) Upon stimulation stored hormone-Tg complexes are 
endocytosed into the follicular cell. f) Tg is proteolytically degraded in the endosomes and the 
hormone is freed. g) Finally, T3 and T4 are secreted into the blood stream. (Modified from 
the review by Schlumberger et al. 2007) 
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In fact, the association between TPO and an NADPH oxidase, later identified 
as Duox2, and the change in subcellular location had been established earlier 
(Mizukami et al. 1985; Wang et al. 2005). The thyroxisome will then process 
both iodine and Tg to form the active precursors for hormone synthesis.  
Iodide organification. The first step in thyroid hormone synthesis is the 
acquisition of I-. It is actively and effectively transported into the gland from 
blood stream with the Na+/I- symporter (Dai et al. 1996) on the basolateral 
membrane whose activity is enhanced by stimulation with TSH (Fenton et al. 
2008). Next, I- is transported across the apical membrane into the follicular 
lumen through an anion transporter pendrin (Royaux et al. 2000) where it is 
oxidized by Duox2-derived H2O2 with TPO as catalyst (Taurog et al. 1996). 
Active iodide intermediate then detaches from TPO and attaches covalently to 
specific Tyr-residues on Tg to form mono- and diiodotyrosines (MIT and DIT, 
respectively) in a iodination process (Lamas et al. 1989; Dunn and Dunn 1999; 
Kessler et al. 2008). 
Iodotyrosine coupling. According to the current understanding, the coupling 
process starts by a DIT radical formation catalyzed by TPO and involves 
oxidation of a second H2O2 molecule (Doerge et al. 1994; Taurog et al. 1994). 
The two activated DITs will then couple in a non-enzymatic condensation 
reaction, and rearrange so that T4 will remain attached to the acceptor site on 
Tg. The same scheme applies also to T3 formation from MIT and DIT. 
Hormone secretion. The hormone-containing Tg remains stored in the 
follicular lumen bound to multimeric Tg (Berndorfer et al. 1996) until TSH 
stimulation. The Tg uptake occurs by micropinocytosis and it is packed into 
coated vesicles, which rapidly fuse with early endosomes (Bernier-Valentin et 
al. 1990; Bernier-Valentin et al. 1991). Thyroid hormones are released from Tg 
in the endosomes by selective proteolysis at the hormonogenic sites (Rousset et 
al. 1989b; lett. Molina et al. 1996) and transported to the blood stream. The 
remaining Tg is then transferred to late endosomes and finally to lysosomes 
where the Tg backbone is extensively degraded to small peptide fragments 
(Rousset et al. 1989a; Rousset et al. 1989b; Kostrouch et al. 1991). The thyroid 
gland produces primarily T4 which is then processed into more active T3 by 
deiodinases (reviewed by Bianco et al. 2002; Maia et al. 2005; reviewed by 
Gereben et al. 2008). 
1.2.3. Thyroid hormone dissemination and function 
T3 and T4 circulate in the body bound to one of the three types of carrier 
proteins so that over 99% of each hormone is unavailable for the tissues but 
these negligible amounts are exerting the hormonal activities of the gland 
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(reviewed by Sterling and Lazarus 1977). The amount of circulating T4 is 
markedly higher than that of T3 but the carriers, thyroxine binding globulin, 
thyroxine binding prealbumin and albumin, bind T4 more tightly than T3, and 
therefore the latter is more readily available for tissues (reviewed by Sterling 
and Lazarus 1977). Majority of the circulating T3 derives from the 
deiodination reactions in tissues, mainly liver and kidneys, and a carefully 
maintained equilibrium is kept between free and bound circulating hormones to 
ensure the correct dosage for tissue homeostasis (reviewed by Sterling and 
Lazarus 1977; reviewed by Bianco et al. 2002). 
The thyroid hormones are actively transported into their target tissues by 
specific transporters such as monocarboxylate transporters (MCT) 8 and 10, 
and organic anion transporting polypeptide C1 (reviewed by Visser et al. 2008; 
reviewed by Heuer and Visser 2009). Once inside the cell, most T4 is 
deiodinated by the tissue specific deiodinases into T3 which is considered the 
active form of the hormone with several times higher potency than T4 
(reviewed bys Bianco et al. 2002; Bianco and Kim 2006; Maia et al. 2005). T3 
then binds one of the thyroid hormone receptors which act as transcription 
factors in the nucleus enhancing the target gene expression in many organs and 
tissues (reviewed by Yen 2001). In addition, non-genomic actions have been 
recognized as an important aspect of thyroid hormone signaling (reviewed by 
Davis et al. 2008). They may initiate multiple signaling pathways and nuclear 
events through activation of various signaling kinases, lipases and the well-
known MAPK cascade, and further phosphorylation of several nuclear 
hormone receptors, as well as regulate plasmamembrane ion transporters and 
actin cytoskeleton (reviewed by Davis et al. 2005; Davis et al. 2008).  
In general, the thyroid hormones have a stimulating effect on all organ 
systems in adults and, thus, induce cell proliferation, tissue turnover and 
increased metabolic rate. However, T3 actions usually need several hours or 
even days to take effect due to the long process of hormone internalization, 
translocation to nucleus and modulation of gene expression. During embryonic 
development T3 participates in e.g. tissue patterning and cell differentiation as 
well as brain and skeletal maturation (Butler-Browne et al. 1990; reviewed by 
Konig and Moura Neto 2002; reviewed by Morreale de Escobar et al. 2004; 
reviewed by Gereben et al. 2008). In adult body thyroid hormones keep the 
anabolic and catabolic reactions in balance, and control the many metabolic 
events such as bone formation, muscle function, heat production, activity of the 
nervous and vascular systems, and energy consumption (reviewed by Kerndt et 
al. 1982; Monzani et al. 1997; Lebon et al. 2001; reviewed by Bassett and 
Williams 2003; reviewed by Klein and Danzi 2007). Additionally, the 
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metabolism of other hormones and pharmacological agents can be enhanced by 
the thyroid hormones which may have influence on e.g. fertility, disease 
progression and medication. Interestingly, many of these effects are mediated 
through regulation of the deiodinases by other hormones and growth factors 
(reviewed by Bianco et al. 2002; reviewed by Gereben et al. 2008).   
1.2.4. H2O2 and thyroid gland 
As described in the section 1.2.2. the thyroid hormone synthesis depends on 
the available H2O2 as an oxidizer for I- and later for iodotyrosyl residue 
activation. This H2O2 is not derived from cell metabolism waste but rather 
generated on demand by the Duox2 enzyme after stimulation by e.g. iodide 
(Corvilain et al. 2000). The hormone generating system is relatively sensitive 
to oxidative stress causing a shutdown of I- uptake and organification at 
elevated H2O2 levels (Nadolnik et al. 2008). However, a certain amount of 
oxygen radicals are needed to maintain the thyrocyte function, confirmed by 
the finding that expression of TPO, Duox, Tg, and pendrin are downregulated 
on ROS depletion (Poncin et al. 2009). 
The thyroid follicular cells in adult thyroid gland can live over 7 years 
(Coclet et al. 1989) after a period of rapid proliferation in childhood (Saad et 
al. 2006). During that time the thyrocytes are constantly exposed to heightened 
levels of H2O2 and other oxygen radicals due to the special characteristics of 
the thyroid hormone synthesis. Therefore, they utilize multiple different 
mechanisms to avoid oxidative stress derived damage; these have been recently 
reviewed by Song et al. (Song et al. 2007). Firstly, the exocytosis of vesicles 
containing the thyroxisome components is regulated. It is also activated only 
on the cell membrane forcing the H2O2 production to take place extracellularly. 
Secondly, the Duox2 enzyme requires post-translational modifications and 
Calsium ion binding for full activity besides the exocytosis. Lastly, the 
diffusion of H2O2 itself back to cells is restricted by special lipid raft-like 
membrane structures, and efficient intracellular H2O2 scavenging systems 
including the GPx, thioredoxin reductase, catalase, and Prx1 and 2 (Ekholm 
and Bjorkman 1997; Howie et al. 1998; Kim et al. 2000). 
Due to their homeostatic effects the thyroid hormones can affect the 
oxidative status of the body. Hyperthyroid tissues suffering from excessive T3 
exposure are known to be under increased oxidative stress as determined by 
higher levels of oxidized lipids and abnormal expression pattern of antioxidant 
enzymes (Venditti et al. 1997; Rybus-Kalinowska et al. 2008). Thyroid 
hormones can enhance tissue susceptibility to oxidative damage by increasing 
the expression of radical formation promoting cytokines and enzymes, 
impairing the global cellular antioxidant systems, affecting the lipid 
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composition of tissues enhancing their predisposition to oxidation, and 
accelerating mitochondrial functions (reviewed by Venditti and Di Meo 2006). 
Thus, hyperthyroidism has a distinct exacerbating effect on many hepatic, 
muscular and cardiovascular diseases which as such burden the tissues by 
heightened oxidative stress (reviewed by Venditti and Di Meo 2006).  
1.2.5. Thyroid disorders 
1.2.5.1. Hypothyroidism and hyperthyroidism 
Hypothyroidism develops in the absence of thyroid hormones leading to 
overall slow metabolic rate of the organism, and it can vary from mild to 
severe according to the extent of hormone deficit. The endogenous disease can 
be classified into primary (thyroid failure), secondary (lack of pituitary TSH or 
hypothalamic thyrotropin releasing hormone), or peripheral tissue resistance 
induced hypothyroidism (reviewed by Topliss and Eastman 2004). Various 
genetic disorders producing e.g. defective hormonogenesis or thyroid response 
to TSH, or dysfunctional thyroid hormone receptors are often found in 
hypothyroid patients (reviewed by Gillam and Kopp 2001; reviewed by Kopp 
2002). Hashimoto‟s thyroiditis is a common hypothyroid disorder 
characterized by expression of TSH-R blocking autoantibodies (reviewed by 
Bindra and Braunstein 2006). Additionally, there are numerous environmental 
factors such as exposure to irradiation, geographic location determining the 
iodine intake, age, microbial infections inducing thyroiditis, and 
pharmacological agents and treatments which may include radioisotope 
imaging or drugs affecting the hormone syntheses (reviewed by Topliss and 
Eastman 2004). However, dietary iodine deficiency remains as the main cause 
for hypothyroidism in the world although use of iodized salt in diet has reduced 
the occurrence of the disease tremendously in developed countries (reviewed 
by Topliss and Eastman 2004). 
Hyperthyroidism is the hyperactive state of the thyroid gland and is 
characterized by overproduction of the thyroid hormones. Untreated 
hyperthyroidism leads to thyrotoxicosis which is a syndrome resulting from 
tissue exposure to large amounts of thyroid hormones by any cause. However, 
the terms are often used interchangeably. Common causes for thyrotoxicosis 
include the Grave‟s disease with stimulating autoreactive TSH-R antibodies, 
autonomous nodular adenomas, multinodular goiter and follicular carcinoma 
capable of hormone production, and different types of thyroiditis (reviewed by 
Topliss and Eastman 2004). Congenital non-autoimmune hyperthyroidism is 
generally characterized by activating mutations in the TSH-R or any of the 
components in the downstream proliferative cyclic AMP (cAMP) cascade 
(reviewed by Duprez et al. 1998; reviewed by Yen 2000). Of environmental 
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factors, excess iodine is capable of inducing hyperactivity in autonomously 
functioning thyrocytes e.g. within a nodule (reviewed by Roti and Uberti 
2001). 
Due to the wide-scale effects of the thyroid hormones their deficiency or 
excess will lead to systemic symptoms affecting the functionality of most 
organs. In newborns and children hypothyroidism causes mental and growth 
retardation, and nervous system abnormalities (reviewed by Gruters et al. 
2003). In adult patients it causes, in addition to frequent goiter, e.g. lower 
cardiac output and respiratory rate, skin conditions, gastrointestinal 
dysfunction, slower renal filtration rate, anemia, neuromuscular complications 
and depression (Holdsworth and Besser 1968; Das et al. 1975; Duyff et al. 
2000; reviewed by Yen 2001; reviewed by Guha et al. 2002; Almeida et al. 
2007; reviewed by Klein and Danzi 2007; Artantas et al. 2009; reviewed by 
Iglesias and Diez 2009). In hyperthyroidism the symptoms are quite the 
opposite. The most evident are weight loss and sensitivity to heat due to 
increased metabolism, muscular and neuronal dysfunction such as weakness 
and numbness, accelerated gastrointestinal and renal function, heart 
arrhythmias and palpitations, and various psychiatric conditions such as 
restlessness and depression (Wegener et al. 1992;  Duyff et al. 2000; reviewed 
by Yen 2001; reviewed by Silva 2003; reviewed by Klein and Danzi 2007; 
reviewed by Peiris et al. 2007; reviewed by Iglesias and Diez 2009). 
Additionally, goiter is a frequent finding especially in the presence of 
stimulating autoantibodies but is also present as hyperplastic nodules (reviewed 
by Topliss and Eastman 2004).  
1.2.5.2. Thyroiditis 
Thyroiditis comprises several inflammatory syndromes affecting the thyroid 
gland, and they can broadly be divided into painless and painful disorders 
(reviewed by Bindra and Braunstein 2006). Painless diseases are Hashimoto‟s, 
postpartum, drug-induced and Riedel‟s fibrotic thyroiditis which generally 
have an autoimmune origin. Hashimoto‟s thyroiditis is the most common form 
of thyroiditis, and like the other autoimmune thyroid disorders it is 
characterized by a high titer of antibodies mainly for TPO and Tg and 
infiltration of immune cells (reviewed by Pearce et al. 2003). Autoimmune 
types have a complex multifactorial origin including genetic and environmental 
factors (reviewed by Dayan and Daniels 1996; reviewed by Burek and Rose 
2008). On the other hand, thyroiditis resulting from a microbial infection, 
tissue trauma or exposure to radiation often causes pain in the thyroid gland. 
Painful thyroiditis types are rather rare since the thyroid gland is well-protected 
from exogenous hazards (reviewed by Bindra and Braunstein 2006). As with 
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many other thyroid diseases, women are more susceptible to the autoimmune 
disease but the painful forms are equally presented in both sexes (reviewed by 
Pearce et al. 2003). 
Common findings in the various types of thyroiditis are hypo- or 
hyperthyroidism, or possibly both. The inflammation or other destructive 
events cause a release of T3 and T4 from the gland and thus promotes 
hyperthyroidism until the stores are depleted and the patient becomes 
hypothyroid (reviewed by Pearce et al. 2003). Thyroiditis may destroy the 
thyroid gland permanently and eventually induce hypothyroidism for which 
suitable T4 administration is needed (reviewed by Pearce et al. 2003). Goiter is 
also involved in most types of thyroiditis with elevated TSH levels (reviewed 
by Bindra and Braunstein 2006). Long-term inflammation associated with e.g. 
Hashimoto‟s thyroiditis may predispose the patients to development of thyroid 
lymphomas (Holm et al. 1985; Kato et al. 1985). 
Inflammatory reaction increases the oxidative stress in the tissues, and the 
main sources of ROS are dysfunctional mitochondria and the phagocytic 
immune cells. Elevated ROS has also been associated with thyroiditis, and may 
participate in the exacerbation of the inflammation by promoting ICAM 
expression and subsequent leukocyte infiltration (Sharma et al. 2008). Another 
factor increasing the ROS load of thyroid is iodine which is known to enhance 
thyroid hormone synthesis and thus H2O2 production. Excess dietary or drug-
derived iodine can therefore induce thyroiditis and subsequent hypothyroidism 
in genetically susceptible persons (reviewed by Burek and Rose 2008). 
1.2.5.3. Goiter 
The most evident symptom in many hypo- and hyperthyroidism conditions 
is an enlarged thyroid gland, or goiter. They are present in multiple forms and 
differ in their function regarding the hormone generation and secretion. 
According to the appearance goiters can be classified into diffuse or nodular 
forms. Diffuse goiters are evenly enlarged producing a clearly visible swelling 
in front of the neck whereas nodular goiters have one or more nodules present 
in one or both lobes of the gland. Functionally goiters are broadly classified 
into toxic and nontoxic goiters. Toxic goiters produce excessive amounts of the 
thyroid hormones, and thus expose the patient to hyperthyroid state. Nontoxic 
goiters are characterized by normal or low thyroid hormone production instead. 
Goiter is the most common thyroid disorder in populations all over the 
world. More than 1.5 billion people live in iodine-deficient areas, including 
many European regions, and are therefore at risk of developing the disorder 
(Delange 1995). Dietary iodine deficiency presents the most eminent cause for 
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the disorder worldwide (Delange 1994). Other dietary factors include certain 
goitrogenic plants, cobalt salt and excess iodine (reviewed by Dobyns 1969; 
Delange 1994). However, genetic factors seem to have a major role in 
predisposition to goiter in females and environmental factors have been 
suggested as the final switch determining the formation of goiter (Brix et al. 
1999). The genetic factors include a number of mutated enzymes and other 
proteins in the thyroid hormone generating system such as Tg (Ieiri et al. 1991; 
Caputo et al. 2007), NIS (reviewed by Pohlenz and Refetoff 1999), pendrin 
(Everett et al. 1997; Coyle et al. 1998), TPO (Kotani et al. 1999; Santos et al. 
1999), and Duox (Varela et al. 2006) which impair the normal hormonogenesis 
thus increasing TSH. Gender and age have been found to correlate with the 
development of goiter and further malignancies so that women and elderly 
people are at higher risk (Giles Senyurek et al. 2008; Morganti et al. 2005). 
Additionally, smoking and pregnancy appear to contribute to goiter if there is 
underlying iodine deficiency since thiocyanate in cigarette smoke inhibits 
normal iodine transport and organification, and the thyroid function changes 
during gestation increasing the need for iodine (reviewed by Glinoer 1997; 
Colzani et al. 1998; Knudsen et al. 2002). Additionally, microbial infections 
and thyroiditis may induce abnormal growth of the gland but this is rather rare 
(reviewed by Hamburger 1986; reviewed by Desailloud and Hober 2009). 
Thyroid growth is regulated by the hypothalamic-hypophysial-thyroid axis 
which secretes the hormones thyrotropin releasing hormone and TSH, and  
elaborate negative feedback signaling system which keeps the thyroid hormone 
levels within narrow limits (reviewed by Chiamolera and Wondisford 2009). 
The ultimate cause of goiter differs in different thyroid disorders (reviewed by 
Dumont et al. 1992). In congenitally hypothyroid patients, defects in thyroid 
hormone production and I- metabolism remove the negative feedback effect of 
T3 on hypothalamus and pituitary and, thus, promote the release of thyrotropin 
releasing hormone and TSH which stimulate thyrocyte proliferation. Similar 
T3 downregulation is caused by antibodies against TPO or TSH-R in 
Hashimoto‟s thyroiditis. Additionally, thyroidal I- depletion removes the 
negative effect of I- on proliferation and sensitizes the gland for the stimulatory 
effect of TSH. The origin of sporadic goiter, i.e. occurring without evident 
congenital factors, remains elusive but iodine deficiency and genetic defects 
have been suggested (Agerbaek 1974; Brix et al. 1999). Finally, goiter 
associated with Grave‟s disease, the most common cause for hyperthyroidism, 
is induced by stimulating antibodies for the TSH-R which activates the 
proliferative pathway. 
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Goitrous thyroid gland with elevated T4 and T3 levels is usually subject to 
increased oxidative stress (Sugawara et al. 1988; Poncin et al. 2008a; Rybus-
Kalinowska et al. 2008). However, in goiter patients with normal levels of 
thyroid hormones the oxidative stress does not seem to be elevated, unlike in 
cancerous thyroid tissue where lipid peroxidation indicating such stress was 
significantly higher (Sadani and Nadkarni 1996). Oxidative stress attracts 
leukocytes which respond to the inflammatory stimuli from thyroid tissue 
during gland involution but, interestingly, a non-growing goiter does not harbor 
inflammatory cells (Poncin et al. 2008a). Furthermore, thyrocytes inhibit their 
own functions by secreting the major inflammatory cytokines IL-1, IFN-γ and 
TNF-α and, thus, reducing their own hormone generation, growth and 
proliferation (Rasmussen et al. 1993; Tang et al. 1995; Gerard et al. 2006; Yu 
et al. 2006; Poncin et al. 2008b; Makay et al. 2009).  
1.2.5.4. Toxic adenoma and thyroid cancers 
Toxic thyroid adenomas are commonly benign, capsulated, and slow-
growing tumors capable of autonomous thyroid hormone generation at variable 
levels (reviewed by Dumont et al. 1992; reviewed by Duprez et al. 1998). They 
present usually as single nodular neoplasia or goiter and are “hot” referring to 
their capability of metabolizing iodine as verified in radiographs after infusion 
of radioactive iodine isotope (reviewed by Dumont et al. 1992). As most 
thyroid diseases it is more prevalent in women and elderly people, especially in 
areas where dietary iodine is scarce (Giles Senyurek et al. 2008). 
Autonomously functioning adenomas suppress TSH production from the 
pituitary and therefore the normal thyroid tissue appears quiescent and 
atrophied (reviewed by Dumont et al. 1992; reviewed by Reid and Wheeler 
2005). The suppressed thyroid tissue may harbor “cold” nodules incapable of 
iodine metabolism but with increased risk for later malignant transformation 
(Giles Senyurek et al. 2008). If the adenoma is large enough and the iodine 
supply is sufficient it may cause hyperthyroidism and thyrotoxicosis with the 
symptoms described above (Ermans and Camus 1972). 
The origin of toxic adenomas has been under thorough investigation. The 
formation of monoclonal nodules is characteristic of toxic adenomas, and they 
arise commonly from various somatic mutations (Hicks et al. 1990; Namba et 
al. 1990a). Several studies have revealed mutations in the TSH-R which render 
it constitutively active and thus continuously stimulate thyrocyte proliferation 
(reviewed by Duprez et al. 1998; reviewed by Polak 1999). Some studies also 
suggest the activation of one of the TSH-R regulated G-proteins, Gαs, but it is 
likely to have lesser impact on the prevalence of toxic adenoma (Lyons et al. 
1990; Parma et al. 1997; Trulzsch et al. 2001). Additionally, Ras oncogene 
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mutations have been indicated in some adenomas (Namba et al. 1990b). 
Ultimately, activation of either TSH-R or Gαs leads to increase in cytosolic 
cAMP which controls the signaling cascade promoting thyrocyte proliferation 
(reviewed by Vassart and Dumont 1992; Corvilain et al. 1994). It has been 
suggested that low-iodine induced initial increase in circulating TSH would 
select a subset of thyrocytes more sensitive to TSH stimulation due to the 
existing activating mutations (Laurberg et al. 1991; reviewed by Porcellini et 
al. 1997b; Trulzsch et al. 2001). This would also account for the high incidence 
of toxic adenomas in areas where iodine is scarce (Laurberg et al. 1991). 
Several types of cancer are prevalent in the thyroid gland. They are broadly 
divided into papillary, follicular, medullary, and anaplastic carcinomas by 
appearance in histology. Papillary carcinoma (PTC) is the most prevalent 
(70%) followed by follicular (17,3%), medullary (3,2%), and anaplastic (2,3%) 
types (Correa and Chen 1995) and, interestingly, PTC incidence has grown 
rapidly over the past three decades as the others have stayed at the same level 
(Davies and Welch 2006). Nevertheless, typically only 5% of all thyroid 
nodule cases prove malignant (reviewed by Riesco-Eizaguirre and Santisteban 
2007). The less aggressive forms, PTC and follicular carcinoma, have higher 
incidence in women but the more aggressive ones have nearly equal 
distribution among the sexes (Correa and Chen 1995). PTC is the least 
aggressive form with only rare occasions of metastasis and the patients have a 
very high survival rate whereas 40% of anaplastic thyroid carcinoma patients 
have metastasis with very poor survival rate (Correa and Chen 1995). 
Approximately 5-10% of PTC patients have familial predisposition (reviewed 
by Kouniavsky and Zeiger 2009). 
Most thyroid cancers originate from single cells harboring mutations in the 
critical growth regulating genes. Characteristically, in thyroid tissue the 
misregulated genes are involved in the TSH-R downstream pathways and 
induce abnormal proliferation (reviewed by Rivas and Santisteban 2003). 
Among them are many growth and apoptosis regulating genes commonly 
mutated in other cancers such as Ras small GTPases, phosphoinositide 3-
kinase (PI3K) and various protein kinases (reviewed by Rivas and Santisteban 
2003). There are also a number of thyroid specific genes, e.g. NIS, TPO and 
pendrin, whose strong downregulation upon malignant transformation cause 
deficiencies in the most important thyroid functions, namely iodide uptake and 
organification (reviewed by Schlumberger et al. 2007). Therefore, malignant 
thyroid nodules are often “cold” and discharge radioiodine which renders them 
resistant to this therapeutic intervention (reviewed by Schlumberger et al. 
2007). However, in addition to various genetic mutations and chromosomal 
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rearrangements, numerous other mechanisms have been associated with 
thyroid cancer initiation such as epigenetic silencing, alternative mRNA 
splicing and even microRNAs (reviewed by Kouniavsky and Zeiger 2009). 
1.3. Signaling pathways in cell proliferation 
1.3.1. Ras and PI3K mitogenic pathways 
The Ras small GTPase is utilized by most receptor tyrosine kinases (RTK) 
to mediate the signal from cell exterior to extracellular signal-regulated kinases 
(Erk) which are the principal mitogenic regulators in many cell types (Figure 
5). In a multitude of studies Ras has been shown to be activated by such factors 
as oxidative stress and H2O2, NO, growth hormones, the inflammatory 
cytokines TNF-α and IL-1, and growth factors (Lander et al. 1995; Lander et 
al. 1996; Aikawa et al. 1997; Auer et al. 1998; Page et al. 1999; Matsumoto et 
al. 1999; Palsson et al. 2000; Caraglia et al. 2003). Several receptors, such as G 
protein coupled receptors (GPCR) and tyrosine kinase receptors (RTK) activate 
Ras. The tyrosine kinase receptor activation and dimerization induces its 
autophosphorylation and binding of various enzymes, adapter proteins, and 
docking proteins which facilitate the propagation of sequential 
phosphorylations in the Ras downstream cascade (reviewed by McKay and 
Morrison 2007).  
The classical Ras activation route initiates as inactive Grb2/Sos guanine 
nucleotide exchange factor (GEF) complex is recruited from cytosol to the 
phosphorylated receptor or associated docking proteins (Figure 5). Moreover, 
Ras activation occurs through different protein assemblies depending on the 
intracellular location e.g. Golgi, endoplasmic reticulum, or endosomes (Burke 
et al. 2001; Chiu et al. 2002; Jiang and Sorkin 2002). The GEF enzymes 
catalyze the GDP>GTP exchange thus activating Ras. Next, GTPase activating 
proteins (GAP) induce the Ras GTPase activity and GTP>GDP hydrolysis 
which enables the signal propagation forward from active Ras. They are in turn 
regulated by e.g. intracellular Ca2+ released on receptor activation or 
phosphatidyl-inositols (Lockyer et al. 1999; Walker et al. 2004; Kupzig et al. 
2005). 
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One of the most prominent and extensively studied signaling networks 
downstream of Ras is the extracellular signal regulated kinase (Erk) 1/2 MAPK 
pathway (Figure 5). Two other MAPK families include JNK 1, 2 and 3, and 
p38 α, β, γ and δ isoforms (reviewed by Chen et al. 2001; reviewed by Raman 
et al. 2007). The MAPKs lay at the end of a phosphorelay cascade starting 
from MAP kinase kinase kinases (MAP3K) such as MEKKs which 
phosphorylate their specific MAP kinase kinases (MAP2K), the MEKs. The 
multiple functions of the MAPK pathways are enabled by highly coordinated 
regulation of the numerous MAP3Ks and MAP2Ks, and by direct regulation of 
the MAPKs themselves. Erk1/2 are in general contributing to e.g. mitogenesis 
and cell division, differentiation, motility, and survival, while JNK and p38 are 
often activated by various stress factors and lead to cytokine production, 
inflammatory response, transformation, apoptosis, and necrosis (reviewed by 
Davis 2000; reviewed by Chen et al. 2001; Zarubin and Han 2005). 
Figure 5. Ras-Erk1/2 and 
PI3K/Akt pathways. Various 
external factors can activate 
RTKs and GPCRs. Stimulated 
RTK (left) binds Grb2/SOS 
complex which induces Ras GTP 
binding. Ras initiates a 
phosphorylation cascade on Raf, 
MEK1/2 and Erk1/2 that 
ultimately results in gene 
expression and various cellular 
responses. A number of scaffold 
proteins bind some or all of the 
three kinases thus conferring 
specificity to the signaling event. 
Both RTKs and GPCRs (right) 
can induce PI3K activation and 
PIP3 second messenger 
generation which results in 
mTOR activation through Akt 
and TSC1/2, and changes in cell 
function. H2O2 derived from the 
Nox system inactivates PTEN, 
an inhibitor of PIP3 signal 
transduction, thus promoting 
signal intensity and duration. 
Additionally, the two pathways 
may interact at several points 
(blue arrows). 
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All Ras family members can bind and activate directly the Raf MAP3 
serine/threonine kinases which are the principal MAP3 kinases on the Erk 
pathway (Figure 5). The intricate multistep process of assembling the 
functional Raf complex has been reviewed by McCubrey et al. 2006 and 
McKay and Morrison 2007. Ras induced heterodimerization of two Raf 
isoforms seems to be essential for their full activation and subsequent MEK 
phosphorylation (Weber et al. 2001; Garnett et al. 2005; Rushworth et al. 
2006). Activated Raf and its downstream kinases MEK and Erk bind various 
scaffold proteins that regulate their interaction with other cascades and 
determine their subcellular localization, e.g. kinase suppressor of Ras (KSR) 
targets the complex to plasma membrane whereas paxillin is an integral part of 
focal adhesions (reviewed by Kolch 2005; Figure 5). In general, scaffold 
proteins are main determinants where in the cell the pathway is activated, and 
thus on the set of target genes expressed leading to specific changes in cellular 
properties. The scaffold proteins also enhance signal transduction as they bring 
the kinases in close contact and increase the signal duration (reviewed by 
Kolch 2005; reviewed by Dhanasekaran et al. 2007).  
In contrast to the complex activation process of Raf, MEK and Erk 
activation by Raf and MEK, respectively, is a simple phosphorylation event of 
serine/threonine and tyrosine residues in their kinase domains (Payne et al. 
1991; Zheng and Guan 1994). The MEK dual specificity kinase family consists 
of at least seven members named MEK1 through MEK7. MEK1 and 2 have 
specificity for Erk1/2, MEK2 being the most potent activator and MEK1 
having a more modest effect (Zheng and Guan 1993). The other MEKs are 
associated with the activation of p38 and JNK in stress responses (reviewed by 
Kyriakis and Avruch 2001; Raman et al. 2007). In addition to Erk1/2 
phosphorylation, MEK1/2 has been suggested to regulate nuclear localization 
of both active and inactive Erk1/2. The nuclear export signal (NES) on 
MEK1/2 and a similar sequence in Erk2 retain the MEK/inactive Erk complex 
in the cytosol until the upstream pathway is stimulated by mitogens leading to 
MEK-dependent Erk activation (Jaaro et al. 1997; Fukuda et al. 1997; 
Rubinfeld et al. 1999). In the nucleus MEK/Erk complex then dissociates, and 
MEK returns quickly back to cytosol driven by the NES. However, there is 
also evidence for constant unregulated MEK traffic in and out of the nucleus 
coexisting with the regulated traffic (Yao et al. 2001). 
Active MEK1/2 phosphorylates conserved tyrosine and threonine residues 
on Erk1/2 inducing its full activation, dimerization and nuclear translocation 
(Canagarajah et al. 1997; Khokhlatchev et al. 1998; reviewed by Cobb and 
Goldsmith 2000; reviewed by Pearson et al. 2001). Active Erk1/2 generally 
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dissociates from the MEK1/2 and the scaffold, and is then either diffused freely 
or transported to the target site by an unknown mechanism (Gonzalez et al. 
1993; Lenormand et al. 1998; Rubinfeld et al. 1999). The Erk binding to the 
target is mediated by binding motifs, two very common being the docking (D)-
domain and docking site for Erk and FXFP (DEF)-domain (Biondi and 
Nebreda 2003; reviewed by Zhang and Dong 2007). Duration of the signal is 
crucial in determining the outcome of Erk1/2 signaling (Marshall 1995), and in 
addition to the persistence of the original stimulus, Erk1/2 itself regulates its 
own activity. For instance, a positive feedback loop to enhance Raf activation 
(Balan et al. 2006), and inactivation of specific phosphatases (Marchetti et al. 
2005) are generally utilized methods. However, Erk can also exert negative 
feedback by phosphorylating many of its upstream Ras/MAPK cascade 
components, including MEK1/2 (Eblen et al. 2004), Raf (Dougherty et al. 
2005), and SOS GEF (Corbalan-Garcia et al. 1996) or the nuclear MAPK 
phosphatase (MKP)1 (Brondello et al. 1997), thus inhibiting them, and finally 
terminating the original signal. 
Erk1 and 2 are expressed ubiquitously in all cell types and throughout the 
cell. They are associated with a number of plasmamembrane receptors for 
growth factors, cytokines, and GPCR ligands, as well as integrins (Ly and 
Corbett 2005; reviewed by Raman et al. 2007; reviewed by Goldsmith and 
Dhanasekaran 2007). Erk1/2 may also regulate membrane transporters for Na+, 
K+, and glucose (Michlig et al. 2004; Izawa et al. 2005; Lin and Chai 2008) 
reflecting the wide range of cellular activities in which they participate. 
Interestingly, Erk1/2 substrate specificity and, thus, its modulation of the target 
proteins in the nucleus or in cytosol is regulated by the Ras subcellular 
localization and is mediated by the specific scaffold proteins to which it 
anchors along with Raf and MEK (Casar et al. 2009). Furthermore, substantial 
amounts of Erk1/2 is bound to microtubules, adherens junctions and focal 
adhesion sites through paxillin underlining their importance in cell motility and 
cell-cell and cell-matrix contacts (Reszka et al. 1995; Ishibe et al. 2004). 
Erk1/2 has also been found in various mitotic structures associating it 
mechanistically with cell division and cell cycle control (Wang et al. 1997; 
Guadagno and Ferrell 1998; Shapiro et al. 1998; Zecevic et al. 1998).  
Activated Erk1/2 can induce phosphorylation of over 100 target proteins 
distributed in the cytosol and the nucleus (Yoon and Seger 2006). Nuclear 
targets of Erk1/2 are mostly transcription factors whose activity or expression 
or both are mediated by Erk1/2. For instance, the transcription factor AP-1 
subunit c-Fos expression is induced by transcription factor Elk-1, and its 
activation is directly controlled by Erk1/2 phosphorylation (Whitmarsh et al. 
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1995; Chen et al. 1996; Hodge et al. 1998). Other important Erk1/2 regulated 
transcription factors are c-Myc and cAMP responsive element binding protein 
(CREB) resulting in the expression of growth factors, cell cycle regulators, 
cytokines, and apoptotic factors (Arany et al. 2005; reviewed by Meloche and 
Pouyssegur 2007). Outside nucleus Erk1/2 regulated targets include e.g. 
cytoplasmic phosphatases, other kinases and cytoskeletal proteins; at the 
plasmamembrane it controls proteins involved in survival, cell cycle 
progression, cell adhesion and migration (Aikawa et al. 1997; reviewed by 
Pearson et al. 2001; reviewed by Meloche and Pouyssegur 2007; reviewed by 
Ramos 2008; Figure 5). 
The PI3K/Akt pathway carries signals from both RTK and GPCR after 
stimulation by e.g. EGF, PDGF and FGF, and is also induced by oxidative 
stress (Shaw et al. 1998; van Weering et al. 1998). Phosphoinositide 3-kinases 
(PI3K) belong to a family of lipid kinases which phosphorylate 
phosphatidylinositol-4,5-bisphosphate (PIP2) into phosphatidylinositol-3,4,5-
trisphosphate (PIP3), the active signal transducing second messenger. PIP3 
signaling then activates the Nox1 or Nox4 enzymes and subsequent H2O2 
generation by inducing Rac small GTPase phosphorylation (Bae et al. 2000; 
Park et al. 2004). H2O2 is needed for oxidative inactivation of PTEN which 
otherwise dephosphorylates PIP3 disabling the signaling cascade to Akt (Leslie 
et al. 2003; reviewed by Rhee et al. 2005b; Figure 5). Akt (aka protein kinase 
B, PKB), is a downstream effector of PI3K activated by binding to PIP3 and by 
following phosphorylations by PDK1 and PDK2 of which the latter was 
recently identified as mammalian target of rapamycin (mTOR) complex 2 
(reviewed by Scheid and Woodgett 2003; reviewed by Yang and Guan 2007). 
Akt activity is a crucially important survival signal in normal and stressed 
cells and has numerous downstream binding partners (reviewed by Brazil et al. 
2002). A direct target of Akt is tuberous sclerosis complex (TSC) 1/2 which is 
inactivated on phosphorylation, and thus releases the mTOR complex 1 from 
inhibition allowing e.g. activation of p70 ribosomal protein S6 kinase 1 (S6K1) 
and inhibition of eukaryotic initiation factor 4E binding protein (4EBP) 1, thus 
contributing to translation initiation (reviewed by Yang and Guan 2007; 
reviewed by Huang and Manning 2009; Figure 5). Another Akt target is the 
glycogen synthase kinase (GSK) 3 which accounts for the regulation of e.g. 
glucose metabolism, the transcription factors AP-1 and CREB, and is involved 
in development (Cross et al. 1995; reviewed by Weston and Davis 2001). A 
feedback loop inhibits stimulus-activated PI3K/Akt cascade as mTOR/S6K1 
inactivates the insulin receptor substrate (IRS) 1 which transfers the signal 
from RTK to PI3K (Zhang et al. 2003; Harrington et al. 2004; Shah et al. 
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2004). The mTOR complex 1 acts as a key integrator of growth signals as it is 
regulated, in addition to growth factors, by the growth promoting Wnt 
signaling, and the cellular energy levels (Inoki et al. 2003; Inoki et al. 2006). 
There is established mutual modulation between the Ras downstream 
MAPK and PI3K/Akt pathways which confers them partially overlapping 
functions, e.g. in cell survival, but also result in differential cellular outcomes 
(Figure 5). Ras and PI3K have been shown to interact directly by binding each 
other which is essential for normal development as well as tumorigenesis 
(Rodriguez-Viciana et al. 2004; Gupta et al. 2007). Previously, it has been 
known that Akt activation inhibits Raf activation by direct phosphorylation and 
promotes vascular smooth muscle cell differentiation (Rommel et al. 1999). 
Recently, it was found out that constitutively active Raf can in turn inhibit Akt 
through MEK1 and thus induce growth arrest in an in vitro setting (Menges 
and McCance 2008). Both MAPK and Akt pathways have been shown to 
regulate TSC1/2 and subsequent mTOR complex 1 activation (Shaw and 
Cantley 2006; Ma et al. 2005), and thus contribute to e.g. proliferation, 
tumorigenesis, and senescence. Further downstream, the mTOR complex 1 
inhibition by rapamycin upregulates the Erk1/2 pathway through a feedback 
loop involving the S6K1 and PI3K (Carracedo et al. 2008) implying that the 
Akt and MAPK pathways both contribute to cell survival (Figure 5). 
1.3.2. TSH receptor pathway 
Thyroid gland function is dependent on regulation by TSH which stimulates 
it to produce the required amounts of T3 and T4 and secrete them into the 
blood stream when necessary. The TSH signal is received and conveyed by the 
TSH receptor (TSH-R) on the follicular cells, and it is considered the most 
important receptor coordinating thyroid growth and function (Vassart and 
Dumont 1992; Szkudlinski et al. 2002). Also autoimmune antibodies may 
either stimulate or inhibit the receptor. The downstream pathway will then 
launch the hormone synthesis, secretion and follicular cell proliferation in a 
highly controlled manner to avoid excessive exposure of the organism to the 
thyroid hormones (Figure 6). 
In addition to TSH, insulin and IGF-1 as well as other growth factors such 
as EGF, FGF and HGF are important inducers of thyrocyte proliferation 
(Medina and Santisteban 2000; reviewed by Kimura et al. 2001; Figure 6). 
There is large variance in responses to these growth factors between different 
cell lines and animal species; for instance, it has been suggested that TSH 
merely enhances the insulin/IGF-1 derived stimulation of DNA synthesis in rat 
PC clone 3 cell line whereas in human thyrocytes TSH/cAMP is the principal 
inducer (reviewed by Kimura et al. 2001). However, it appears that both TSH 
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and insulin/IGF-1 are required for thyrocyte growth in vivo since growth 
hormone treatment leading to normalized IGF level of patients with deficiency 
in both factors did not induce thyroid growth (Cheung et al. 1996). The 
requirement for both factors has been seen also in vitro according to several 
studies with human, rodent and dog thyroid cell lines (Tramontano et al. 1988; 
Takahashi et al. 1990). Additionally, TSH has been suggested to promote 
thyrocyte growth by inducing autocrine growth factors and growth factor 
receptor expression (Takahashi et al. 1990; Becks et al. 1994; Burikhanov et al. 
1996; Cocks et al. 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The TSH-R is a G-protein coupled membrane-spanning receptor located on 
the basolateral surface of thyrocytes (Parmentier et al. 1989; Nagayama et al. 
1989; Loosfelt et al. 1992). Its post-translational modifications include early 
glycosylation and cleavage after insertion into the plasmamembrane (Misrahi 
et al. 1994). The cleavage process takes place only when the cells have 
established cell-cell contacts (Hai et al. 2008) and are properly glycosylated 
(Misrahi et al. 1994) to ensure that the hormonogenesis occurs only in mature 
follicles. The protease responsible for the cleavage has not been determined 
Figure 6. The TSH receptor 
pathways. TSH-R stimulation 
by various growth factors 
activates the α-subunits of Gs 
and Gq proteins. Gαs induces the 
cAMP dependent pathway 
leading to thyrocyte proliferation 
mainly through PI3K regulated 
Ras and Akt. Gαq mediates the 
activation of PLC dependent 
pathway which promotes Duox2 
activity by Ca2+ release and 
PKC-induced phosphorylation, 
and thus contributes to thyroid 
hormone synthesis. 
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but, for instance, the matrix metalloprotease family member ADAM10 has 
been suggested (Kaczur et al. 2007). Moreover, the receptor is internalized 
upon ligand binding and recycled back to the plasma membrane as the 
hormone ligand is degraded in lysosomes (Baratti-Elbaz et al. 1999). 
The cleavage results in formation of two subunits named A and B which 
remain linked to each other by disulfide bridges (Loosfelt et al. 1992). The 
extracellular subunit A binds the TSH whereas the membrane-spanning subunit 
B is the candidate to interact with two G-proteins, Gs and Gq/11 (Nagayama et 
al. 1991; Allgeier et al. 1994). The G-proteins initiate separate downstream 
pathways referred to as the second messenger cAMP or phospholipase C (PLC) 
dependent pathway (Figure 6). Specific roles in thyroid hormone secretion and 
thyrocyte growth, or Tg iodination and hormone synthesis have been suggested 
for cAMP or PLC pathways, respectively (Corvilain et al. 1994). The decision 
on which pathway is activated appears to depend at least partly on TSH 
concentration so that low TSH can stimulate cAMP pathway but higher 
concentration is needed to induce also PLC pathway activation (Laurent et al. 
1987; Allgeier et al. 1994; Corvilain et al. 1994). 
In thyrocytes and other endocrine cells cAMP is a mitogenic inducer 
(reviewed by Iyengar 1996), and thus results in thyrocyte proliferation, thyroid 
specific gene expression and also I- organification. Additionally, it is required 
for the secretion of the hormone in response to TSH (Corvilain et al. 1994) 
implying that the cAMP and PLC pathways have partly overlapping roles. The 
early steps in the cAMP pathway follow the classical G-protein coupled signal 
transduction pathway in which the Gαs subunit mediates the TSH signal from 
the receptor to adenylate cyclase which then initiates a rapid intracellular 
cAMP production (Figure 6). The role of Gβγ subunit remains elusive in the 
thyroid follicular cell physiology. This branch of the pathway seems to be 
independent of the TSH-R cleavage (Hai et al. 2008). The main downstream 
effector kinases activated by cAMP are protein kinase A (PKA), and PI3K 
which induce further downstream signaling cascades (Cass et al. 1999; Figure 
6) with the help of several modulators also activated by cAMP. 
The regulation of PKA and PI3K is closely interconnected. Direct small G-
protein Rap1 activation by cAMP induces a weak PI3K response which is 
markedly enhanced by the exchange protein activated by cAMP (Epac), and 
PKA-mediated Rap1 phosphorylation as shown by increased phospho-Akt 
formation and cell cycle progression (Tsygankova et al. 2001; Hochbaum et al. 
2008). Simultaneously, Rap1 phosphorylation enables the small GTPase Ras to 
interact with its downstream target Raf (Hu et al. 1999), further stimulated by 
cAMP induced indirect Ras activation (Tsygankova et al. 2000). Additionally, 
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PKA can phosphorylate a PI3K regulatory subunit and promote its binding 
affinity to Ras (De Gregorio et al. 2007). However, the role of Ras in thyrocyte 
proliferation is ambiguous, although at least in rat cell lines it seems to be a 
requirement for cAMP induced proliferation (Ciullo et al. 2001). Studies on 
cAMP and PKA in a rat thyroid cell line and 3T3 fibroblasts revealed that they 
inhibit Raf activation (Hafner et al. 1994; reviewed by Burgering and Bos 
1995), and therefore it seems that cAMP-induced Ras downstream signaling 
cascade is actively directed towards other substrates than Raf and MAPK, a 
strong candidate being guanine nucleotide dissociation stimulator for the Ras-
related protein Ral (RalGDS) (al-Alawi et al. 1995; Miller et al. 1997; Miller et 
al. 1998). This is supported by an earlier finding that MAPK pathway can 
activate independently of cAMP (Saunier et al. 1995). Another study showed, 
however, how IGF-induced cAMP activated PI3K and MAPK pathways in 
parallel (Ariga et al. 2000). 
The mitogenic pathway downstream from PKA and PI3K involves a 
number of transcription factors and signal regulators. The major route for 
cAMP to regulate mitogenic signaling in thyroid is the cAMP response element 
binding proteins (CREB) and modulators (CREM) which function as PKA-
activated transcription factors for genes that contain the CRE in their promoters 
or enhancer regions (Woloshin et al. 1992; Uyttersprot et al. 1999). For 
instance, dominant negative CREB transgene caused marked growth 
retardation and hypothyroidism in mice, and the genes for TSH-R, TPO, Tg, 
and the thyroid specific transcription factors Pax-8, TTF-1 and TTF-2 were 
downregulated (Nguyen et al. 2000) causing deficient iodide metabolism and 
lack of thyroid hormones. Other PKA regulated factors are RalGDS and 
ribosomal protein p70s6 kinase (S6K) 1 which have a prominent role in DNA 
synthesis and mitogenesis (Miller et al. 1997; McManus and Alessi 2002). 
Regulation of thyrocyte proliferation through PI3K is a complex network 
where different original stimuli can induce different downstream cascades. 
IGF-I and cAMP have been shown to regulate the cell cycle progression from 
G1 to S phase through distinct effects on the various PI3K-activated cyclins, 
cyclin dependent kinases and their inhibitors (Fukushima et al. 2008). In 
general, PI3K appears to be the main transducer of proliferative growth factor 
signals in thyrocytes (Coulonval et al. 2000; Saito et al. 2001). Its immediate 
downstream effector is Akt/PKB, and recently the Akt regulated mTOR/S6K1 
pathway was shown to be a prominent route in thyroid follicular cell 
proliferation regulating e.g. the translation of cyclins D1 and D3 (Yeager et al. 
2008). S6K1 activation by PI3K/Akt is apparently independent of PKA (Cass 
et al. 1999).  
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The second major pathway activated upon TSH-R stimulation relies on the 
Gq/11 protein, and results in the PLC-β pathway initiation, thyroid hormone 
synthesis, and also in enhancement of thyrocyte proliferation (Figure 6). In in 
vitro studies of human thyroid, TSH can activate the PLC pathway 
independently of the Gs/cAMP pathway but requires higher TSH 
concentration, and is a slower reaction (Laurent et al. 1987; Allgeier et al. 
1994; Corvilain et al. 1994). The established classical pathway from GPCR to 
PLC applies also in the thyroid gland, and thus activated Gαq subunit directly 
stimulates PLC which then cleaves the phosphatidyl inositol anchored to the 
plasmamembrane and produces the two second messengers, inositol 
phosphates and DAG (reviewed by Ginsberg 1992; Figure 6). The inositol-tris-
phosphate (IP3) then induces the release of Ca2+ from the endoplasmic 
reticulum to the cytosol, and DAG in turn activates the protein kinase C (PKC) 
(reviewed by Ginsberg 1992).  
Production of IP3 and subsequent increase in intracellular Ca2+ 
concentration in response to TSH and various Ca2+ releasing chemicals in 
experimental settings have been found essential for H2O2 generation in thyroid 
hormonogenesis (Deme et al. 1985; Lippes and Spaulding 1986; Raspe et al. 
1991; Figure 6). An important modulator of intracellular Ca2+ content is H2O2 
itself which inhibits further Ca2+ release and thus protects the cell from 
excessive H2O2 production (Tornquist et al. 2000). Additionally, the 
phospholipase A2 and its product arachidonate have been suggested to act 
downstream of the PLC/Ca2+ pathway and promote H2O2 generation (Kimura 
et al. 1995). In addition to Ca2+ mobilization, the adenylyl cyclase function 
and cAMP generation need to be downregulated to avoid mitogenic activity 
during hormone synthesis, although a certain level of cAMP seems necessary 
for the process (Corvilain et al. 1994). Sphingosine 1-phosphate is a putative 
second messenger in a number of signaling pathways (reviewed by Kihara et 
al. 2007), and in thyroid it appears to enhance Ca2+ release and suppress 
adenylyl cyclase activity through different G proteins (Okajima et al. 1997). 
Once in the cytosol, the Ca2+ ions will then bind the EF-hand motifs in Duox1 
and 2 enzymes as a cofactor, and thus promote H2O2 generation (Deme et al. 
1985; Ameziane-El-Hassani et al. 2005).  
The DAG/PKC branch is likewise regulated by multiple factors in synergy 
with the cAMP/PKA pathway and has several functions in thyroid physiology 
(Figure 6). Stimulation of thyroid hormone synthesis by PKC and PKA 
converge in phospholipase D mediated DAG generation to promote and 
increase the duration of PKC activation (Gupta et al. 1995; Ginsberg et al. 
1997). PKC has recently been shown to be responsible for Duox2 
46 
phosphorylation and activation along with bound Ca2+ thus enabling efficient 
hormone synthesis upon TSH stimulation (Rigutto et al. 2009). Additionally, 
PKC in association with cAMP has been implicated in protection of the thyroid 
gland from hazardous autoimmune reactions through enhanced expression of 
the transcription factor signal transducer and activator of transcription (STAT) 
3 which represses the IFN-γ mediated antigen expression (Park et al. 2002; 
Kim et al. 2003). 
Duox 1 and 2 activation and subsequent H2O2 generation is the rate-limiting 
step in the thyroid hormone synthesis (Figure 6). However, in addition to the 
need for cytosolic Ca2+ and phosphorylation, not much is known about their 
regulation. They do not depend on the cytosolic regulatory subunits as the Nox 
enzymes but the respective dual oxidase maturation factors (DuoxA) 1 and 2 
are necessary for their proper translocation from ER to the plasmamembrane 
(Grasberger and Refetoff 2006; Grasberger et al. 2007). A more recent study 
showed that these factors can also determine whether the Duox generates H2O2 
or O2•
- 
(Morand et al. 2009). Insulin was found to upregulate Duox2 mRNA 
expression (Morand et al. 2003) but TSH and TSH-R activation, on the other 
hand, seem to have only a modest effect on the expression level of the Duox 
enzymes in normal or goitrous thyroid gland implying that variations in the 
H2O2 production level in disease are brought on by modulating the enzyme 
activity (Milenkovic et al. 2007). Furthermore, whereas Duox2 is the main 
H2O2 producing enzyme in the human thyroid and is activated by the 
PLC/Ca2+ cascade, Duox1 has a minor role in the normal thyroid and is 
preferentially stimulated by the cAMP/PKA cascade (Rigutto et al. 2009). 
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2 AIMS OF THE STUDY 
The aim of this study was to characterize the signal transduction routes and 
the role of the antioxidative SOD3 enzyme in the thyroid gland, as well as its 
anti-inflammatory and tissue healing promoting features in tissue injuries. 
Thyroid gland itself is dependent on oxygen radical generation for normal 
physiological function which renders it an interesting subject for redox biology 
studies. Ischemia, inflammation, and goiter, on the other hand, are associated 
with increased oxidative stress which may impede tissue healing and produce 
tissue damage at molecular level. Signaling networks around SOD3 are poorly 
known and therefore extensive signaling studies were conducted with the 
prospect of possible therapeutic intervention. More specifically the aims were: 
 
I. Characterization of the role of SOD3 in tissue recovery from 
ischemic damage and inflammation. 
II. Elucidation of the signaling cascades which are regulated by 
SOD3 expression and of the molecular mechanisms that mediate 
its effects in tissue healing and pathogenesis. 
III. Characterization of SOD3 expression and function in normal and 
hyperproliferative thyroid gland. 
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3 MATERIALS AND METHODS 
3.1. Adenovirus production (Manuscript (MS) I&II) 
Complementary DNAs (cDNA) of rabbit sod3 and bacterial β-galactosidase 
were cloned into replication deficient E1-partially-E3-deleted AdBglII virus 
vector and transfected into 293 cells for AdSOD3 and AdLacZ virus 
production in University of Turku Biotechnology Center (see manuscript I for 
references). The titer of the virus stock was 1x10
10
 pfu/ml. 
3.2. Animal models 
All animal experiments were conducted according to the European Union 
guidelines, and approved by the Experimental Animal Committee of the 
University of Turku. The animals had water and food ad libitum. 
3.2.1. Rat hind limb ischemic injury (MS I&II) 
Male Fisher 344 rats (age 4-6 weeks, weight 86-115 g; Harlan, Horst, the 
Netherlands) were divided randomly into groups and followed for 3, 7, 10 or 
14 days after inducing the ischemia. The rats were first anesthetized by 
intraperitoneal injection of fentanyl-fluanisone (Janssen Pharmaceutica, 
Beerse, Belgium) and midazolame (Roche, Basel, Switzerland). Acute 
ischemia was induced by closing surgically proximal femoral artery, lateral 
circumflex femoral artery and distal femoral artery. The SOD3 or LacZ gene 
transfer was done immediately after ligation by intramuscular injection of 
0.5x10
9
 pfu AdSOD3 or AdLacZ in 50 µl of PBS. Uninjured muscle tissue was 
collected for additional control. 
3.2.2. Mouse peritonitis (MS II) 
SOD3 or LacZ gene transfer was done to female Balb/C mice (age 8-10 
weeks; local colony) by intraperitoneal (i.p) injection of 0.5x10
9
 pfu AdSOD3 
or AdLacZ in 200 µl of PBS. After 72 hours peritoneal inflammation was 
induced by i.p. injection of 5% proteose peptone (BD Difco, Sparks, MD) in 1 
ml of PBS complemented with 10 ng of IL-1β (R&D Systems, Minneapolis, 
MN). Control mice were injected i.p. with 50 mg/kg Dexamethasone 
(Oradexon, Organon, Oss, the Netherlands) 30 min before the peritonitis 
induction. Inflammatory cells were collected from the peritoneal cavity 18 
hours after the induction of peritonitis by washing the cavity with 10 ml of 
RPMI complemented with 5 U/ml heparin (Løvens Kemiske Fabrik, Ballerup, 
Denmark). The cells in the lavage were counted, centrifuged onto glass slides 
at 1000 rpm for 5 min (Shandon cytospin 3, Shandon, Pittsburgh, PA), and 
stained with Reastain Diff-Quick (Reagena, Toivala, Finland) for leukocyte 
subtype analysis. 
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3.2.3. Rat PTU-induced goiter (MS III) 
Male Sprague-Dawley rats (age 4-5 weeks; local colony) were given 0.25% 
6-propyl-2-thiouracil (PTU; Sigma-Aldrich, St. Louis, MO) in deionized 
drinking water for 2 weeks ad libitum. The rats were then sacrificed and tissue 
samples from thyroid gland, aorta, heart, kidney and liver were collected, 
weighed, and prepared for histological examination and expression analysis 
with quantitative real-time PCR. 
3.3. Analyses of the in vivo experiments 
3.3.1. Immunohistochemistry 
Muscle samples from rat hind limbs were snap frozen in 2-methylbutane 
(Riedel-de-Haën, Seelze, Germany) cooled with liquid nitrogen. The samples 
were then mounted in optimal cutting temperature compound (Tissue-Tek, San 
Francisco, CA, MS I; Sakura Finetek, Torrance, CA, MS II&III) and cut into 
10 µm sections. 
Frozen muscle tissue sections were stained with von Willebrand Factor 
(vWF; Abcam, Cambridge, UK), Ki67 (DakoCytomation, Glostrup, Denmark), 
3-nitrotyrosine (Millipore, Billerica, MA), CD3 (Serotec, Oxford, UK), and 
CD68 (Serotec, Oxford, UK) antibodies, and counterstained with hematoxylin-
eosin (Sigma-Aldrich, St. Louis, MO).  
X-Gal (Promega, Madison, WI) staining for 6 h at 37C and hematoxylin-
eosin counterstaining (Sigma-Aldrich, St. Louis, MO) were performed to 
assess the transduction efficiency of the adenoviral gene transfer into muscle 
tissue. Dihydroethidium bromide staining was performed as described 
previously (Zanetti et al. 2005) on freshly cut sections to detect the ROS, and 
the proportion of DHE-positive vs. total nuclei was determined. (MS I)  
The size of the inflammatory area, i.e. the area with infiltrated CD68+ cells, 
and number of positively stained CD3 and CD68 cells were determined from 
total sections with Zeiss Axiovert 200M (Carl Zeiss, Oberkochen, Germany). 
(MS II) 
Thyroid glands from PTU treated rats were similarly processed into 10 µm 
sections and stained with hematoxylin-eosin (Sigma-Aldrich, St. Louis, MO). 
(MS III) 
3.3.2. PET imaging (MS I) 
In vivo glucose metabolism in the injured hind limbs at 10-day time point 
was analyzed by positron emission tomography as described (see manuscript I 
for reference). Frozen muscle tissue samples were cut into sequential 30 µm 
sections onto glass slides, exposed to imaging plate (Fuji, Tokyo, Japan) and 
scanned with Fuji Analyzer (Fuji, Tokyo, Japan). 
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3.4. Cell cultures and in vitro experiments 
3.4.1. Culture conditions and transfections 
Human embryonic kidney (HEK) 293 cells were cultured in Dulbecco‟s 
modified Eagle‟s medium (DMEM) supplemented with 10% fetal bovine 
serum, 2 mmol/l L-glutamine, and 100U/ml penicillin-streptomycin. The 
thyroid follicular cell line PC Cl3 is derived from Fisher 344 rats, and is 
maintained in Coon‟s modified Ham F12 medium (Sigma-Aldrich, St. Louis, 
MO) supplemented with 5% calf serum (Life Technologies Inc., Paisley, PA), 
and a hormone mix (Fusco et al. 1987) including 10 nmol/l thyrotropin (TSH), 
10 nmol/l hydrocortisone, 100 nmol/l insulin, 5 µg/ml transferrin, 5 nmol/l 
somatostatin, and 20 µg/ml glycyl-histidyl-lysine (Sigma-Aldrich, St. Louis, 
MO). Plasmid transfections were made by Polyfect (Sigma-Aldrich, St. Louis, 
MO) or FUGENE-6 (Roche Applied Science, Indianapolis, IN) according to 
the manufacturer‟s protocols for each reagent. 
3.4.2. HEK 293T and PC Cl3 transfections and incubations (MS I&III) 
For signaling studies HEK 293T cells were transfected with 5 µg of SOD3, 
both SOD3 and catalase, Ras, BRaf, MEK1, Erk1, or Akt. Another set of 
transfected cells was incubated in serum free medium containing 20 µmol/l 
MEK inhibitor UO126 (Sigma-Aldrich, St. Louis, MO), 20 µmol/l 
diphenyleneiodonium (DPI; Sigma-Aldrich, St. Louis, MO), 50 µmol/l NADP 
(Sigma-Aldrich, St. Louis, MO) or 500 µmol/l H2O2 (Sigma-Aldrich, St. 
Louis, MO) for 6 hours. Samples were then collected for Ras-pulldown, 
western blotting, luciferase assay, SOD activity measurements, and 
quantitative real-time PCR. 
To assess the effect of TSH-R pathway activation on SOD3 expression PC 
Cl3 cells were incubated in serum free medium with 1 mU/ml TSH or 40 
µmol/l adenylate cyclase inhibitor forskolin (both Sigma-Aldrich, St. Louis, 
MO), 1 µmol/l PKA inhibitor N(2-((-Bromocinnamyl)amino)ethyl)-5-
isoquinoline-sulfonamide (H89) (both Calbiochem, San Diego, CA), or 0.5 M 
thapsigargin (Research Biochemicals International, Natick, MA). TSH-R 
pathway signaling molecules Gαs-protein, Gαq-protein, and PKA in pCEF-
expression vector were transfected into PC Cl3 cells using 5 µg of each 
plasmid. Samples were collected for quantitative real-time PCR and western 
blotting. 
3.4.3. Ras-pulldown assay (MS I) 
After transient transfection with 5 µg of SOD3, control vector, or signaling 
molecules the HEK 293T cells were lysed in the lysis buffer containing 50 
mmol/l HEPES pH 7.5, 150 mmol/l NaCl, 10% glycerol, 1% Triton X-100, 1 
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mmol/l EGTA 1.5 mmol/l MgCl, 10 mmol/l NaF, 10 mmol/l Na 
pyrophosphate, 1 mmol/l Na3VO4, 10 µg approtinin/ml, 10 µg leupeptin/ml 
(Sigma-Aldrich, St. Louis, MO). The supernatants were incubated with the 
GST-Raf1-RBD beads for 15 min at 4°C. The beads were then washed with the 
lysis buffer, and prepared for western blot analysis. Active Ras was detected 
with anti-Ras antibody (Millipore, Billerica, MA). Frozen muscle tissue 
samples were homogenized in the lysis buffer and treated similarly to 
determine in vivo Ras activation. 
3.4.4. Luciferase reporter gene assay (MS I&II) 
Luciferase reporter vectors pAP1-Luc, pCRE-Luc, pFA2-cJun-Luc, and 
pNFκB-Luc (all Stratagene, Cedar Creek, TX) were transfected into HEK 293T 
cells with SOD3 or control vector. The luciferase bioluminescence was 
detected with Tecan Ultra XFluor4 Fluorescence Reader (Tekan, Mannedorf, 
Switzerland). 
3.4.5. SiRNA and BrdU labeling (MS III) 
PC Cl3 cells were transfected with 20 nmol/l of sod3 or control gapdh 
OnTargetplus SMART Pool oligos according to the manufacturer‟s protocol 
(Dharmacon, Lafayette, CO). Briefly, the oligos were resuspended in 100 µl of 
transfection buffer, mixed with the same volume of Optimem (Life 
Technologies, Carlsbad, CA) and incubated at room temperature for 5 minutes. 
For transfection solution, 5 µl of Dhermofect 4 reagent was added to 190 µl of 
Optimem and incubated at room temperature for 5 minutes. These two 
solutions were then combined, incubated at room temperature for 20 minutes 
and added dropwise to the cells for 48 hours, after which total RNA was 
isolated. 
The 5‟bromo-3‟deoxyuridine (BrdU) Labeling and Detection Kit I 
(Boehringer Mannheim, Mannheim, Germany) was used to determine the DNA 
synthesis rate of the siRNA transfected cells. Briefly, the cells cultured on glass 
coverslips were starved for 16 hours in serum free medium and then stimulated 
with TSH for 6 hours after which BrdU (10µM) was added for 2 hours. The 
cells were then fixed with 3% paraformaldehyde (Sigma-Aldrich, St. Louis, 
MO) and permeabilized with 0,2% Triton-X100 (Sigma-Aldrich, St. Louis, 
MO). BrDU was detected by labeling with FITC conjugated antibodies 
(Jackson ImmunoResearch Laboratories Inc., West Grove, PA). Lastly, the cell 
nuclei were labeled with Hoecst (1 µg/ml; Sigma-Aldrich, St. Louis, MO), and 
mounted on microscopic slides. The minimum of 300 cells were counted on 
different microscope fields and the percentage of BrdU stained nuclei was 
calculated. 
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3.4.6. Calcium uptake assay (MS III) 
Intracellular Ca2+ concentration ([Ca2+]) was measured from PC Cl3 cells 
after thapsigargin treatment. Briefly, the cells were detached from culture plate 
using PBS/5 mmol/l EDTA, washed with HEPES-buffered medium (HBM; 
137 mmol/l NaCl, 5 mmol/l KCl, 1 mmol/l CaCl2, 0.44 mmol/l KH2PO4, 4.2 
mmol/l NaHCO3, 10 mmol/l glucose,
 
20 mmol/l HEPES, and 1.2 mmol/l 
MgCl2, pH 7.4), and loaded with 2 µmol/l fura-2 acetoxymethyl ester at 37 °C 
for 20 minutes. Then the cells were diluted with HBM without Ca2+ to final 
concentration of 0.3 mmol/l CaCl2 and stored at room temperature. Cellular 
Ca2+ content was monitored with a Hitachi F-2000 fluorescence 
spectrophotometer at 340 nm (excitation) and 505 nm (emission). For this 
measurement, an adequate amount of cells were spinned down, washed with 
and resuspended in HBM, and put in a thermostatted (37ºC) cuvette with 
magnetic stirring. Calibration was done with 60 µg of digitonin/ml (Fmax) and 
10 mmol/l EGTA (Fmin). The intracellular [Ca
2+
] was calculated from the 
fluorescence (F) using the equation [Ca
2+] = (F−Fmin)/( Fmax−F) × 224 nmol/l 
(Kd for fura-2), in which the extracellular fura-2 fluorescence was subtracted 
from F values. 
3.4.7. Assays for O2•- and H2O2 detection (MS III) 
Cos-7 monkey kidney cells were first cotransfected with Duox2 and 
DuoxA1 or DuoxA2 maturation factors, or in combination with SOD1 or 
SOD3. 
O2•
- 
release in extracellular space was determined by a chemiluminescence 
assay using the Diogenes reagent (National Diagnostics, Atlanta, GA) which is 
inhibited by superoxide dismutases. The cells were resuspended in HBSS + 10 
mmol/l glucose, and 1 µmol/l ionomycin was added to stimulate Duox activity. 
The cells were then transferred to 96-well white plates (1.5x10
5
 cells/250 µl 
well), and the measurements were taken automatically every 22 seconds during 
the total follow-up time of 10 minutes by a Microplate Luminometer at 37ºC. 
The curves were analyzed and the peak values of the curves are presented as 
relative light units (RLU)/second. 
H2O2 release was determined by the homovanillic acid-based fluorimetric 
assay (Benard and Brault 1971). The cells were first transfected with human 
SOD3 (cDNA kindly provided by Professor Stefan L. Marklund from the 
University of Umeå, Sweden, and cloned into pcDNA3 vector (Life 
Technologies, Carlsbad, CA)), and after 48 hours incubated in Krebs-Ringer 
HEPES (KRH) medium pH 7.4 containing 0.1 µg/ml horseradish peroxidase 
type II, 440 µmol/l homovanillic acid and 1 µmol/l ionomycin at 37ºC for 2 
hours 30 minutes. The fluorescence from oxidized homovanillic acid was 
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measured at 315 nm excitation and and 425 nm emission. The results are 
presented as ng of H2O2 per 6-well plate well, accumulated during the 2 h 30 
min incubation.  
3.5. SOD3 purification and activity assay (MS I) 
SOD3 protein was purified from homogenated rat muscle tissue samples 
using Concanavalin A sepharose (GE Healthcare, Chalfont St. Giles, UK) as 
described previously (Marklund 1984). A volume of 500 µl of homogenized 
and centrifuged tissue sample was applied on the column and washed with 
phosphate buffer. SOD3 was then eluted with 50 mmol/l Na phosphate buffer 
containing 150 mmol/l α-methyl D-mannoside. Total SOD protein activity 
assay was performed as described (see manuscript I for reference) with control 
vector transfection and serum free medium as controls. 
3.6. Quantitative real-time (q) PCR (MS I-III) 
Total RNA (totRNA) was extracted from pooled tissue samples of 3-4 rats 
or cultured experimental cells by homogenizing them with Tri reagent (Sigma-
Aldrich, St. Louis, MO) and using the standard phenol-chloroform extraction 
protocol. Messenger RNA (mRNA) was extracted from prepared totRNA using 
the GenElute mRNA Miniprep kit (Sigma-Aldrich, St. Louis, MO).  
Complementary (c)DNA synthesis was done with Revert-Aid M-MuLV 
(Fermentas, Burlington, Canada; MS I&II) or QuantiTect Reverse 
Transcription (Qiagen, Hilden, Germany; MS III), and PCR amplification with 
JumpStart RedTaq ReadyMix (Sigma-Aldrich, St. Louis, MO). QPCR was 
done using SYBR Green PCR Master mix (Applied Biosystems, Foster City, 
CA). The used primers and running conditions for the qPCR are presented in 
Table 2.  
3.7. Western blotting (MS I-III) 
Tissue samples or cultured cells were homogenized in lysis buffer 
(50mmol/L HEPES pH 7.5, 150 mmol/L NaCl, 10% glycerol, 1% Triton X-
100, 1mmol/L EGTA, 1.5 mmol/L MgCl2, 10 mmol/L NaF, 10 mmol/L 
sodium pyrophosphate, 1mmol/L Na3VO4, 10 g approtinin/ml, 10 g 
leupeptin/ml) (Sigma-Aldrich, St. Louis, MO), and their protein concentration 
was determined by modified Bradford assay (Bio-Rad, Munich, Germany). 
Nitrocellulose membranes were stained with BRaf, IκB, SOD3 (all Santa Cruz 
Biotechnology, Santa Cruz, CA), MEK1/2, p-MEK1/2, 42/44 MAPK (Erk1/2), 
p-42/44 MAPK, Akt, and p-Akt (all Cell signaling, Danvers, MA), and α-
tubulin (Sigma-Aldrich, St. Louis, MO) antibodies. 
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3.8. Statistical analyses 
Statistical significance was analyzed by two-tailed t-test for means. 
Variation has been presented as ±SD (MS I and III) or ±SEM (MS II). The 
limit p-values for significance are p <0.05 (*), p <0.01 (**), and p <0.001 
(***). 
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Table 2. Primers and running conditions     
Gene Primer sequence Tm Manuscript 
AdSOD3 for GTT GCG TGA GCG GAA AGA TG 60 I 
AdSOD3 rev GTG AGC GCC TGC CAG ATC TC   I 
huSOD3 for CTT CGC CTC TGC TGA AGT CT 60 I, III 
huSOD3 rev GGG TGT TTC GGT ACA AAT GG   I, III 
ratSOD3 for GAC CTG GAG ATC TGG ATG GA 60 I, III 
ratSOD3 rev GTG GTT GGA GGT GTT CTG CT   I, III 
ratCycD1 for AAC GTC ACA CGG ACT ACA GG 55 I 
ratCycD1 rev TGT TCC ATG GCT GGG GCT CTT   I 
huVEGF-A for TCC GGG TTT TAT CCC TCT TC 55 I 
huVEGF-A rev TCT GCT GGT TTC CAA AAT CC   I 
ratVEGF-A for CAA TGA TGA AGC CCT GGA GT 50 I 
ratVEGF-A rev TTT CTT GCG CTT TCG TTT TT   I 
ratTNF for AGA TGT GGA ACT GGC AGA GG 60 II 
ratTNF rev CCC ATT TGG GAA CTT CTC CT   II 
ratIL-1α for TCG GGA GGA GAC GAC TCT AA 58 II 
ratIL-1α rev GAA AGC TGC GGA TGT GAA GT   II 
ratIL-6 for CCG GAG AGG AGA CTT CAC AG 55 II 
ratIL-6 rev ACA GTG CAT CAT CGC TGT TC   II 
ratMCP-1 for CTC ACC TGC TGC TAC TCA TTC ACT 55 II 
ratMCP-1 rev TGC TGC TGG TGA TTC TCT TGT AGT   II 
ratMIP2 for ATC CAG AGC TTG ACG GTG AC 55 II 
ratMIP2 rev GGA CTT GCC GCT CTT CAG TA   II 
ratICAM for AGG TAT CCA TCC ATC CCA CA 55 II 
ratICAM rev GCC ACA GTT CTC AAA GCA CA   II 
ratVCAM for TGA CAT CTC CCC TGG ATC TC 55 II 
ratVCAM rev CTC CAG TTT CCT TCG CTG AC   II 
ratPSEL for TTC CCA CAC TTC CTT CTG CT 57 II 
ratPSEL rev CAC GCT GTA GTC GGG GTA TT   II 
ratESEL for TTT TTG GCA CGG TAT GTG AA 57 II 
ratESEL rev AGG TTG CTG CCA CAG AGA GT   II 
huβ-actin for TGC GTG ACA TTA AGG AGA AG 55 I, II, III 
huβ-actin rev GCT CGT AGC TCT TCT CCA   I, II, III 
ratβ-actin for TCG TGC GTG ACA TTA AGG AG 55 I, II, III 
ratβ-actin rev GTC AGG CAG CTC GTA GCT CT   I, II, III 
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4 RESULTS 
4.1. Analysis of the biological functions of SOD3 in vivo 
4.1.1. Increased SOD3 expression and attenuated oxidative stress after 
adenoviral gene transfer (MS I) 
Adenovirus mediated gene transfer is a widely used method to introduce 
foreign gene expression in various tissues. We transferred AdSOD3 and 
AdLacZ as control into the rat hind limb muscle tissue immediately after 
inducing acute ischemia by femoral artery ligation and followed the animals 
for 3, 7, 10, or 14 days. Adenoviral LacZ expression was detected by X-Gal 
staining from 3-, 7-, and 10-day tissue sections (Figure 7). The virus 
transduction efficiency was in the range of 0.8-5% varying between the time 
points.  
SOD3 mRNA expression was detected by reverse transcriptase (RT-)PCR 
from 3-day muscle tissue homogenate. The expected 547 bp SOD3 sequence 
was amplified from the AdSOD3 treated muscle but not from the uninjured or 
AdLacZ treated muscle tissue (Figure 7). Control RT-PCR reaction with β-
actin primers showed amplification from all tissue samples (Figure 7). SOD3 
enzyme activity was increased 2-fold in the 3-day tissue sample purified by 
Concanavalin A sepharose further confirming the expression of functional 
SOD3 after gene transfer (see MSI).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Expression of adenoviral transgenes. Photos show AdLacZ expression 
determined by β-galactosidase staining at 3, 7 and 10 days after transfection in rat hind limb 
muscle tissue. SOD3 expression was determined by RT-PCR. Upper panel shows the 574 bp 
SOD3 fragment and lower panel the 122 bp β-actin fragment. Lanes: 1, uninjured control 
muscle; 2, AdLacZ muscle; 3, AdSOD3 muscle; 4, SOD3 positive control; 5, water control. 
(Modified from MSI) 
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To assess the oxidative status of the muscle tissue we performed the DHE 
assay to detect ROS and 3-nitrotyrosine staining to detect reactive nitrogen 
species. DHE assay showed a significant 28% (p<0.01) decrease in DHE 
positive nuclei in AdSOD3 treated tissue sections as compared to AdLacZ 
animals (see MSI). The same trend was seen in the 3-nitrotyrosine stained 
sections, which showed less staining in AdSOD3 expressing tissues (see MSI). 
Thus, SOD3 had a clear antioxidative effect as shown in previous studies 
(Laukkanen et al. 2001; Laukkanen et al. 2002).  
4.1.2. SOD3 improved tissue healing (MS I) 
Tissue glucose uptake indicates the metabolic rate of the tissue (reviewed by 
Wasserman and Ayala 2005), and it can be measured with positron emission 
tomography (PET) imaging of radioactive [
18
F] FDG glucose accumulation 
into tissues. The ratio of accumulated glucose between normal uninjured and 
operated hind limb was determined from 10-day AdSOD3 and AdLacZ treated 
animals after systemic injection of the PET marker. Injured AdLacZ legs vs. 
normal control legs in the same animal showed 46%, 64%, and 58% (p<0.05) 
higher glucose accumulation, whereas in the AdSOD3 legs it was closer to 
normal metabolic rate with only 24%, 27%, and 35% difference (see MSI). 
Formation of new blood vessels and cell proliferation is characteristic to 
tissue healing and they are regulated by the oxidative status of the tissues 
(reviewed by Tidball 2005; reviewed by Ushio-Fukai 2006b). We determined 
the effect of SOD3 to angiogenesis and cell proliferation by von Willebrand 
Factor (vWF) and Ki67 staining, respectively, at 3-, 7-, 10-, and 14-day time 
points. The number of capillaries per mm
2
 increased slightly in the course of 
the follow-up period, and peaked at 10 days (see MSI). However, there were no 
significant differences between the AdLacZ and AdSOD3 treated animals. 
Ki67 staining revealed significantly (p<0.05) increased cell proliferation at 3 
and 7 days in the AdSOD3 group (see MSI). The overall number of 
proliferating cells in muscle tissue was low, about 0-8 cells per section which 
reflects the low muscle tissue turnover. These results indicate that SOD3 gene 
transfer improves tissue recovery from ischemic damage by normalizing the 
tissue metabolism and inducing cell proliferation.  
4.1.3. SOD3 reduced leukocyte accumulation in ischemia and 
inflammation (MS II) 
Ischemia induces tissue inflammation by hypoxia derived tissue damage 
such as large amount of ROS and necrotic cell debris which activate a number 
signaling pathways leading to cytokine and chemokine expression, and 
leukocyte accumulation (reviewed by Alom-Ruiz et al. 2008; reviewed by 
Bosco et al. 2008). The first to appear are neutrophils and 
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monocyte/macrophages within hours or a few days (Paoni et al. 2002; reviewed 
by Tidball 2005), whereas lymphocytes appear later and fully activate only if 
they encounter microbial pathogens presented by antigen presenting cells. 
To start elucidating the healing-promoting mechanism of SOD3 we first 
determined the inflammatory area of the tissue sections by calculating the ratio 
of CD68+ macrophage infiltrated area to the whole section area from 3-, 7-, 
and 10-day tissue sections. At all time points studied AdSOD3 treatment 
reduced the inflamed area significantly inducing a 3-fold difference (p <0.001) 
already after 3 days, and growing to 12-fold at 10 days (see MSII).  
The numbers of infiltrated CD68+ macrophages and CD3+ lymphocytes 
were determined from whole sections. For the whole 10-day period the amount 
of CD68+ macrophages remained 3-5 fold (p <0.05) lower in AdSOD3 treated 
animals as compared to AdLacZ treated animals (Figure 8A). However, CD3+ 
cell numbers in both groups were at the same level at 3 days, and as the 
number of CD3+ cells remained at that level until 10-day time point in 
AdSOD3 animals the number increased gradually in AdLacZ animals 
rendering the difference significant (p <0.05; Figure 8B). Thus, SOD3 gene 
transfer has an anti-inflammatory effect in tissue damage as indicated by 
reduced inflammatory area and leukocyte accumulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To further confirm and characterize the role of SOD3 in leukocyte 
trafficking in inflammation we induced mild acute peritonitis in mice and 
treated them with AdLacZ, AdSOD3, PBS, and the clinically approved anti-
Figure 8. Inhibition of leukocyte migration in ischemic rat hind limb. (open bars: AdLacZ 
animals, black bars: AdSOD3 animals) Adenoviral SOD3 treatment of ischemic rat hind limb 
reduced efficiently the accumulation of CD68+ macrophages on a 10-day follow-up period 
(A). The number of CD3+ T lymphocytes remained at a steady low level throughout the same 
follow-up period in SOD3 treated animals (B). (Modified from MSII) 
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inflammatory glucocorticoid drug Dexamethasone. The asset of this model is 
that the leukocyte subtypes can be readily analyzed from cytospinned 
peritoneal lavage containing the infiltrated cells. The adenoviruses were 
injected 3 days before the induction of peritonitis to ensure maximal SOD3 or 
LacZ expression. AdSOD3 treatment reduced the total number of infiltrated 
cells by 30% (p<0.01), and had the most prominent effect on the 
monocyte/macrophage portion with 67% reduction (p<0.001; Figure 9A). 
Neutrophil and lymphocyte numbers were reduced by 20% (p= not significant) 
and 33% (p<0.05), respectively (Figure 9A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment with Dexamethasone reduced the number of leukocytes by 20% 
(p<0.05) as compared to PBS control. Dexamethasone had no effect on the 
neutrophil subpopulation but monocyte/macrophages and lymphocyte counts 
were reduced by 60% (p<0.01) and 50% (p= not significant), respectively 
(Figure 9B). In these two groups the overall number of migrated cells was 
Figure 9. Inhibition of leukocyte migration in mouse peritonitis. (open bars: AdLacZ 
animals, black bars: AdSOD3 animals) AdSOD3 injection decreased the accumulation of 
leukocytes into peritoneum with the most notable effect on the monocyte (mono) 
subpopulation (A). A similar effect was seen in the Dexamethasone (Dex) treated animals (B). 
Either SOD3 or Dexamethasone did not affect significantly the neutrophil (neutro) migration, 
and only SOD3 could reduce the lymphocyte (lympho) infiltration. (Modified from MSII) 
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markedly lower than in the virus-infected animals indicating an inflammation-
enhancing effect for the virus, especially on the initial neutrophil accumulation. 
However, the AdSOD3 treatment was able to lower the monocyte/macrophage 
and lymphocyte numbers to the same level as Dexamethasone. Additionally, 
SOD3 showed a selective effect on the macrophage subpopulation suggesting a 
role in attenuation of early inflammatory reactions. 
4.1.4. Enhanced expression of growth factors, cytokines and cell 
adhesion molecules by SOD3 (MS I,II) 
In order to reveal the mechanisms by which SOD3 can mediate cell 
proliferation and regulate leukocyte migration we determined by qPCR the 
mRNA expression of several growth factors, cytokines, and cell adhesion 
molecules known to participate in these events. Vascular endothelial growth 
factor (VEGF-) A is an important vascular growth regulator but it has also a 
role in muscle regeneration (Rissanen et al. 2002), and cyclin D1 is the major 
factor determining the cell cycle propagation from G1 to S phase (reviewed by 
Tashiro et al. 2007). VEGF-A expression was increased 3-fold (p<0.01) in 
AdSOD3 treated tissue at 10-day time point as compared to both normal 
uninjured and AdLacZ controls (Figure 10A). At similar setting, the cyclin D1 
expression in AdSOD3 animals was increased 2-fold (p<0.05) as compared to 
uninjured tissue but, interestingly, it was 6-fold (p<0.01) higher when 
compared to AdLacZ animals (Figure 10B). Indeed, SOD3 is capable of 
activating growth factor expression explaining its proliferative effect on muscle 
tissue.  
Transcription factor NFκB is an important mediator of the inflammatory 
reaction and is responsible for the expression of a wide scale of cytokines and 
adhesion molecules (reviewed by Ghosh et al. 1998). We performed a 
luciferase assay for NFκB activation upon SOD3 transfection into HEK 293T 
cells to see if SOD3 could affect this transcription factor. The experiment 
showed that SOD3 gene expression reduced NFκB expression to approximately 
half of the original (p<0.01; see MSII). To further elucidate the mechanism 
behind this result we blotted a protein preparation from SOD3 transfected cells 
and stained the membrane with an antibody for inhibitor of κB (IκB)  which 
binds and restricts NFκB to cytosol (reviewed by Ghosh et al. 1998). As 
expected, SOD3 induced increased IκB expression which is at least in part 
responsible for the reduced NFκB expression (see MSII).  
We then studied the mRNA expressions of the cytokines tumor necrosis 
factor (TNF-) α, interleukin (IL-) 1α, IL-6, macrophage inhibitory protein 
(MIP-) 2, and monocyte chemoattractant protein (MCP-) 1 from the 3-day 
tissue samples. Their relative expressions were significantly decreased in 
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AdSOD3 treated animals to 10%-30% (p<0.05 or p<0.01) from the control 
AdLacZ animals set as 100% (Figure 10C). 
The cell adhesion molecules (CAM) and selectins are in turn upregulated by 
the cytokines from leukocytes and tissue cells in order to facilitate leukocyte 
transmigration into the inflammation area. We therefore determined from the 
same samples the expression of E- and P-selectins, and intercellular (ICAM) 
and vascular (VCAM) cell adhesion molecules which mediate the leukocyte 
rolling and firm attachment to the vascular wall (reviewed by Ley et al. 2007). 
These results were in line with the cytokine study as the expressions of 
selectins and CAMs were significantly reduced after AdSOD3 treatment as 
compared to AdLacZ animals (p<0.05 or p<0.01; Figure 10D). Consequently, 
these results indicate that SOD3 is able to modulate the inflammatory reaction 
by inhibiting cytokine and adhesion molecule expression in an NFκB 
dependent manner, and thus preventing the inflammatory cells from 
accumulating in the inflicted tissues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. SOD3 effect on growth factor, inflammatory cytokine and cell adhesion 
molecule expression. Quantitative RT-PCR analysis showed significant increases in growth 
factor VEGF-A (A) and cell cycle regulator cyclin D1 (B) expression after AdSOD3 treatment 
in rat hind limb as compared to normal uninjured or AdLacZ treated muscle tissue. AdSOD3 
reduced significantly many major inflammatory cytokines and leukocyte chemokines (C) and 
cell adhesion molecules (D) as compared to AdLacZ treated rat hind limbs. (Modified from 
MSI and MSII) 
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4.1.4. High SOD3 expression was found in rat thyroid tissues (MS III) 
The thyroid gland is naturally subject to high oxidative stress since its 
hormone production is dependent on H2O2 generation, and to prevent the 
harmful effects it also has extensive antioxidant defense systems (reviewed by 
Song et al. 2007). In order to characterize the role of SOD3 more specifically at 
organ level we studied its expression in the thyroid gland by isolating several 
tissues from untreated rats and running a qPCR with the extracted total 
mRNAs. When compared to heart, aorta had the highest level of expression 
with 4-fold increase (p<0.05; Figure 11) which is consistent with the major role 
of SOD3 as a vascular regulatory and protective enzyme (reviewed by Fukai et 
al. 2002). Thyroid gland compares well with aorta and kidneys with 2,5-fold 
higher SOD3 expression (p<0.05) whereas liver, despite its high metabolic 
activity, was at the same level with heart (Figure 11). Thus, the high level of 
SOD3 expression in the thyroid gland, also seen in a previous enzyme activity 
study (Marklund 1984),  suggests a physiological role for it in this organ.  
 
 
 
 
 
 
 
 
 
 
4.2. Analysis of the role of SOD3 in cell signaling 
4.2.1. SOD3 activated the mitogenic Ras/MAPK pathway (MS I) 
Our studies with rat hind limb ischemia model suggested that SOD3 can 
induce cell proliferation through growth factor expression. One of the most 
prominent mitogenic signaling pathways is the Ras/mitogen activated protein 
kinase (MAPK) pathway consisting of Ras and its downstream Braf, MEK1/2, 
and Erk1/2 kinases. Akt/PKB is another crucial cell survival factor and an 
inducer of angiogenesis, and is also in part under Ras regulation (Kandel and 
Hay 1999). Therefore, we investigated the relationship between the Ras/MAPK 
pathway, Akt, and SOD3 expression. 
Ras-pulldown assay from the 7-day rat tissues revealed increased amount of 
Ras-GTP after SOD3 gene transfer as compared to AdLacZ animals (Figure 
Figure 11. Abundant expression of 
SOD3 in rat thyroid. Thyroidal SOD3 
expression was close to that in aorta 
which is one of the main expression 
sites of SOD3. Less expression was 
observed in liver and kidney. (Modified 
from MSIII) 
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12A). Similarly, the MAPK cascade components MEK1/2 and Erk1/2 were 
increasingly phosphorylated in AdSOD3 treated animals (Figure 12B). 
However, Akt phosphorylation was not affected by SOD3 gene transfer in vivo 
at 7-day time point (Figure 12B). The inability of SOD3 gene transfer to induce 
long-term Akt activation and thus angiogenesis could explain the similar 
capillary formation patterns in AdSOD3 and control groups (see MSI).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We also studied the Ras/MAPK pathway activation in a more controlled 
setting by transfecting SOD3 into HEK 293T cells. Similar Ras-pulldown assay 
showed likewise increased Ras-GTP loading, and blotted protein samples from 
cell preparations contained more phosphorylated MEK1/2 and Erk1/2 as 
compared to control vector transfected cells (Figure 12). Furthermore, we 
exposed untransfected cells to H2O2 to mimic functional SOD3, and this 
Figure 12. SOD3 activates the mitogenic Ras/Erk pathway. Ras-pulldown assay showed an 
increase in activated Ras (Ras-GTP) 7 days after AdSOD3 treatment in vivo (A, left panel) 
and after SOD3 transfection in vitro (A, right panel). Ras downstream signaling molecules 
MEK1/2 and Erk1/2 but not Akt were phosphorylated in 7-day tissues by SOD3 (B, left 
panel) and a similar expression pattern was seen in vitro with the exception that also Akt was 
activated (B, right panel). DPI diminished the activating effect of SOD3 but catalase did not 
have such a clear effect on MEK1/2 and Erk1/2 whereas H2O2 distinctly reproduced the effect 
of SOD3 on the signaling molecules (right panels). (Modified from MSI) 
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resulted again in Ras, MEK1/2, and Erk1/2 activation suggesting that the 
SOD3 end-product is needed for the stimulatory function (Figure 12). 
Incubation of the SOD3 transfected cells in the NADPH oxidase (Nox) enzyme 
inhibitor DPI reduced Ras/MAPK pathway phosphorylation indicating that 
SOD3 mediated Ras/MAPK activation is dependent on the availability of its 
substrate, superoxide (O2•
-
) (Figure 12). Treatment with catalase, the H2O2 
scavenger, did not interrupt Ras, MEK1/2, or Erk1/2 activation (Figure 
12A,B). However, Akt was phosphorylated upon SOD3 transfection unlike in 
the in vivo setting, and its phosphorylation pattern was similar to those of 
MEK1/2 and Erk1/2 in all experimental conditions (Figure 12).  
Erk1/2 has several downstream target genes whose functions are mediated 
by such transcription factors as AP-1, its component c-Jun, and CREB 
(Eriksson and Leppa 2002; Gelain et al. 2006). Their expression was studied by 
luciferase reporter gene assay. SOD3 and SOD3/catalase transfections induced 
significant increase (p<0.05) in the expression of pAP1-, pFA2-cJun- and 
pCRE-luciferase reporter genes as compared to control vector, and H2O2 had 
similar effect on AP-1 and c-Jun but actually decreased CREB expression. DPI 
prevented efficiently the SOD3 induced transcription factor expression (see 
MSI).  
AP-1 and CREB target VEGF-A and cyclin D1 as their downstream 
effectors (Wu et al. 2007; Shen et al. 2008) providing a link between the SOD3 
activated Ras/Erk pathway and growth factor or cell cycle regulator expression. 
We determined the effect of SOD3 transfection on VEGF-A and cyclin D1 
mRNA expression in vitro to confirm our in vivo results. Both molecules were 
significantly upregulated (p<0.05) upon SOD3 transfection as well as upon 
Ras, BRaf, MEK1, and Erk1 transfections supporting the role of SOD3 as a 
mitogenic signal molecule which exerts its effect through Ras/Erk pathway 
(see MSI).  
4.2.2. SOD3 protein activity and expression were regulated through a 
positive feedback loop (MS I) 
As described above SOD3 action is dependent on the substrate O2•
-
 but it is 
likely regulated by other means as well. We studied whether SOD3 activation 
could be modified by a feedback signal from its downstream pathway by 
transfecting HEK 293T cells with the cascade kinases. Endogenous SOD3 
protein activity was significantly increased upon Ras, MEK1, Erk1 (all 
p<0.05), and BRaf (p<0.001) expression but after Akt transfection the activity 
remained at the same level with control (see MSI). Additionally, H2O2 
incubation had a similar positive effect (p<0.05) as the signaling molecules 
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suggesting that the SOD3 end-product is necessary for both Ras/MAPK 
activation and stimulatory feedback signaling (see MSI).  
Finally, to determine if increased SOD3 activity was due to enhanced gene 
expression we performed a qPCR for SOD3. The significant rise in SOD3 
mRNA after Ras, BRaf, MEK1, and Erk1 transfections (all p<0.001), and H2O2 
incubation (p<0.05) indicated that increased SOD3 gene expression is indeed 
behind its higher activity (see MSI). As expected, Akt had no effect on SOD3 
expression (see MSI). Furthermore, we incubated untransfected cells with 
NADP which is an essential cofactor for the Nox enzymes, and detected again 
significantly increased SOD3 mRNA expression (p<0.001) (see MSI). This 
effect was reversed by DPI and a MEK inhibitor UO126 (both p<0.05) 
confirming that the Nox derived O2•
-
 and Ras/Erk pathway regulate SOD3 
expression (see MSI).  
4.2.3. TSH-R pathway activation induced SOD3 expression (MS III) 
Thyroid function mainly depends on the activation of TSH receptor 
pathway. It stimulates two G proteins, Gαs and Gαq, which initiate follicular 
cell proliferation through cAMP dependent pathway and thyroid hormone 
synthesis through PLC dependent pathway, respectively (Allgeier et al. 1994; 
Corvilain et al. 1994). Interestingly, TSH stimulation of PC Cl3 cells induced a 
significant 3-fold (p<0.01) increase in SOD3 expression (Figure 13A), and we 
therefore studied by qPCR whether these pathways could induce SOD3 mRNA 
expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. TSH-R activation induces SOD3 expression in PC Cl3 rat thyroid cell line. 
Stimulation of cells with TSH increased SOD3 expression, and was not abolished by the PKA 
inhibitor H89 (A). Activating the proliferative cAMP pathway by forskolin and transient 
transfections of Gαs and PKA also promoted SOD3 expression (A). The hormonogenic PLC 
pathway had similar effect as transient transfection of Gαq and treatment with Ca2+ releasing 
thapsigargin promoted SOD3 expression (B). (Modified from MSIII) 
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The Gαs signal is mediated through sequential activation of adenylate 
cyclase/cyclic AMP (cAMP) and protein kinase A (PKA). Overexpression of 
pCEF-Gαs and pCEF-PKA by transient transfections induced significant 5,5- 
(p<0.01) and 6-fold (p<0.001) increases in SOD3 expression as compared to 
untreated control cells, respectively. Incubation with adenylate cyclase 
activator forskolin also resulted in 6-fold (p<0.05) increase, thereby confirming 
that the Gαs/cAMP/PKA pathway is upstream of SOD3. However, the TSH 
induced SOD3 expression was decreased (p<0.05) with simultaneous PKA 
inhibitor H89 incubation but was not completely abolished (Figure 13A) 
suggesting that SOD3 expression is likely regulated by other mechanisms as 
well. 
The second major TSH-R pathway starting from Gαq utilizes phospholipase 
C and subsequent Ca2+ release from the endoplasmic reticulum. SOD3 mRNA 
was increased 3-fold (p<0.01) after pCEF-Gαq transfection, and a similar 
increase (3-fold, p<0.05) was observed after treating the cells with the Ca2+ 
ATPase inhibitor thapsigargin, which induces Ca2+ accumulation into cytosol, 
as compared to untreated control (Figure 13B). Thus, both TSH-R signaling 
branches induce SOD3 expression upon receptor activation implying a wider 
role for SOD3 in thyroid physiology.  
4.2.4. SOD3 participated in thyrocyte proliferation but not in hormone 
synthesis (MS III) 
These findings prompted us to investigate what role SOD3 could play in the 
thyroid gland. Since SOD3 had a clear growth stimulating effect in the muscle 
tissue (MS I) we studied whether it could function similarly in thyroid gland. 
The high endogenous SOD3 expression compelled us to inhibit it by small 
interfering RNA (siRNA) since further upregulation of SOD3 by plasmid 
transfection could have proven difficult. We transfected rat PC Cl3 cells with 
siSOD3 or siGAPDH, a general housekeeping gene commonly used in siRNA 
studies, and determined the SOD3 expression by qPCR analysis. A significant 
95% interference (p<0.001) in SOD3 mRNA production was detected 48 hours 
later (Figure 14A). In vitro cell proliferation was then assessed by BrdU and 
Hoecst double labeling which stain the nuclei of proliferating and all cells, 
respectively. SiSOD3 transfection reduced TSH-stimulated cell proliferation by 
15% (p<0.05) as compared to siGAPDH transfected cells (Figure 14B). Thus, 
SOD3 seems to have a mitogenic effect also on thyrocytes. 
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We next compared the H2O2 production of SOD3 and Duox2, which in vivo 
is required for efficient thyroid hormone synthesis after Gαq/PLC pathway 
activation, to see if SOD3 could contribute to this function. To confirm the 
functionality of the heterologous Cos-7 model we first made a set of 
transfections with Duox2 and DuoxA1 maturation factor with and without 
SOD1 and SOD3 co-transfections, and measured the O2•
- 
production. The 
maturation factors DuoxA1 and DuoxA2 function with the Duox1 and Duox2 
oxidases, respectively, and Duox2/DuoxA1 combination causes leakage of O2•
-
 
while Duox2/DuoxA2 complex produces H2O2 (Grasberger and Refetoff 2006; 
Morand et al. 2009). A chemiluminescence assay for O2•
-
 showed highest 
Figure 14. SOD3 participates in thyrocyte proliferation but not in hormone synthesis. 
SOD3 siRNA (siSOD3) transfection knocked down 95% of SOD3 expression in PC Cl3 cells 
as compared to control GAPDH siRNA (siGAPDH) (A). TSH stimulated proliferation was 
diminished by 15% in the SOD3 knock-down cells as determined by 5‟-bromo-3‟-
deoxyuridine (BrdU) assay (B). Superoxide generation was reduced by SOD3 and SOD1 in 
Cos-7 cells cotransfected with Duox2 (D2) and the incompatible maturation factor DuoxA1 
(A1) which cannot promote H2O2 conversion (C). Duox2 alone or with DuoxA1 cannot 
produce H2O2 but requires the compatible DuoxA2 (A2) maturation factor (D). Cotransfection 
of SOD3 and Duox2/DuoxA1 does not lead to significant H2O2 generation as compared to 
functional Duox2 (D). (Modified from MSIII) 
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RLU/sec values when SODs were not present but when they were expressed 
simultaneously the peak values dropped dramatically (Figure 14C) indicating 
functional SOD activities in this in vitro model. H2O2 measurements with a 
fluorimetric assay showed a markedly 28-fold lower amount of H2O2 
generation by SOD3 than by the functional Duox2 (Figure 14D). Therefore, it 
seems that SOD3 participates in thyrocyte proliferation as indicated by the 
siRNA experiment but is not required for Gαq/PLC regulated hormonogenesis 
since the Duox2 can produce all the H2O2 necessary.  
4.3. SOD3 in thyroid hyperproliferation 
4.3.1. SOD3 expression was increased in goiter (MS III) 
Goiter is one of the most common thyroid pathologies associated with 
nutritional iodine defects and disorders that compromise the balance of TSH 
and thyroid hormone secretion (reviewed by Dumont et al. 1992). 
Characteristic to goiter is the rapid proliferation of follicular cells stimulated by 
excess TSH or activating antibodies (reviewed by Dumont et al. 1992). Since 
SOD3 was upregulated upon TSH stimulation in normal rat thyroid cells we 
studied whether it participates in the goiter formation. 
We induced goitrogenesis in rats by delivering 0.25% 6-propyl-2-thiouracil 
(PTU) in drinking water for two weeks and analyzed the isolated thyroid 
glands. PTU induced approximately 4-fold (p= not significant) increase in the 
thyroid weight as shown in Table 3. Additionally, typical morphological 
changes in thyroid histology were observed with diminished colloid in the 
follicular lumen and appearance of tall columnar follicular cells lining the 
lumen walls indicating hyperactive metabolism in goiter tissue (Figure 15A,B). 
These results were in line with a previous study in a similar setting (Laezza et 
al. 2006) confirming the typical signs of goiter formation in our experiment. 
 
Table 3. Thyroid weight  
Normal thyroid 12,2 mg 
  15,6 mg 
  15,1 mg 
PTU treatment 17 mg 
  46 mg 
  51 mg 
  130 mg 
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We then determined SOD3 mRNA expression from normal and PTU treated 
rat thyroid glands by qPCR to see how SOD3 expression pattern changes in 
this pathological condition. In rat goiter tissue the level of SOD3 expression 
increased 10-fold (p<0.01) as compared to normal tissue (Figure 15C). 
However, further studies with human patient samples of endemic goiter and 
toxic adenoma did not reveal differences in SOD3 expression as compared to 
normal thyroid tissue (Figure 15D) suggesting that chemically induced goiter 
in rat may not fully compare to natural human disease regarding the SOD3 
regulation.  
4.3.2. SOD3 expression was decreased in thyroid malignancies (MS III) 
Malignant transformation of any cell type is characterized by abnormally 
high proliferation rate as the growth-promoting oncogenes are activated. We 
performed a qPCR on the rat PC Cl3 papillary thyroid carcinoma (PC PTC) 
Figure 15. SOD3 expression increases in goiter formation. PTU administration to rats 
induced typical morphological changes in thyroid tissue such as shrinked follicles and 
hyperproliferation of follicular cells (A normal thyroid, B goiter). SOD3 expression was 
significantly higher in rat goiter tissue as compared to normal thyroid gland (C). However, in 
human patient samples of endemic goiter and toxic adenoma the SOD3 expression remained 
at the same level with normal tissue (D). (Modified from MSIII) 
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and PC E1A undifferentiated thyroid carcinoma cell lines to further 
characterize SOD3 expression in hyperproliferation. In PC PTC cell line the 
SOD3 expression was significantly (3-fold, p<0.01) lower when compared to 
normal PC Cl3 cells (Figure 16A). Interestingly, the more aggressive PC E1A 
cell line showed minimal SOD3 expression  (p<0.001; Figure 16A) as 
compared to normal cells or the less aggressive PTC cell line (Fusco et al. 
1987; Berlingieri et al. 1993; Farid et al. 1994). This indicates that SOD3 is 
progressively downregulated as the cancer type becomes more aggressive. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PTC is the most common thyroid cancer comprising 70% of all cases, and is 
more prevalent in women (Correa and Chen 1995). To further characterize the 
role of SOD3 in human thyroid hyperproliferation we tested the expression of 
SOD3 from clinical human PTC tumor samples by DNA array and qPCR. 
Quantitative PCR from the tumor samples revealed deceased (p<0.01) SOD3 
mRNA expression (Figure 16B) and, similarly, DNA array of the same 
samples gave significantly (p<0.001) decreased SOD3 expression (Figure 16C) 
as compared to normal human thyroid tissue thereby establishing correlation 
between the rat model and the human disease. These opposing expression 
patterns of SOD3 in goiter and cancer establish SOD3 as a differentiation 
marker to estimate the stage of transformation in thyroid malignancies. 
 
Figure 16. SOD3 is downregulated in thyroid cancer. SOD3 expression was significantly 
lower in rat PC papillary thyroid carcinoma (PTC) cell line and even lower in the more 
aggressive PC E1A cell line indiating a clear correlation with the degree of malignancy (A). 
Similar results were obtained from human PTC patient samples by quantitative (q)PCR (B) 
and DNA array (C). (Modified from MSIII) 
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5 DISCUSSION 
The extracellular SOD3 has been studied in various settings for its role in 
relieving oxidative stress under ischemic or inflammatory conditions such as 
myocardial and cerebral infarction, atherosclerosis, inflammatory bowel 
disease, lung injury and arthritis (Sheng et al. 1999; Landmesser et al. 2000; 
Bowler et al. 2001; Ross et al. 2004; Kruidenier et al. 2003; Tasaki et al. 2006). 
Interestingly, its expression level is often decreased in chronic pathological 
conditions resulting in reduced capacity to remove oxygen radicals from the 
inflicted tissues (Marklund et al. 1986; Kruidenier et al. 2003; Tasaki et al. 
2006; Ueda et al. 2008), although it does not seem to be necessary under 
normal conditions since healthy SOD3 knock-out mice show normal phenotype 
(van Deel et al. 2008). However, in some acute ischemic events and in young 
hypercholesterolemic patients SOD3 may be upregulated (Landmesser et al. 
2000; Horiuchi et al. 2004). Re-establishing SOD3 expression by e.g. 
adenoviral gene transfer has shown significant positive effects on tissue 
recovery by reducing oxidative stress (Li et al. 2001; Laukkanen et al. 2001; 
Brasen et al. 2007). 
In our study, we observed reduced inflammatory reaction as well in both the 
rat hind limb ischemia model and the mouse peritonitis model after adenoviral 
SOD3 gene transfer. Analysis of the gene transfer efficiency by histological 
staining and gene expression studies revealed sustained expression even 10 
days after virus injection (MS I). Diminished oxidative stress, close to normal 
glucose metabolism, and higher cell proliferation rate indicated improved 
tissue functionality and recovery process in the SOD3 treated ischemic hind 
limbs (MS I). However, capillary formation in both hind limb ischemia groups 
followed the same course suggesting that exogenous SOD3 does not affect 
angiogenesis (MS I) although an important role has been suggested in another 
study where endogenous SOD3 was investigated (Kim et al. 2007b). 
Consistently, smaller inflammatory areas at all time points in rat tissues (MS 
II) and leukocyte counts from rat tissue sections and mouse peritoneal lavage 
confirmed that SOD3 can reduce tissue inflammation as determined by 
leukocyte accumulation (MS II). 
Adenovirus gene transfer is an efficient method to deliver genes into in vivo 
systems but both adverse immunogenic effects and low toxicity of the 
adenoviruses have been reported and, thus, the safety of this method still 
remains under debate (Martin-Martinez et al. 2004; Li et al. 2008; reviewed by 
Hartman et al. 2008). Adenovirally induced gene expression peaks at three 
days after the infection in normal rats (Schulick et al. 1997 and our 
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observations, data not published), and therefore we chose the 3-day timepoint 
as the first one in our experiments to ensure that we see the early effect of 
SOD3 expression. Here, the cell counts from mouse peritoneum revealed 
higher total number of leukocytes in virus-injected animals as compared to 
animals injected with PBS or Dexamethasone (MS II) indicating that 
adenovirus injection itself enhances inflammation. However, no animals had to 
be sacrificed prematurely because of virus-related problems suggesting that in 
our models the adenoviral gene transfer is reasonably safe. Additionally, we 
used replication-deficient viruses to avoid systemic spreading from the original 
injection site. Determination of the long-term health effects of adenoviral 
vector gene transfer in our models would require further studies. 
After determining the beneficial effects of SOD3 gene transfer we started to 
investigate how SOD3 regulates and is regulated by different signaling 
pathways. The pathways upstream and downstream of SOD3 are poorly 
characterized but it has been associated with various cellular events such as 
survival, migration and proliferation (Turkseven et al. 2007; Ueda et al. 2008; 
Na et al. 2007; Auten et al. 2006). The observed improvement in tissue healing 
lead us to study the well-known Ras/MAPK and Akt signaling pathways which 
are known to be activated under ischemic and inflammatory conditions to 
promote cell proliferation and survival (Arany et al. 2005; Kwon et al. 2006; 
Sung et al. 2007). Our Ras pull down assay and western blots showed clearly 
how SOD3 gene transfer induces phosphorylation of Ras small GTPase and its 
downstream signaling kinases MEK1/2 and Erk1/2 both in vivo at 7 days and 
in vitro (MS I). Interestingly, Akt was not activated in vivo but showed 
phosphorylation in vitro (MS I) underlining the importance of the cellular 
environment.  
Further analysis by luciferase assay of possible signaling events after Erk1/2 
activation showed upregulation of the transcription factors AP-1/c-Jun and 
CREB (MS I) which mediate the Ras/Erk signals (Cook et al. 1999; Arany et 
al. 2005). Moreover, two target genes for these transcription factors, VEGF and 
cyclin D1 (Wu et al. 2007; Shen et al. 2008), were significantly upregulated 
both in vivo 10 days after SOD3 and in vitro after SOD3, Ras, Braf, MEK1 and 
Erk1 gene transfers (MS I) indicating their involvement in this signaling 
pathway. VEGF expression is upregulated in ischemic muscle tissue, and it has 
been suggested that it induces an autocrine effect on the inflicted tissue during 
recovery from an ischemic insult to promote healing (Rissanen et al. 2002; 
Germani et al. 2003). Together these results demonstrate that one mechanism 
for SOD3 mediated tissue healing is the induction of mitogenic Ras-Erk1/2 
signaling, and subsequent growth factor expression and cell cycle progression.  
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The only substrate of the SOD3 enzyme is O2•
-
 which is frequently 
converted to H2O2. Thus, the regulatory functions of SOD3 depend on its 
ability to modulate the extracellular ROS balance. Exposure of the cells to Nox 
inhibitor DPI which abolishes O2•
-
 production reduced Ras/Erk 
phosphorylation, and transcription factor and target gene expression whereas 
H2O2 incubation increased them (MS I). It seems therefore that SOD3 
regulatory function is determined by substrate availability and that the end-
product H2O2 is the principal signal mediating molecule. Consistently, previous 
studies have found O2•
-
 and H2O2 to be associated with Ras and Erk activation 
(Lander et al. 1995; Milligan et al. 1998; Sigaud et al. 2005; Novo et al. 2006). 
The H2O2 incubation (500 µM for 6 hrs) done here equals to transient oxidative 
stress, which can induce the activation of Erk pathway and increase cell 
survival (Arany et al. 2004; Arany et al. 2005).  
In order to further characterize the relationship between Ras/Erk pathway 
and SOD3 expression we looked into the possibility of feedback mechanism 
regulating SOD3 function. We found that Ras, Braf, MEK1, and Erk1 
transfections increased significantly SOD3 protein activity whereas Akt had no 
effect (MS I) indicating that the Ras-Erk1/2 pathway can exert positive 
feedback to SOD3. The qPCR analysis confirmed that the increase in SOD3 
activity was due to increased mRNA expression (MS I). Thus, the mitogenic 
Ras-Erk1/2 pathway can enhance its own H2O2-dependent activation by 
inducing SOD3 gene expression until the original signal from tissue is 
gradually terminated during the healing process. Our data did not reveal the 
exact molecular mechanism stimulating SOD3 but we found that NADP 
induced SOD3 expression while DPI and MEK inhibitor UO126 reduced it 
(MS I). Additionally, SOD3 gene is suggested to have binding sites for at least 
two Erk1/2 regulated transcription factors, AP-1 and CREB, and also for 
glucocorticoid response element (GRE) and antioxidant response element 
(ARE) binding proteins (Folz and Crapo 1994). Consequently, feedback 
stimulation for SOD3 expression appears to depend on the substrate O2•
-
 
generation as well as Erk1/2 mediated transcription factor activation. 
Next, we set out to explain the observed anti-inflammatory function of 
SOD3 and analyzed its effect on leukocyte accumulation into the inflamed 
tissue. Neutrophils and macrophages are the first leukocyte populations to 
appear at the site (Fielding et al. 1993; Belcastro et al. 1996), and they are 
responsible for initial oxidative tissue damage brought about by the oxidative 
burst intended as the first-line defense against pathogens (reviewed by Jordan 
et al. 1999; reviewed by Fujiwara and Kobayashi 2005). High oxidative stress 
and tissue damage cause an inflammatory reaction which is nevertheless 
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required for the healing process initiation in muscle tissue (reviewed by Tidball 
2005). 
Our data showed that SOD3 inhibits leukocyte accumulation with the most 
prominent effect on the macrophage subpopulation, and minor effect on the 
neutrophils (MS II). The overall lymphocyte counts from both rat tissue 
sections at 3-day time point and mouse peritoneum remained low, probably 
because they characteristically migrate somewhat later; only 10 days after the 
gene transfer into rat hind limb was accumulation of CD3+ lymphocytes 
observed in LacZ control animals whereas in SOD3 treated animals the number 
of lymphocytes was still negligible (MS II). Lowered amount of O2•
-
 due to 
SOD3 activity at the injury site could partly explain the diminished 
macrophage accumulation since O2•
- 
has been found to enhance monocyte 
adhesion to endothelial cells and subsequent migration (Van der Goes et al. 
2001). 
Glucocorticoid drugs are potent inhibitors of leukocyte function and 
migration through various mechanisms, mainly inhibiting the expression of 
cytokines such as TNFα and MCP-1 (Steer et al. 2000; Zhou et al. 2007; 
Nehme and Edelman 2008), and are widely used in different clinical settings as 
anti-inflammatory and immunosuppressive drugs. We compared the effect of 
the clinically available glucocorticoid drug Dexamethasone and SOD3 on 
leukocyte accumulation into the mouse peritoneum, and found rather similar 
reduction in leukocyte counts in both groups with largest reduction again in the 
macrophage subpopulation and minor effect on the other subtypes (MS II). It 
seems therefore that SOD3 gene transfer has a potent anti-inflammatory effect 
similar to glucocorticoids regarding the leukocyte migration. However, direct 
functional comparisons cannot be done since the two molecules have different 
mechanisms of action. 
Endothelial activation and leukocyte migration is a complex interplay of 
numerous signaling molecules, such as chemo- and cytokines and adhesion 
molecules, secreted by leukocytes and endothelial cells alike (reviewed by Ley 
et al. 2007). Many of these molecules are regulated by the ROS sensitive NFκB 
transcription factor which activates early under cellular stress (reviewed by 
Ghosh et al. 1998; Souza et al. 2000). We performed an in vitro luciferase 
assay to determine how SOD3 influences the expression of NFκB in muscle 
tissue. After SOD3 transfection NFκB expression was significantly reduced 
(MS II) which is in line with previous studies showing attenuation of NFκB 
expression by SOD3 in lung and liver injuries (Bowler et al. 2001; He et al. 
2006). Interestingly, also the MEK-Erk pathway appears to inhibit NFκB 
(Janssen-Heininger et al. 1999), and therefore it would be interesting to further 
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study the Ras/Erk/SOD3 cascade effects on NFκB regulation, and its impact on 
the early inflammatory events. Additionally, we observed an increase in the 
expression of the main NFκB inhibitor, IκB, after SOD3 transfection (MS II). 
IκB is known to be regulated by multiple stimuli such as inflammatory 
cytokines, microbial lipopolysaccharides and oxidative stress which induce its 
phosphorylation and subsequent degradation (reviewed by Kabe et al. 2005), 
and therefore the influence of SOD3 on its expression would require further 
studies.  
Cytokines induce endothelial expression of several cell adhesion molecules 
which attach to their counterparts on the leukocytes and thus allow them to 
transmigrate through the vascular endothelium into the site of injury (reviewed 
by Ley et al. 2007). We therefore determined the expression of important 
NFκB regulated chemokines and cytokines three days after SOD3 or LacZ gene 
transfer in rat hind limbs. We found significantly reduced expression of the 
cytokines TNFα, IL1α, IL6, MIP2 and MCP-1 in AdSOD3 treated animals 
(MS II). Since TNFα, IL1α and IL6 are known to enhance cell adhesion 
molecule expression we also checked the relative expressions of the major 
adhesion molecules ICAM, VCAM, E-selectin and P-selectin. They all were 
significantly reduced in AdSOD3 treated rats as compared to the LacZ animals 
(MS II) indicating that SOD3 can indeed regulate cytokine expression and 
subsequent leukocyte recruitment through adhesion molecule expression. 
Similar results have been acquired previously in SOD3 knock-out and 
overexpressing mouse models (Bowler et al. 2004). These results also clarified 
the relationship between SOD3 and IκB. According to a study by Milligan and 
coworkers (1998) TNFα induces the proteolysis of IκB, and therefore SOD3 
mediated downregulation of this cytokine could partly explain the observed 
increase in IκB expression. 
The more pronounced effect of SOD3 on the macrophage population raised 
the question whether it has a specific effect on them. MCP-1 is a potent 
chemotactic factor for blood-borne monocytes but not tissue-resident 
macrophages (Sica et al. 1990; Lu et al. 1998), and its reduced expression 
could explain the marked reduction in the number of infiltrated macrophages 
which is supported by a previous study by Huang and coworkers (2001) (MS 
II). Additionally, MCP-1 does not affect the neutrophil subpopulation (Lu et al. 
1998) and therefore it was not surprising that their accumulation was not 
drastically decreased (MS II). Reduced number of macrophages could further 
explain the decreased expression of MIP2 (MS II) since they start to secrete it 
once activated attracting more neutrophils to the site (Wolpe et al. 1989; 
reviewed by Driscoll 1994). This would prevent neutrophil accumulation after 
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the initial phase of the inflammation and, thus, reduce the overall severity of 
the inflammatory reaction. Furthermore, the lack of neutrophil and macrophage 
accumulation could partly explain the absent lymphocyte infiltration since their 
presence is required for lymphocyte chemotaxis (Taub et al. 1996; Huang et al. 
2001; reviewed by Bosco et al. 2008). Consequently, we propose a second 
mechanism for SOD3 to enhance tissue healing in which SOD3 inhibits the 
early inflammatory reaction by downregulating cytokine and cell adhesion 
molecule expression thus reducing the oxidative damage induced by the 
accumulating neutrophils and macrophages. Souza and coworkers (2000) have 
previously suggested the dependence of early oxidative stress to the extent of 
tissue injury thus supporting our findings.  
According to our studies presented this far SOD3 seems to have an 
important role in attenuating the oxidative stress and tissue injury after an 
ischemic insult in rat hind limb muscle tissue or an immunogenic challenge 
with proteose peptone in mouse peritoneal cavity. Under normal circumstances 
SOD3 does not seem to have a particular role in these tissues and is 
upregulated only when necessary (van Deel et al. 2008). In this respect, the 
thyroid gland is an interesting organ since its oxidative status is much higher 
due to the H2O2 needed for the thyroid hormone synthesis, and a certain basal 
level of ROS is actually required for normal thyroid function (reviewed by 
Song et al. 2007; Poncin et al. 2009). Thyroid is known to have efficient 
antioxidative defense systems based on the various peroxiredoxins, glutathione 
peroxidases, thioredoxin and its reductase as well as catalase (reviewed by 
Song et al. 2007). However, the role of SOD3 has been only little characterized 
in thyroid function under normal or disease conditions. Therefore, we 
investigated the SOD3 expression in and its effect on normal thyroid gland and 
analyzed the changes in hyperproliferative glands. 
We first determined the degree of SOD3 expression in normal rat thyroid 
gland, and when compared to other tissues with higher than average oxidative 
status, namely aorta, kidney and liver, thyroid gland had expression levels 
close to those in aorta which is considered a major SOD3 expression site (MS 
III; Laukkanen et al. 2002). This represents only the relative amount of SOD3 
mRNA, and it would be useful to measure also SOD3 enzyme activity in 
thyroid tissue to see how it compares to the other tissues. Conveniently, 
Marklund (1984) has presented extensive data on SOD3 enzyme activity in 
different tissues of several animal species, and indeed thyroid SOD3 activity 
was consistently higher as compared to heart or the average of all tissues, 
respectively, supporting our finding. The differences were smaller in rat than in 
human but, on the other hand, even rather little changes in tissue SOD3 
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concentration can induce marked physiological effects as shown in MS I and 
previous studies (Laukkanen et al. 2001; Laukkanen et al. 2002). 
TSH, acting through the TSH-R, is the main regulatory factor of thyroid 
function being responsible for the thyrocyte proliferation as well as T3/T4 
hormone synthesis. Interestingly, we found out that TSH stimulation of thyroid 
cells upregulated SOD3 expression (MS III) which indicated some function for 
SOD3 in thyroid physiology. Proliferating cells in vitro increase their ROS 
production (Pani et al. 2000; Bello et al. 2003; Duval et al. 2003) and H2O2 is a 
crucial component in the process of thyroid hormone synthesis. Therefore, our 
next step was to assess whether the main thyroid signaling pathways 
downstream of TSH-R could stimulate SOD3 expression and whether SOD3 in 
turn could affect them. Indeed, stimulation of the cAMP dependent pathway 
leading to thyrocyte proliferation as well as the PLC dependent pathway 
leading to hormone synthesis both increased SOD3 expression (MS III). 
Additionally, Ca2+ is an important cofactor for the Duox2 activation 
(Ameziane-El-Hassani et al. 2005), and therefore the observed increase in 
SOD3 expression after thapsigargin administration (MS III) would indicate that 
SOD3 expression is induced during hormonogenesis. However, the H2O2 
generation capacity of Duox2 was considerably higher than that of SOD3 (MS 
III) and, thus, a role of SOD3 derived H2O2 in thyroid hormone synthesis 
seems very unlikely.  
On the other hand, our siRNA data (MSIII) suggests that SOD3 could rather 
participate in thyrocyte proliferation instead. Considering a previous study in 
which THS was found to activate the MAPK/Erk in rat FRTL-5 thyroid cells in 
a cAMP-dependent manner (Iacovelli et al. 2001) and our data on 
Ras/Erk/SOD3 cascade (MSI) there seems to be a possibility that TSH could 
induce SOD3 expression through Erk. However, later another study with dog 
and human thyrocytes suggested that the TSH effect is an artifact produced by 
proliferation stimulating contaminants in the hormone preparation (Vandeput et 
al. 2003). It was established, though, that Erk activation was still necessary for 
DNA synthesis in thyroid cells but the actual mechanism still remains 
uncertain. 
Goiter formation is a result of thyrocyte hyperproliferation due to various 
causes such as thyroid hormone depletion, TSH-R stimulating autoantibodies 
as in Grave‟s disease or dietary iodine deficiency producing overt TSH release 
and subsequent endemic goiter.  As an indication of heightened oxidative stress 
in goitrous thyroid gland the antioxidant enzymes peroxiredoxins and 
glutathione peroxidases as well as oxidized lipids are upregulated (Nadolnik 
and Valentyukevich 2007; Poncin et al. 2008a). However, usually the 
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antioxidant system can adequately process the increased ROS load during 
goitrogenesis and, thus, maintain the functionality of the gland (Poncin et al. 
2008a; Poncin et al. 2009). On the other hand, elevated but subtoxic H2O2 level 
has been shown to be a potent mitogenic factor in cell cultures (reviewed by 
Burdon 1995), and also in this study SOD3 promoted cell proliferation through 
increased Ras-mitogenic pathway activation and likely through H2O2 
generation (MS I). 
To determine whether SOD3 was involved in thyroid hyperproliferation, we 
induced goiter growth in rats with a PTU treatment and the analyses revealed 
significantly higher SOD3 expression in hyperproliferative goiter tissue (MS 
III), as has been previously shown in mouse models (Maier et al. 2007). 
However, the SOD3 expression level in human endemic goiter or toxic 
adenoma did not show any differences when compared to normal thyroid tissue 
although the standard deviations were larger suggesting higher variation in the 
human disorders (MS III). In addition, some discrepancy was observed in the 
rat goiter wet weight (MS III) which implies that PTU administration in 
drinking water is not necessarily a secure way to induce goiter since it is 
difficult to assess whether the animals drink similar amounts. It is also possible 
that the rat with extremely large goiter had an undetected deficiency or illness 
making it more vulnerable to thyroid hormone depletion. Therefore, it is likely 
that there are several regulatory mechanisms involved which determine the 
final SOD3 expression level in tissues. Furthermore, the results from rat and 
mouse models may not be fully comparable to the human disease which should 
be taken into account while interpreting and extrapolating the data. 
Hyperproliferation is characteristic also to transformed cells and therefore 
we investigated if SOD3 expression is further upregulated in cancerous thyroid 
cells in vitro and in vivo. To our surprise, a qPCR assay revealed a marked 
reduction of SOD3 mRNA in rat thyroid cancer cell lines and also in human 
patient samples (MS III). This experiment brought out an interesting 
controversy in SOD3 expression in goitrous and cancerous thyroid cells: SOD3 
expression increases in goiter and decreases in cancer. In many cases, cancer 
cells from e.g. ovary, pancreas, liver and breast are known to depend on high 
level of ROS generation which seems to aid in their proliferation (Szatrowski 
and Nathan 1991; Laurent et al. 2005; Teoh et al. 2007) since ROS and H2O2 
induce several mechanisms which promote tumor growth such as VEGF 
expression, angiogenesis and activation of MAPK pathways (Lin et al. 2007; 
Ushio-Fukai and Nakamura 2008). Our finding could be explained by the 
differential effect of SOD mimetics on normal and cancer cells described by 
Laurent and coworkers (2005) who suggest that such factors raise the H2O2 to 
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toxic levels for cancer cells with often defective antioxidant defenses but do 
not present a threat to normal cells and, thus, SOD downregulation would be 
beneficial for cancer progression. Therefore, SOD3 expression could be a 
necessity for goitrous hyperplastic thyrocytes which respond to proliferative 
H2O2 signal as they are still able to keep its concentration at a subtoxic level 
but in thyroid cancer tissue and cells the downregulated SOD3 could not raise 
the H2O2 level high enough to prevent their proliferation. 
Interestingly, the reduction in SOD3 expression was clearly dependent on 
the degree of cancer malignancy. In the least aggressive form, rat PC PTC 
cells, the SOD3 expression still remained at detectable level whereas in the 
very aggressive PC E1A cells, similar to human anaplastic carcinoma cells, it 
was almost completely missing (MS III). Similar tendency was seen in the PTC 
patient samples. Recent findings suggest that the increased number of Ras 
oncogene activating mutations correlate with the aggressiveness of thyroid 
tumor cells (Garcia-Rostan et al. 2003). Furthermore, excessive Ras activity 
could downregulate the traditional thyroid cancer differentiation markers such 
as Tg, TPO, NIS and some thyroid specific transcription factors possibly by 
epigenetic regulation (De Vita et al. 2005; Gazin et al. 2007). This model could 
also be applicable to our findings since SOD3 is known to have a GpC island 
whose methylation is decreased in the proliferating cell population in 
atherosclerotic plaques (Laukkanen et al. 1999). Accordingly, SOD3 
expression could be considered as a differentiation marker for thyroid cancer 
indicating approximately the level of transformation, but the true connections 
between Ras, SOD3 and cancer aggressiveness as well as the molecular 
mechanism of SOD3 downregulation require further in-depth studies. 
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6 CONCLUSIONS 
Our studies have elucidated the role of an antioxidative enzyme SOD3 in 
various tissues under normal and pathological conditions. Generally, SOD3 
expression is activated when the tissues are confronted with oxidative stress, 
and therefore we studied the effect of ischemic injury and inflammation on 
SOD3 expression. Furthermore, since thyroid gland is naturally under high 
oxidative stress even in normal conditions we wanted to see if SOD3 has a 
functional role in this organ. 
We found that SOD3 promoted tissue healing after an ischemic insult by at 
least two mechanisms. Firstly, SOD3 activated the Ras-Erk1/2 mitogenic 
pathway known to be a major regulator of cell proliferation. This pathway 
induced the pro-proliferative factors VEGF and cyclin D1 which resulted in 
myocyte proliferation. This study described a novel mechanism for SOD3 as a 
growth regulating molecule (MS I). Secondly, SOD3 prevented inflammatory 
leukocyte migration thereby reducing the oxidative stress induced tissue 
damage by neutrophils and macrophages. It had a marked inhibitory effect on 
the activation of the ROS sensitive transcription factor NFκB and the 
expression of many proinflammatory cytokines, chemokines and cell adhesion 
molecules which take part in leukocyte migration (MS II). 
Studies with the thyroid gland revealed an important role for SOD3 related 
to our previous findings (MS III). In thyroid gland SOD3 expression was high, 
comparable even to the known high level in the vasculature, and markedly 
stimulated by TSH suggesting a role in thyroid physiology. Indeed, we found 
that thyrocyte proliferation was partly dependent on the SOD3 expression in 
normal thyroid cells and, analogously, SOD3 expression was increased in 
hyperproliferative goitrous thyroid tissue. However, we discovered an 
interesting exception in thyroid cancer tissue: SOD3 expression was 
increasingly downregulated in correlation with cancer aggressiveness and 
despite the fact that oxidative stress and inflammation are common in tumor 
microenvironment.  
These studies have shown that SOD3 can act as a growth promoting factor 
in injured muscle tissue and in thyroid gland, as well as an anti-inflammatory 
factor regulating leukocyte migration. We have described new mechanisms of 
action for SOD3 at the molecular level, and started to characterize its 
previously poorly known role in the thyroid gland. According to our results 
SOD3 could be used as a therapeutic agent in treatment of ischemic injuries 
and as a differentiation marker in malignant thyroid transformation. 
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Extracellular superoxide dismutase (SOD3) gene therapy 
has been shown to attenuate tissue damages and to 
improve the recovery of the tissue injuries, but the cel-
lular events delivering the therapeutic response of the 
enzyme are not well defined. In the current work, we 
overexpressed SOD3 in rat hindlimb ischemia model 
to study the signal transduction and injury healing fol-
lowing the sod3 gene transfer. The data suggest a novel 
sod3 gene transfer–derived signal transduction cascade 
through Ras-Mek-Erk mitogenic pathway leading to acti-
vation of AP1 and CRE transcription factors, increased 
vascular endothelial growth factor (VEGF)-A and cyclin 
D1 expression, increased cell proliferation, and conse-
quently improved metabolic functionality of the injured 
tissue. Increased cell proliferation could explain the 
improved metabolic performance and the healing of the 
tissue damages after the sod3 gene transfer. The present 
data is a novel description of the molecular mechanism 
of SOD3-mediated recovery of tissue injury and suggests 
a new physiological role for SOD3 as a Ras regulatory 
molecule in signal transduction.
Received 7 July 2008; accepted 20 November 2008; advance online 
publication 23 December 2008. doi:10.1038/mt.2008.282
IntroductIon
Acute ischemic injury and consequent healing process involve 
a cascade of cellular events including increased expression of 
growth factors and endothelial cell migration and proliferation. 
Reactive oxygen species (ROS) that are synthesized in injured tis-
sues are important factors in injury response mediating a number 
of cellular functions.1–5 It has been previously reported that ROS, 
e.g., NADPH oxidase-derived superoxide anion (O2
•−) and hydro-
gen peroxide (H2O2), are able to activate cell stress Ras-Erk1/2 
signaling pathway leading to the induction of vascular endothelial 
growth factor (VEGF) production.6,7 However, the extracellular 
sources of H2O2 causing induction of signal transduction are not 
thoroughly investigated yet.
Superoxide dismutases (SOD1, SOD2, and SOD3) are utilizing 
O2
•− in dismutase reaction resulting in H2O2 formation, which is 
further metabolized to oxygen and water by catalase and glutathi-
one peroxidase.8–15 Extracellular superoxide dismutase, sod3, gene 
transfer has been shown to have a therapeutic response in various 
animal injury models e.g., hamster ischemia model, mouse liver 
intoxication model, and rabbit restenosis model16–19 indicating 
the importance of the enzyme for the tissue recovery. Commonly, 
SOD3 has been suggested to be an antioxidative enzyme12 that has 
also an anti-inflammatory nature,20 which could partially explain 
reduced injuries after sod3 gene transfer, but the exact cellular 
mechanisms leading to improved healing have not been defined.
In the present work, we focused on the SOD3-driven healing 
process in rat hindlimb ischemia injury model and characterized 
the cellular events derived from SOD3 gene transfer. According 
to our data, SOD3 caused at the biological level increased glucose 
metabolism and cell proliferation suggesting improved function-
ality of the tissue with consequent therapeutic response in the 
injured region. At the biochemical level, we identified a novel sig-
nal transduction pathway mediating the therapeutic response of 
adenovirus SOD3 (AdSOD3) gene transfer. SOD3 overexpression 
resulted in the activation of mitogenic Ras-Erk1/2 and PI3 kinase-
Akt signaling pathways with consequently increased expression 
of transcription factors (like CRE and AP1) and VEGF-A. The 
effect of SOD3 on the Ras growth factor pathway may at least 
partially explain the improved healing reported in our previous 
publications.17–19
results
AdSOD3 gene transfer improves the functionality  
of the injured tissue
SOD3 (AdSOD3) and LacZ (AdLacZ) adenoviruses (0.5 × 109 pfu) 
were injected into rat hindlimb muscle tissue simultaneously with 
ligation of femoral artery, and detected by β-galactosidase stain-
ing, reverse transcription (RT)-PCR techniques, and SOD activity 
measurement from Concanavalin A–purified muscle homoge-
nates at the end of the follow-up periods. The β-galactosidase 
staining showed in vivo expression of transferred gene in muscle 
and connective tissue cells at the injury site indicating that mostly 
these cells, and the cells having direct contact to them, medi-
ated the effect of adenovirus gene transfer. The overall transduc-
tion efficiency in the injury region in different time points varied 
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between 0.8 and 5% based on the X-gal staining. AdSOD3 mRNA 
expression in the injury was detected by RT-PCR amplifica-
tion of the expected 574 bp sequence from the muscle prepara-
tion (Figure 1a). The increased SOD enzyme activity caused by 
adenovirus gene transfer was determined from Concanavalin 
A–purified 3-day muscle tissue homogenates.21 The AdSOD3 gene 
transfer increased the tissue SOD3 activity approximately twofold 
as compared to LacZ control muscles (2.6 U/mg ±0.09 and 1.5 U/
mg ±0.31, P < 0.01, respectively). The overall effect of AdSOD3 
gene transfer at 3-daytime point on ROS and reactive nitrogen 
species by dihydroethidium and 3-nitrotyrosine is shown in 
Figure 1b, and is in line with the transgene expression as well as 
with the generally recognized antioxidative role of SOD3. We have 
demonstrated the in vivo antioxidative capacity of AdSOD3 in our 
previous reports using vascular wall as a model tissue,18,19 and a 
recent article suggested a major role for SOD3 in ROS and reac-
tive nitrogen species biology22–24 confirming that SOD3 is able to 
reduce expression of superoxide and reactive nitrogen species.
To study the healing of the injured tissue, we monitored the 
in vivo functionality by determining the ratio of radioactive [18F]
FDG glucose accumulation into injured vs. healthy hindlimb after 
systemic delivery of the Positron emission tomography marker. 
The analysis showed significantly (P < 0.05) increased tissue met-
abolic performance at 10-daytime point in AdSOD3 animals as 
compared to AdLacZ-transduced animals, which yielded higher 
signal ratio intensity between injury and healthy leg (Figure 1c). 
The individual differences in glucose metabolism in AdLacZ rats 
between injured and healthy uninjured leg were 46, 64, and 58% 
(56% ± 9.17), whereas the corresponding differences in AdSOD3 
rats were 24, 27, and 35% (29% ± 5.69).
Biological effects of SOD3 gene transfer
To analyze the biological phenomena responsible for the SOD3-
mediated injury recovery, we investigated the effects on angio-
genesis and proliferation. Interestingly, the analysis of new vessel 
formation in tissue sections showed increased vascular develop-
ment in both AdSOD3 and AdLacZ animals till 10-daytime point 
without significant differences (Figure 2a). On the other hand, 
when analyzing the cell proliferation in injured tissues by Ki67 
staining we found a significantly (P < 0.05) increased cell division 
in AdSOD3-transduced ischemic muscles at 3-day and 7-daytime 
points as compared to AdLacZ controls (Figure 2b), even though 
the overall proliferation rate in skeletal muscle tissue injury was 
extremely low (on average 0–8 cell proliferations/histological sec-
tion). These results lead us to hypothesize a proliferative effect of 
SOD3 as a mechanism of tissue injury healing upon sod3 gene 
transfer.
sod3 induces activation of the ras-erk and Akt 
signaling pathways
The analysis of the biological effects derived from sod3 gene trans-
fer and the finding of increased in vivo cell proliferation prompted 
us to investigate a role for SOD3 in controlling cell growth through 
mitogenic signaling cascades. Because it has been shown that 
H2O2 is able to activate the Ras-MAPK signaling pathway,
25 we 
investigated by pull-down assay the activation of Ras in response 
to SOD3 both in vivo and in vitro. As shown in Figure 3a, SOD3 
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Figure 1 detection of transgenes and their effect on glucose metab-
olism. (a) AdLacZ transgene expression at 3-day, 7-day, and 10-daytime 
points was analyzed with β-galactosidase staining and adenovirus super-
oxide dismutase 3 (AdSOD3) expression by reverse transcription (RT)-
PCR analysis; 1, uninjured control muscle; 2, AdLacZ control muscle; 3, 
AdSOD3-transduced muscle; 4, SOD3-positive control; 5, water control. 
Upper-lane amplification shows specific 574 bp sod3 RT-PCR fragment 
and lower lane 122 bp β-actin RT-PCR fragment. (b) Upper panels show 
in AdSOD3 tissues 28% decreased dihydroethidium (DHE) labeling for 
reactive oxygen species (P < 0.01). The lower panels show 3-nitrotyrosine 
staining for reactive nitrogen species modified proteins from 3-day tissue 
sections. (c) Positron emission tomography in vivo imaging. The analysis 
at 10-daytime point showed increased accumulation of [18F]FDG in the 
injury leg as compared to the healthy leg from the same animal reflecting 
decreased metabolic performance. The percentage describes the differ-
ence in accumulation between injured tissue and normal control tissue. 
Each imaging figure contains digital autoradiography of injury leg (i), 
control leg (c), and their corresponding hematoxylin–eosin stainings.
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Figure 2 determination of new vessel formation and cell prolif-
eration. (a) Measurement of capillary density from ischemic tissues. 
Solid line represents adenovirus superoxide dismutase 3 (AdSOD3) and 
hatched line AdLacZ animals. The neoangiogenesis increased in both 
groups till 10-daytime point. (b) Ki68 staining showed significantly 
increased proliferation in AdSOD3-treated skeletal muscles at 3-day 
and 7-daytime points. Solid line represents AdSOD3 and hatched line 
AdLacZ animals. Arrows indicate Ki67+ proliferating cells.
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markedly increased the GTP loading on Ras 7 days after AdSOD3 
gene transfer as well as after sod3 transfection into HEK 293T 
cells. Because NADPH oxidase and catalase are closely related to 
SOD3-driven reaction by providing the substrate and metaboliz-
ing the reaction end product, respectively, we checked their effects 
on SOD3-derived Ras activation. As shown in Figure 3a, diphe-
nyleneiodonium sulfate (DPI) caused clear reduction in Ras GTP 
loading, whereas catalase, as an intracellular molecule, had no 
inhibitory effect on SOD3-driven Ras activation. The dismutase 
reaction end product, H2O2, strongly induced Ras supporting 
our data that SOD3 is able to stimulate mitogenic signal cascade 
(Figure 3a, Supplementary Figure S1).
GTP-bound Ras is activating a number of signaling cascades, 
including angiogenic and mitogenic pathways. We, therefore, 
investigated the status of Mek1/2-Erk1/2 and PI3K-Ak pathways 
in response to sod3 gene transfer in vivo in tissue environment 
where other redox enzymes originating from different cell types 
are interacting with SOD3. Interestingly, AdSOD3 gene transfer 
caused increased in vivo phosphorylation of Mek1/2 and Erk1/2 
in rat hindlimb injury model at 7-daytime point, but the activa-
tion status of Akt in tissues was not affected by the virus trans-
duction supporting our observation that angiogenesis was not 
increased by AdSOD3 (Figure 3b, Supplementary Figure S1). 
To further characterize the signal transduction pathways and 
to study the interactions between different proteins in vitro, we 
chose HEK 293T cells as a model system, which show the gen-
eral effect on signaling that corresponds to previously published 
data. In cell culture conditions SOD3 increased phosphorylation 
of Mek1/2, Erk1/2, and Akt showing that a single-cell–type model 
may be functionally different from the tissues consisting of multi-
ple cell types with different functions (Figure 3b, Supplementary 
Figure S1). In line with Ras pull-down assay DPI showed mod-
est decrease in SOD3-derived Mek1/2 and Erk1/2 activation and 
H2O2 caused increased phosphorylation of Mek-Erk and PI3K-
Akt pathways.
The signal transduction cascades activated by Ras lead to 
changes in gene expression. Thereby, Ras signaling controls funda-
mental cell biological processes like proliferation, differentiation, 
survival, and invasion, which are mediated through the involve-
ment of several transcription factors inside the nucleus. We ana-
lyzed whether SOD3 could stimulate the activation of different 
transcription factors as final readout of the Ras-Mek1/2-Erk1/2 
pathway. As shown in Figure 3c, the co-transfections of sod3 with 
pAP1-Luc, pCRE-Luc, and pFA2-cJun luciferase reporter genes 
into HEK 293T cells resulted in significantly (P < 0.05) increased 
AP1 and cJun activity, which was evident also after H2O2 expo-
sure, whereas sod3-mediated increased CRE activation was not 
reproduced by H2O2 (Figure 3c). Interestingly, incubation of 
sod3-transfected cells with NADPH oxidase inhibitor DPI dimin-
ished the activation of the transcription factors, whereas catalase 
had no inhibitory effect on SOD3-derived activation. The activa-
tion of AP1 and CRE nuclear molecules could then explain the 
 proliferative effect mediated by SOD3 in vivo.
Finally, we analyzed the expression of the CRE/AP1 tar-
get genes cyclin D1 and vegf-a in vivo and in vitro. As shown in 
Figure 4a,c, 10 days after the injury, we found increased levels of 
both molecules upon AdSOD3 transduction. In AdSOD3 animals 
the vegf-a mRNA expression was increased threefold and cyclin D1 
twofold at 10-daytime point (P < 0.01 and P < 0.05, respectively) 
as compared to uninjured muscle preparation (Figure 4a,c). 
Interestingly, the cyclin D1 expression in AdLacZ rats was sixfold 
decreased as compared to AdSOD3 tissues (P < 0.01) supporting 
the pro-proliferative effect of sod3 gene transfer. These data are in 
line with our observation that the sod3/Ras/Braf/Mek/Erk mole-
cules have a clear stimulatory impact on both cyclin D1 and vegf-a 
mRNA synthesis, as shown by qRT-PCR analysis (Figure 4b,d).
A positive feedback loop couples ras and sod3
To determine the possibility for feedback stimulation of SOD3 
we measured the levels and the activity of SOD3 in HEK 293T 
cells transiently transfected with Ras, Braf, Mek1, Erk1, and Akt. 
Interestingly, mRNA levels and protein activity of SOD3 increased 
upon expression of Ras/Erk but not of Akt (Figure 4e,f). Further on, 
incubation of HEK 293T cells for 6 hours with 500 µmol/l concen-
tration of SOD3 dismutase reaction end product, H2O2, or 50 ng/ml 
NADP significantly increased (P < 0.05 and P < 0.001, respectively) 
sod3 mRNA production. Finally, a Mek-specific inhibitor, U0126, 
and DPI showed decreased sod3 mRNA expression (P < 0.05) con-
firming that Ras-Erk1/2 pathway is a major signal transduction 
cascade controlling SOD3 production, which is also controlled by 
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Figure 3 superoxide dismutase 3 (sod3)-derived signal transduc-
tion. (a) Pull-down assay resulted in Ras activation after sod3 gene trans-
fer in vivo (AdLacZ and AdSOD) and in vitro (control, SOD3, SOD3 + DPI, 
SOD3 + catalase, H2O2). (b) SOD3 affects the phosphorylation of growth 
factor signaling molecules. Analysis of Mek1/2 and Erk1/2 phosphory-
lation from 7-day adenovirus SOD3 (AdSOD3) tissue homogenates 
showed increased Mek1/2 and Erk1/2 phosphorylation as compared to 
AdLacZ control muscles. In vitro analysis SOD3 transfection increased 
phosphorylation of Akt and Mek-Erk signaling pathways. (c) Luciferase 
activity assay showed increased SOD3-driven activation of AP1, cJun, 
and CRE, which was affected by NADPH oxidase inhibitor DPI but not 
by catalase.
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NADPH oxidase activity. These observations together with ability 
of SOD3 to activate Ras-Erk and Akt led us to postulate that Ras 
and SOD3 activation might be coordinately regulated through a 
positive feedback loop most likely through H2O2.
dIscussIon
Hindlimb ischemia creates an optimal in vivo environment to 
study the interaction between redox molecules and surrounding 
tissue in response to changes in tissue homeostasis. We have pre-
viously demonstrated SOD3-derived therapeutic effect in differ-
ent injury models,17–19 although the exact molecular mechanism 
responsible for the response has not been presented yet. In the 
current work, we investigated the mechanism of SOD3-derived 
healing focusing on the influence of SOD3 on intracellular signal-
ing networks and consequent biological responses. We used aden-
ovirus-mediated gene transfer to obtain high temporal expression 
and clear cellular response in the target tissue, which is further 
enhanced by the ability of secreted SOD3 to reversibly bind to 
the cell membranes,26,27 bringing cells that are not infected by the 
virus vector under the influence of exogenous SOD3. Staining 
of AdLacZ-transducted tissue sections showed strong expres-
sion that was scattered over the injury region indicating spread-
ing of the virus from initial injection sites expanding the injury 
region affected by the virus-mediated expression of the transgenes 
(Figure 1a). We have previously shown in a mouse model that 
relatively high virus amount, 1 × 109 pfu, is needed to significantly 
increase plasma SOD activity after systemic tail vein injection of 
AdSOD3,17 which could be explained by tight posttranscriptional 
and posttranslational regulation of sod3 affecting also transgene 
expression in the target tissues.28–30 The twofold increase in the 
total SOD3 activity in Concanavalin A–purified muscle homoge-
nates after AdSOD3 gene transfer yielding a therapeutic response 
is in line with our previous studies showing decreased LDL oxida-
tion in vitro with 10 ng/ml concentrations,28 and decreased liver 
damages and attenuated neointima formation with two- to three-
fold increased SOD3 concentrations.17,18
In the current work, we observed higher in vivo functional 
muscle metabolic performance in Positron emission tomography 
imaging of AdSOD3-transduced tissues as compared to AdLacZ 
controls (Figure 1c), suggesting an important role for SOD3 in 
controlling the growth factor pathway leading to improved tissue 
injury healing. It is noteworthy that decreased accumulation of 
[18F]FDG Positron emission tomography tracer demonstrated the 
biological functionality of the AdSOD3 gene transfer proving that 
adenovirus-derived expression of SOD3 results in a therapeutic 
response in vivo. To explain the improved tissue functionality 
caused by AdSOD3 gene transfer, we first focused on angiogen-
esis in damaged muscles. Endothelial staining analysis showed 
increased new vessel formation both in AdSOD3 and AdLacZ rats 
without significant differences (Figure 2a), therefore, suggesting 
that SOD3 is not a major angiogenic factor and that the SOD3-
mediated, improved metabolic performance of injured tissue is not 
due to promotion of new vessel formation. We next investigated 
whether the sod3 gene transfer could correspond to increased cell 
division. Ki67 staining for proliferating cells in injured muscle 
tissues showed a two- to sevenfold increase in AdSOD3-treated 
animals at 3-day and 7-daytime points (Figure 2b). Such a phe-
nomenon could at least partially explain the observed improved 
performance in glucose metabolism.
To explain the mechanism causing the increased cell prolifera-
tion, we focused on the intracellular signaling activated by either 
AdSOD3 in vivo or by sod3 transfection in vitro. Both AdSOD3 
transduction of tissues and transient transfection of sod3 activated 
Ras G-protein in the target cells, indicating a regulatory role for 
the enzyme in mitogenic signal transduction. Interestingly, DPI 
attenuated SOD3-derived Ras activation showing an upstream 
regulatory effect for NADPH oxidase in SOD3 signaling, suggest-
ing that the availability of the substrate superoxide anion creates a 
rate-limiting step in the dismutase reaction. Hydrogen peroxide–
derived Ras activation, on the other hand, suggests that SOD3 sig-
nal is mediated by the dismutase reaction end product (Figure 3a). 
Previous studies have shown that H2O2 is able induce the phos-
phorylation of a large number of cell surface molecules, such as 
fibroblast growth factor receptor 1,31 epidermal growth factor 
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Figure 4 Gene expression analysis from 10-day tissue samples. 
Hatched bar represents uninjured control tissue, white bar represents 
AdLacZ-transduced tissue, and black bar adenovirus superoxide dis-
mutase 3 (AdSOD3) transduced tissue. (a) Quantitative reverse tran-
scription (RT)-PCR analysis for vegf-a expression in injured tissue. 
AdSOD3 increased significantly rat vegf-a mRNA production. (b) Vegf-a 
mRNA expression was significantly increased in vitro after transfection 
with sod3 and mitogenic signaling pathway molecules RasV12, Braf 
V600E, Mek1, and Erk1. (c) Quantitative RT-PCR analysis for cyclin D1 
expression in injured tissue. AdSOD3 increased significantly cyclin D1 
expression in damaged tissue as compared to normal, uninjured con-
trol tissue. Difference was more prominent when compared to AdLacZ-
treated tissue injury. (d) Cyclin D1 mRNA expression after sod3, RasV12, 
Braf V600E, Mek1, and Erk1 transfection in vitro. (e) SOD protein activity 
is activated in vitro by mitogenic Ras-Erk1 pathway molecules, and by 
H2O2 treatment. Akt transfection failed to increase the SOD3 production. 
(f) Quantitative RT-PCR analysis shows that increased SOD activity was 
due to increased sod3 mRNA production.
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receptor,32 platelet-derived growth factor receptor β,33 Axl recep-
tor tyrosine kinase,34 and insulin receptor,35 which all are involved 
in Ras G-protein activation. In addition, H2O2 can mediate the 
cellular signaling by inactivating protein tyrosine phosphatases,36 
suggesting a wide variety of cell membrane–associated molecules 
involved in H2O2 signaling. Therefore, it is likely that the effect of 
SOD3 on Ras-Erk activation is not mediated by a single factor but 
rather by a collaborative effect of tyrosine kinase receptors and 
protein tyrosine phosphatases.
By analyzing the Ras-Erk pathway, we detected increased 
phosphorylation in Mek1/2 and Erk1/2 mitogenic signal trans-
duction pathway in AdSOD3-treated hindlimb injuries. To con-
firm these observations, we then investigated the same pathway 
in vitro. Transfection of sod3 promoted the activation of Mek1/2 
and Erk1/2, suggesting that SOD3 is able to modulate mitogenic 
growth signaling. The Akt phosphorylation was increased in vitro 
but not in vivo, further stressing the importance of mitogenic 
pathway activation after sod3 gene transfer (Figure 3b).
Finally, at the nuclear level, our experiments proved that SOD3 
significantly induces CRE and AP1/cJun transcription factors 
(Figure 3c) that are known to be involved in cell survival through 
activation of target genes such as vegf-a and cyclin D1.37,38 In line 
with Ras pull-down assay, luciferase assay showed decreased CRE 
and AP1/cJun activation in the presence of DPI, whereas catalase 
had no inhibitory effect on SOD3-derived transcription factor 
activation, further suggesting the regulatory effect of substrate 
availability on SOD3 activity.
Interestingly, previous reports have shown the ability of 
VEGF-A to promote new myoblast generation after muscle 
transplantation,39 to enhance myoblast migration, and to decrease 
apoptosis in hindlimb ischemia model,40 suggesting more gen-
eral proliferative effect for VEGF-A. To further analyze the role 
of SOD3 in tissue recovery and in increased cell proliferation in 
recovering muscles, we determined the effect of AdSOD3 gene 
transfer on VEGF-A (Figure 4). The analysis of vegf-a expres-
sion from the damaged tissues showed that AdSOD3 gene transfer 
significantly increased rat endogenous vegf-a mRNA expression. 
Accordingly, the MAPK mitogenic pathway has been shown to 
be involved in tissue damage recovery causing increased cell pro-
liferation.41 Transfection of RasV12, Braf V600E, Mek1, and Erk1 
into HEK 293T cells increased vegf-a mRNA production in vitro, 
supporting the connection between SOD3 and VEGF-A signal 
transduction. Even though SOD3 failed to increase Akt phospho-
rylation in vivo, increased vegf-a expression can be explained by 
SOD3-driven activation of Ras-Erk mitogenic pathway. Moreover, 
we also identified activation of cyclin D1 expression in vivo in 
response to sod3 gene transfer supporting AdSOD3-driven cell 
proliferation. To further characterize SOD3-related signaling, we 
investigated the effect of Ras-Erk pathway on SOD3. By transfect-
ing RasV12, Braf V600E, Mek1, Erk1, and Akt into HEK 293T cells 
we observed increased SOD3 production, suggesting a possible 
positive feedback on SOD3-mediated Ras activation. Lastly, as a 
final confirmation for the regulatory role of NADPH oxidase in 
sod3 gene expression, NAPD significantly increased and DPI sig-
nificantly reduced endogenous sod3 mRNA synthesis, suggesting 
that extracellular H2O2 production is linked to the availability of 
extracellular superoxide anion.
In summary, we have shown that SOD3 regulates molecules 
of the Ras-Erk cascade and promotes nuclear signals of cellular 
proliferation and demonstrated how AdSOD3 gene transfer into 
hindlimb ischemia affects the endogenous vegf-a and cyclin D1 
expression. A scheme of the suggested signaling pathway causing 
SOD3-mediated cellular responses is described in Figure 5. SOD3 
activates the Ras-Braf-Mek1/2-Erk1/2 and Akt signal transduc-
tion by increasing Ras GTP loading. The activation of the cascade 
leads to the nuclear events through the involvement of the CRE 
and AP1/cJun transcription factors that, by increasing the expres-
sion of cell survival and proliferation-related target genes, induce 
improved healing process.
In conclusion, our findings describe a novel physiological 
role for SOD3 as a Ras signal transduction pathway regulatory 
molecule that is able to stimulate mitogenic signaling and eluci-
date the molecular mechanism for SOD3 gene transfer–mediated 
 therapeutic response in tissue damages.
MAterIAls And Methods
Adenovirus production. Rabbit sod3 and bacterial β-galactosidase cDNAs 
were cloned into replication-deficient E1-partially-E3-deleted AdBglII for 
AdSOD3 and AdLacZ adenovirus production in 293 cells in the University 
of Turku Biotechnology Center as described.28,42 The virus titer was adjusted 
to 1 × 1010 pfu/ml for gene transfer experiments.
Hindlimb injury. Male 4- to 5-weeks-old (86–115 g) Fisher 344 rats (n = 
16) (Harlan, Horst, the Netherlands) randomized to 3-day, 7-day, 10-day, 
and 14-day groups were anesthetized with intraperitoneal administra-
tion of fentanyl-fluanisone (Janssen Pharmaceutica, Beerse, Belgium) and 
midazolame (Roche, Basel, Switzerland). Hindlimb ischemia was induced 
by surgical closure of the proximal femoral artery, lateral circumflex femo-
ral artery, and distal femoral artery. The gene transfer with 0.5 × 109 pfu 
AdSOD3 or AdLacZ in 50 µl volume was done immediately after ligation 
SOD3
Ras
Braf
Mek1/2
Erk1/2
Increased
cell proliferation
SOD3-mediated healing
Akt
Figure 5 suggested signaling pathway for superoxide dismutase 3 
(sod3). SOD3 transfection activates Ras GTP loading, causing increased 
phosphorylation of Ras-Erk and PI3K-Akt pathways. The activation of 
mitogenic signaling cascade could explain partly the improved healing 
in SOD3 gene therapy experiments. The SOD3-driven Ras activation 
and Ras-Braf-Mek1-Erk1-derived increased production of SOD3 suggests 
positive feedback for SOD3 at the level of Ras.
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of the vessels. Uninjured muscle tissue was used as an additional control. 
Experimental Animal Committee of Turku University approved all experi-
mental procedures according to the European Union guidelines.
Immunohistochemistry. Muscle tissues were embedded in optimal cutting 
temperature compound (Tissue-Tek, San Francisco, CA). Ten microm-
eter sections were stained with X-gal (Promega, Madison, WI), CD68 
(Serotec, Oxford, UK), von Willebrand Factor (Abcam, Cambridge, UK), 
Ki67 (DakoCytomation, Glostrup, Denmark), 3-nitrotyrosine (Millipore, 
Billerica, MA), and counterstained with hematoxylin/eosin (Sigma, 
St Louis, MO). ROS were detected from fresh tissue sections by dihydro-
ethidium bromide staining as described previously and ratio of dihydro-
ethidium-positive nuclei/total nuclei was counted.
PCR. Messenger RNA was isolated from the pool of three to four animals 
or HEK 293T cells using Tri-reagent (Sigma) and GenElute mRNA mini-
prep kit (Sigma). The first strand synthesis was done using Revert-Aid 
M-MuLV (Fermentas, Burlington, Canada), PCR with JumpStart RedTaq 
ReadyMix (Sigma), and quantitative RT-PCR with SYBR Green PCR mas-
ter mix (Applied Biosystems, Foster City, CA). Primers and cycling condi-
tions are shown in the Table 1.
Cell culture experiments. Signaling molecules and control vectors were 
transfected with Polyfect transfection reagent (Sigma) in to HEK 293T cells 
for expression studies. To determine the endogenous SOD3 expression, cells 
were treated with 20 µmol/l Mek inhibitor U0126 (Sigma), 500 µmol/l H2O2 
(Sigma), 50 ng/ml NADP (Sigma), or 20 µmol/l DPI for 6 hours in serum-
free media. Serum and cell samples were taken after incubation in serum-
free medium for total SOD activity and quantitative RT-PCR analysis.
SOD3 protein activity assay. SOD total protein activity was determined as 
described.43 Control vector transfection and serum-free media were used 
as controls for plasmid transfections and H2O2 incubations.
Concanavalin A sepharose purification. Concanavalin A sepharose (GE 
Healthcare, Chalfont St Giles, UK) purification was done as described.21 
Briefly, the tissues were homogenated, centrifuged, and applied to column 
in 500 µl volumes. The columns were washed with phosphate buffer, and 
SOD3 was eluted with 150 mmol/l α-methyl D-mannoside in 50 mmol/l 
sodium phosphate buffer.
Reporter assay. HEK 293T cells were transfected with expression vectors 
together with pAP1-Luc, pCRE-Luc, and pFA2-cJun luciferase reporters 
(Stratagene, Cedar Creek, TX). Luciferase activity was quantified with Tecan 
Ultra XFluor4 Fluorescence Reader (Tekan, Mannedorf, Switzerlard).
Western blotting analysis. Tissue samples or HEK 293T cells were homog-
enized in lysis buffer (50 mmol/l HEPES pH 7.5, 150 mmol/l NaCl, 10% 
glycerol, 1% Triton X-100, 1 mmol/l EGTA, 1.5 mmol/l MgCl2, 10 mmol/l 
NaF, 10 mmol/l sodium pyrophosphate, 1 mmol/l Na3VO4, 10 µg appro-
tinin/ml, 10 µg leupeptin/ml) (Sigma). Antibodies were rabbit anti-Braf 
(Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-Mek1/2 (Cell 
Signaling, Danvers, MA), pMek1/2 (Cell Signaling), 44/42 MAPK (Cell 
Signaling), p44/42 MAPK (Cell Signaling), Akt (Cell Signaling), and pAkt 
(Cell Signaling).
Ras pull-down assay. HEK 293T cells at 10 cm dishes were transfected 
with 5 µg of plasmids. The supernatant from lysed cells or tissue homo-
genates was incubated with GST-Raf1-RBD beads for 15 minutes at 4 °C 
and washed with lysis buffer. Active Ras G-protein-containing beads were 
collected, prepared for western blot, and analyzed by mouse anti-Ras 
(Upstate).
Analysis of in vivo glucose metabolism. Positron emission tomography 
imaging was done to 10-daytime point animals as described previously.44 
Sequential 30 µm cryo sections were exposed to imaging plate (Fuji, Tokyo, 
Japan) and scanned with Fuji Analyser (Fuji).
Statistical analysis. Statistical analysis was done using two-tail t-test for 
means.
suPPleMentArY MAterIAl
Figure S1. Signal intensities for western blot analysis in Figure 3a,b.
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SOD3 Reduces Inflammatory Cell Migration by
Regulating Adhesion Molecule and Cytokine Expression
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Abstract
Inflammatory cell migration characteristic of ischemic damages has a dual role providing the tissue with factors needed for
tissue injury recovery simultaneously causing deleterious development depending on the quality and the quantity of
infiltrated cells. Extracellular superoxide dismutase (SOD3) has been shown to have an anti-inflammatory role in ischemic
injuries where it increases the recovery process by activating mitogen signal transduction and increasing cell proliferation.
However, SOD3 derived effects on inflammatory cytokine and adhesion molecule expression, which would explain reduced
inflammation in vascular lesions, has not been properly characterized. In the present work the effect of SOD3 on the
inflammatory cell extravasation was studied in vivo in rat hind limb ischemia and mouse peritonitis models by identifying
the migrated cells and analyzing SOD3-derived response on inflammatory cytokine and adhesion molecule expression.
SOD3 overexpression significantly reduced TNFa, IL1a, IL6, MIP2, and MCP-1 cytokine and VCAM, ICAM, P-selectin, and E-
selectin adhesion molecule expressions in injured tissues. Consequently the mononuclear cell, especially CD68+ monocyte
and CD3+ T cell infiltration were significantly decreased whereas granulocyte migration was less affected. According to our
data SOD3 has a selective anti-inflammatory role in ischemic damages preventing the migration of reactive oxygen
producing monocyte/macrophages, which in excessive amounts could potentially further intensify the tissue injuries
therefore suggesting potential for SOD3 in treatment of inflammatory disorders.
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Introduction
The inflammatory process is initiated by endothelial cell (EC)
activation comprising upregulation of chemokines and cell
adhesion molecules, leukocyte activation and transmigration,
and secretion of proinflammatory factors by leukocytes [1]. The
inflammatory reaction is necessary for tissue recovery as it
provides the correct cytokine signals and cell machinery to clear
up the site for regeneration of the tissue [2]. However,
uncontrolled inflammation has unfavorable effects on the course
of tissue healing since the inflammatory cells are also capable of
inducing tissue damage [2] and therefore many conditions
involving inflammation, e.g. autoimmune diseases and tissue
transplantations, are treated with immunosuppressants to reduce
harmful leukocyte infiltration. Among the most potent drugs are
glucocorticoids that downregulate the expression of numerous
inflammatory chemokines, cytokines and adhesion molecules [3–
5], which, however, are not entirely without adverse effects such as
delayed myocardial tissue healing, osteoporosis, and blood vessel
calcification [6–9].
The most prominent outcome in the initial phase of
inflammation is the enhanced production of cytokines, such as
TNF-a and IL-1, and chemokines, such as monocyte chemoat-
tractant protein-1 (MCP-1) [10,11], which further induce
expression of a number of inflammatory cytokines [4]. Many of
the stimulus-specific pathways converge in the production of
superoxide (O2
2) and hydrogen peroxide (H2O2) as signal
mediators, which in turn result in e.g. NFkB activation responsible
for numerous stress-related functions [12–14]. Leukocytes are thus
recruited by expression of various cell adhesion molecules, e.g.
selectins, and intercellular and vascular cell adhesion molecules
(ICAM-1 and VCAM-1, respectively) [15,16]. They promote
rolling and firm adhesion of leukocytes to endothelial wall, the
necessary interactions preceding transmigration [17]. To aid
leukocyte migration the vessel wall cells change their morphology
by assuming cytoskeletal and cell-cell junction modifications in
response to e.g. ligand binding to ICAM-1 and VCAM-1 [18–20],
and when stimulated by O2
2 or TNF-a [21,22].
Previously, it has been shown that extracellular superoxide
dismutase (SOD3) can attenuate tissue damage and inflammation
but so far its mechanism of action has not been completely defined
[23–27]. Since excess inflammation prevents the tissue injury
recovery we investigated in the present study the effect of SOD3
overexpression on cell migration. We used two in vivo acute
inflammation models to determine how SOD3 affects leukocyte
extravasation, and compared the results to efficacy of the
glucocorticoid immunosuppressant dexamethasone. The mouse
peritonitis and rat hind limb ischemia models have been
characterized previously: they induce rapid infiltration of leuko-
cytes to the peritoneal cavity and large femoral muscles,
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respectively [28–30]. We then analyzed the proportions of the
infiltrated leukocyte subtypes, and determined the effects on
several mediators of the inflammatory reaction.
Materials and Methods
Ischemia model
Fischer 344 rats (Harlan, Horst, Netherlands) and Balb/C mice
(local colony) were maintained in specific pathogen-free conditions
and had access to food and water ad libitum. All experimental
procedures were approved by the Experimental Animal Commit-
tee of University of Turku.
Ischemic hind limb injury was induced to male Fischer 344 rats
(5 to 6 weeks old, 86–115 g) by surgical closure of the distal
femoral artery, lateral circumflex femoral artery, and the proximal
femoral artery. The animals were anesthetized for the procedure
by intra peritoneal administration of fentanyl fluanisone (Janssen
Pharmaceutica, Beerse, Belgium) and midazolame (Roche, Basel,
Switzerland). Gene transfer was done immediately after the
ligation by intra muscular injection of 0.56109 pfu adenovirus
SOD3 (AdSOD3) or LacZ (AdLacZ) in 50 ml PBS as described
[27,31,32]. Uninjured muscle tissue was used as control.
Peritonitis model
Gene transfer was done to 8–10 week old female balb/c mice with
intra peritoneal injection of 0.56109 pfu AdSOD3 or AdLacZ.
Acute peritoneal inflammation was induced 72 hours later by i.p.
injection of 1 ml PBS containing 5% proteose peptone (BD Difco,
Sparks, MD, USA) and 10 ng of IL-1b (R&D Systems, Minneapolis,
MN, USA). As a control treatment, animals were given 50 mg/kg of
Dexamethasone (Oradexon, Organon, Oss, Holland) half an hour
before proteose peptone injection. Cells from the peritoneal cavity
were collected 18 hours after the induction of inflammation by
washing with 10 ml of RPMI containing 5 U/ml heparin (Løvens
Kemiske Fabrik, Ballerup, Denmark). Cells from peritoneal lavage
were counted and cytocentrifuged at 1000 rpm for 5 minutes
(Shandon cytospin 3, Shandon, Pittsburgh, PA, USA). Slides were
stained with Reastain Diff-Quick (Reagena, Toivala, Finland) to
analyze different leukocyte subtypes.
Immunohistochemistry
Rat muscle samples were frozen in liquid nitrogen and
embedded in Tissue-Tek optimal cutting temperature compound
(Sakura Finetek, Torrance, CA, USA). Ten micrometer sections
were fixed in acetone and stained with rabbit anti-rat CD3 and
mouse anti-rat CD68 (Serotec, Oxford, UK). The sections were
counterstained with hematoxylin/eosin (Sigma, Saint Louis, MI,
USA). The number of CD3+ and CD68+ cells were analyzed from
whole sections with Zeiss Axiovert 200 M (Carl Zeiss, Oberko-
chen, Germany).
Reporter assay
HEK 293T cells were used for in vitro assay to provide a general
cell model that we have previously used in our reporter,
expression, and cell signalling studies allowing the comparison of
the data with our previous results. HEK 293T cells were
transfected with SOD3 expression vector together with pNFkB
Luc reporter (Stratagene, Cedar Creek, TX, USA). Luciferase
activity was quantified with Tecan Ultra XFluor4 Fluorescence
Reader (Tekan, Mannedorf, Switzerlard).
Western blot analysis
HEK293 cells were homogenized in lysis buffer (50 mmol/l
HEPES pH 7.5, 150 mmol/l NaCl, 10% glycerol, 1% Triton X-
100, 1 mmol/l MgCl, 10 mmol/l NaF, 10 mmol/l sodium
pyrophosphate, 1 mmol/l Na3VO4, 10 mg/ml approtinin, 10 mg/
ml leupeptin) (Sigma, Saint Louis, MI, USA). Mouse anti-human a-
IkB (Santa Cruz, Santa Cruz, CA, USA) was used to detect IkB
levels from tissues.
Quantitative PCR
Total RNA was extracted from a pool of four animals using Tri-
reagent (Sigma, Saint Louis, MI, USA). The first strand synthesis
was done with Revert-Aid M-MuLV (Fermentas, Burlington,
Canada), and the following quantitative PCR with SYBR Green
PCR master mix (Applied Biosystems, Foster City, CA). Primers
and cycling conditions are shown in the Table 1.
Statistical Analysis
All results are expressed as mean6SEM. A paired t-test was
used to determine differences between groups.
Results
SOD3 inhibits leukocyte migration in acute ischemia
Neutrophils, macrophages, and other inflammatory cells
mediate a number of important cellular functions in injured tissue
[33,34]. Phagocytotic macrophages clear cellular debris and
secrete inflammatory cytokines such as MIP-2, a strong neutrophil
attracting agent leading to further increase in inflammatory
signaling [35]. However, excessive inflammatory reaction may also
contribute to tissue damage by enhancing macrophage infiltration,
which increases tissue free radical load leading to further tissue
injury [36]. In addition, decreased neutrophil accumulation leads
to reduced infarct size, reduced vascular permeability, and
resistance in ischemia/reperfusion (I/R) injury [37,38]. Thus, it
is suggested that the tissue recovery is dependent on the factors
Table 1. Primers and cycling conditions.
Gene Primer Tm
TNFa for AGA TGT GGA ACT GGC AGA GG 60
TNFa rev CCC ATT TGG GAA CTT CTC CT
IL-1a for TCG GGA GGA GAC GAC TCT AA 58
IL-1a rev GAA AGC TGC GGA TGT GAA GT
IL-6 for CCG GAG AGG AGA CTT CAC AG 55
IL-6 rev ACA GTG CAT CAT CGC TGT TC
MCP-1 for CTC ACC TGC TGC TAC TCA TTC ACT 55
MCP-1 rev TGC TGC TGG TGA TTC TCT TGT AGT
MIP2 for ATC CAG AGC TTG ACG GTG AC 55
MIP2 rev GGA CTT GCC GCT CTT CAG TA
ICAM for AGG TAT CCA TCC ATC CCA CA 55
ICAM rev GCC ACA GTT CTC AAA GCA CA
VCAM for TGA CAT CTC CCC TGG ATC TC 55
VCAM rev CTC CAG TTT CCT TCG CTG AC
PSEL for TTC CCA CAC TTC CTT CTG CT 57
PSEL rev CAC GCT GTA GTC GGG GTA TT
ESEL for TTT TTG GCA CGG TAT GTG AA 57
ESEL rev AGG TTG CTG CCA CAG AGA GT
b-actin for TCG TGC GTG ACA TTA AGG AG 55
b-actin rev GTC AGG CAG CTC GTA GCT CT
doi:10.1371/journal.pone.0005786.t001
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regulating the inflammatory cell migration into the injuries. In the
present work we studied leukocyte migration in acute ischemia and
peritonitis models and analyzed the contribution of SOD3 on
inflammatory cytokine and adhesion molecule expression.
We determined the effect of SOD3 overexpression on the
degree of inflammation by analyzing the size of inflamed tissue
and the number of infiltrated macrophages and T cells in acute
ischemic injury model. In a mouse model of femoral artery
ligation, macrophage infiltration into ischemic muscle reaches
peak values 3 days after the injury [39]. Histological analysis of the
rat hind limb ischemia showed 3-fold reduction in the inflamed
tissue area as determined by the presence of CD68+ macrophages
(p,0.001) in SOD3 vs. LacZ control animals 3 days after vessel
ligation (Figure 1). The reduction became even more prominent in
later time points reaching 12-fold difference 10 days after vessel
ligation. Additionally, the number of infiltrated CD68+ macro-
phages was 3–5 fold higher in LacZ control animals as compared
to SOD3 animals (p,0.05). Maximal macrophage accumulation
to the injured tissue was seen at 7-day time point in LacZ animals
indicating that the inflammatory reaction was still developing in
control animals at the initial phase of the follow-up period while
the inflammation was decreasing in SOD3 animals. Throughout
the experiment the number of macrophages remained higher in
control animals than initially observed in SOD3 animals, which by
the 10-day time point showed values close to the background levels
further underlining the beneficial effect of SOD3.
Figure 1. Reduced macrophage infiltration in to ischemic muscle. Open bars represent LacZ animals and black bars represent SOD3 animals.
CD68 staining showed significantly reduced inflammatory area and macrophage infiltration in SOD3 animals at all time points studied. Histological
stainings show CD68+ macrophages around the femoral artery in ischemic muscles (206magnification).
doi:10.1371/journal.pone.0005786.g001
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Figure 2. Inhibition of T-cell migration. Open bars represent LacZ animals and black bars represent SOD3 animals. Infiltration of CD3+
lymphocytes was inhibited in SOD3 animals 10 days after injury remaining at the level seen at earlier 3-day time point (206magnification).
doi:10.1371/journal.pone.0005786.g002
Figure 3. Anti-inflammatory effect of SOD3 affects predominantly macrophages in peritonitis model. Open bars represent LacZ animals
and black bars represent SOD3 animals. (a) SOD3-mediated reduction in total leukocyte number in peritoneal lavage 18 hours after induction of
inflammation. SOD3 treated animals had 55.66104 (64.1) cells/milliliters of lavage as compared to 91.66104 (66.7) found from LacZ control animals.
(b) Analysis of different leukocyte subtypes showed strongest effect in macrophages although lymphocyte migration was also reduced. Monocyte
accumulation in LacZ vs. SOD3 treatment was reduced from 33.56104 (61.8) to 10.96104 (62.5) cells/ml whereas lymphocytes were reduced from
11.46104 (62.2) to 7.66104 (61.2) cells/ml, and neutrophils from 47.06104 (64.7) to 37.56104 (62.9) cells/ml.
doi:10.1371/journal.pone.0005786.g003
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As compared to neutrophils and macrophages, the role of CD3+
T-cells in recovery of ischemic tissue has remained uncertain.
Despite relatively low level of infiltration, studies suggest an early
role for T-cells in attracting neutrophils and macrophages to site of
myocardial or peripheral ischemia/reperfusion injury [40,41].
The histological analysis at 3-day time point showed 114623 and
153646 (p = ns.) CD3+ T cells per ischemic tissue section in
SOD3 and LacZ animals, respectively (Figure 2). At 10-day time
point number of T cells had increased in LacZ animals by 60% to
247631 whereas in SOD3 animals T cell accumulation remained
at similar level as compared to 3 day time point (125630,
p,0.05). The analysis of leukocyte accumulation in the rat hind
limb ischemia model shows selective inhibition of inflammatory
cell migration and suggests SOD3 to have more prominent effect
on macrophage infiltration as compared to lymphocytes.
SOD3-mediated inhibition of leukocyte accumulation in
peritonitis model
To confirm the findings and to further analyze the SOD3-derived
selective inhibition of cell migration we examined leukocyte
migration in a mouse peritonitis model, which provides an efficient
way to analyze leukocyte traffic in an acute inflammatory response.
To induce peritoneal inflammation we used 5% solution of proteose
peptone supplemented with IL-1b and counted the numbers of
different leukocyte subtypes from the peritoneal lavage 18 hours
after induction of inflammation. The analysis of SOD3 overexpres-
sion derived inhibition of cell migration showed 20% (p=ns), 67%
(p,0.001), and 33% (p,0.05) reduction in migrating neutrophils,
monocytes/macrophages, and lymphocytes, respectively (Figure 3B).
Moreover, the total number of infiltrated leukocytes was decreased
by 30% in SOD3 animals as compared to LacZ controls (Figure 3A)
(p,0.01), which is mostly caused by the effect of attenuated
macrophage migration. The data effectively confirmed our findings
in rat hind limb ischemia showing vastly stronger inhibition of
macrophage infiltration as compared to other leukocyte subtypes.
Dexamethasone, a corticosteroid that reduces swelling and
inflammation is a potent anti-inflammatory drug used to treat
many bacteria-free inflammatory conditions, including rheuma-
toid arthritis and anaphylactic shock. Glucocorticoids exert their
anti-inflammatory effect e.g. through repression of NF-kB
mediated cytokine expression, which takes place after cytoplasmic
glucocorticoid receptor translocates into the nucleus [5,42]. To
compare SOD3 to clinically approved medication we gave an
intra-peritoneal injection of dexamethasone (Oradexon) to animals
30 minutes before induction of peritoneal inflammation. Leuko-
cyte traffic to the inflamed peritoneum was reduced by 20%
(p,0.05) after treatment with 50 mg/kg dexamethasone
(Figure 4A). Monocyte/macrophage migration was reduced by
60% (p,0.01), and that of lymphocytes by marked 50% indicating
tendency, while no significant difference was seen in neutrophil
accumulation in this setting (Figure 4B). PBS mock treated animals
exhibited lower neutrophil and monocyte accumulation as
compared to animals subjected to LacZ gene transfer, which
may be result of the adenovirus vector used in the study.
Intriguingly, SOD3 treatment reduced peritoneal monocyte and
lymphocyte numbers to similar level as dexamethasone treatment
although neutrophil numbers remained higher than what was
observed in either PBS or dexamethasone treated animals.
SOD3 inhibits NF-kB activation and suppresses the
inflammatory cytokine and adhesion molecule
expression
Proinflammatory stimuli activate vascular endothelium leading
to up-regulation of cell adhesion molecules and chemokines, NF-
kB has been shown to be both necessary and sufficient for
endothelial up-regulation of ICAM, VCAM, and MCP-1 [43].
Furthermore, ectopic expression of IkBa effectively abrogates
expression of VCAM, IL-1, and IL-6 [44]. In vitro luciferase assay
revealed 50% (p,0.01) decrease in NF-kB activity due to SOD3
transfection, which could at least partially be explained by
increased IkBa expression (Figure 5A) suggesting that SOD3
promotes cytoplasmic localization of NF-kB rendering it incapable
of binding DNA. NF-kB plays a central part in responses to
inflammatory signaling by regulating the expression of cytokines
suggesting that reduced NF-kB activity could lead to reduction in
expression of inflammatory cytokines and chemokines. Therefore,
we quantified cytokine and chemokine expression level in vivo from
rat muscle three days after vessel ligation and SOD3 gene transfer.
Quantitative RT-PCR showed significantly reduced expression of
TNFa, IL1a, IL6, MIP2, and MCP1 (Figure 5B) in SOD3 animals
suggesting reduced expression of several important inflammatory
mediators. Specifically, MCP1 is an important macrophage
Figure 4. Anti-inflammatory effect of dexamethasone. Open bars represent PBS treated animals and black bars represent dexamethasone
animals (dosage 50 mg/kg). (a) Leukocyte infiltration was reduced by dexamethasone treatment from 51.56104 (64.7) to 36.56104 (67.1) cells/
milliliters of lavage. (b) Dexamethasone treatment had no effect on neutrophil migration, 16.66104 (62.9) and 21.56104 (65.2) cells/ml were found in
PBS control group and dexamethasone treated animals, respectively. In contrast, accumulation of monocytes and lymphocytes were reduced from
21.46104 (62.7) to 8.86104 (62.2), and from 13.76104 (63.2) to 6.56104 (62.4), respectively.
doi:10.1371/journal.pone.0005786.g004
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attractant [45,46], possibly explaining markedly reduced macro-
phage accumulation. Furthermore, since TNFa, IL1a, and IL6
are important regulators of endothelial adhesion molecule
expression we analyzed expression of ICAM, VCAM, E-selectin,
and P-selectin from the tissue (Figure 5C). We found significant
reduction in adhesion molecule expression, which further confirms
the reduction in overall inflammation in the muscle of SOD3
recipient rats as compared to LacZ control animals.
Discussion
Tissue damage launches rapid recruitment of inflammatory
leukocytes into injured tissue due to activation of endothelial cells.
Inflammatory reaction promotes tissue healing by eliminating
pathogens, clearing cellular debris, and promoting cell prolifera-
tion. However, excessive inflammatory reaction promotes injury
e.g. through neutrophil-derived superoxide production [47]. In
fact, reactive oxygen species function as inflammatory mediators
by activating expression of cytokines such as TNFa, IL-1, and IL-6
[48] and therefore ROS may contribute to tissue injury by not
only directly damaging the tissue but also by enhancing further
leukocyte accumulation.
In the current work we showed that SOD3 is an important
mediator of reduced CD68+ macrophage migration into the
inflammatory area. Macrophages accumulate in high numbers to
ischemic muscle forming the primary leukocyte population three days
after injury [39]. CD68 staining showed significantly reduced
inflammatory area and macrophage migration in SOD3 treated
ischemic tissue as compared to LacZ control animals (Figure 1). The
SOD3-mediated reduction in macrophage accumulation was evident
in all of the studied time points. T-cells accumulate to ischemic
muscle in vastly lower numbers as compared to macrophages.
However, their presence is required for efficient neutrophil traffic,
and they attract macrophages by secreting IL-16 [40]. In our studies,
SOD3 did not prevent initial low level T-cell migration, but efficiently
inhibited further increase at 10-day time point (Figure 2). Late effect
on T-cell migration suggests an indirect mechanism for SOD3
mediated inhibition in T-cell traffic, which might be result of general
decrease in inflammation. Inflammatory cytokines secreted by
infiltrating macrophages attract other leukocytes to injured tissue
[49]. Thereafter, inhibition of macrophage infiltration could lead to
overall reduction in inflammatory reaction.
Since the SOD3-derived reduction in inflammation showed
selective inhibition of macrophage migration, we were prompted
to confirm the finding and to better characterize the cell specific
effect. The mouse peritonitis model supported the SOD3-derived
reduction in the number of infiltrating leukocytes (Figure 3A),
which was predominantly due to reduced macrophage numbers
(Figure 3B). These results confirm the anti-inflammatory property
of SOD3 and show a stronger inhibition of monocyte migration as
compared to other analyzed leukocyte subtypes. The data suggest
that reduced superoxide tissue concentrations caused by SOD3
overexpression may explain the anti-inflammatory effect of the
enzyme. It has been previously shown that superoxide treatment of
rat cerebral endothelial cells increases monocyte adhesion and
migration, which, however, was not replicated by H2O2 treatment
but was instead abrogated by superoxide scavengers suggesting
superoxide as an inflammatory mediator [21]. We have shown in
our previous works that SOD3 overexpression in vivo efficiently
decreases the production of superoxide in cardiovascular injuries
including our hind limb ischemia model [25–27].
Anti-inflammatory medications currently available for clinical
use include glucorticoid drugs such as dexamethasone. Dexa-
methasone binds the glucocorticoid receptor, which subsequently
translocates to the nucleus and represses inflammatory gene
expression by inhibiting e.g. NF-kB activity [4,5,42]. To compare
the efficacy of SOD3 mediated anti-inflammatory effect to existing
medication we determined the effect of Dexamethasone in mouse
peritonitis. As a dose of 50 mg/kg, dexamethasone reduced
leukocyte traffic in comparable levels to SOD3 gene transfer
(Figure 4A). Dexamethasone-mediated effect was equally effective
in monocyte/macrophage and lymphocyte lineages whereas no
significant effect was seen in neutrophils (Figure 4B). Neutrophil
Figure 5. SOD3-mediated reduction in activity of inflammatory
mediators. Open bars represent LacZ tissue and black bars represent
SOD3 animals. (a) Luciferase assay shows 50% reduction in NF-kB
activity in vitro, and western blot analysis shows increased IkBa
expression. (b) Quantitative RT-PCR analysis for cytokines and
chemokines. SOD3 overexpression derived reduced expression of TNFa,
IL-1a, IL-6, MCP-1, and MIP2 in injured tissue. (b) Analysis of ICAM,
VCAM, P-selectin, and E-selectin expression. Expression of inflammatory
adhesion molecules was significantly reduced in SOD3 muscle.
doi:10.1371/journal.pone.0005786.g005
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accumulation has been shown to be at its highest as early as
4 hours after induction of inflammation in zymosan induced
peritonitis [50]. Therefore, lack of effect on neutrophil migration
could be due to late time point analyzed. The data suggests that
SOD3 overexpression and dexamethasone administration have
similar anti-inflammatory effect in acute inflammation and
therefore suggesting SOD3 as a potential candidate molecule for
clinical treatments.
NF-kB plays a crucial role in mediating inflammation due to its
role in activating expression of pro-inflammatory genes such as
cytokines TNFa and IL1a, and adhesion molecules ICAM-1 and
VCAM-1 [43,44]. Since NF-kB is a redox sensitive transcription
factor being activated by oxidative stress, [12,13] we analyzed the
effect of SOD3 on NF-kB activity in vitro and showed significantly
decreased activity. (Figure 5A). The data is in line with previous
work in cardiovascular and liver transplantation models showing
that increased NAPDH oxidase-derived superoxide production
correlates with increased NF-kB activity, which is attenuated by
SOD3 overexpression [51–54].
Since cytokines TNFa, IL1a, IL6, MIP2, and MCP1 are known
to contain NF-kB binding sites in their gene promoters and are
thus up-regulated by NF-kB activation [55–61], we analyzed their
expression levels in rat muscle by quantitative PCR. All of the
analyzed cytokines and chemokines were significantly down-
regulated in SOD3 animals as compared to LacZ control animals
(Figure 5B). TNFa, IL1a, and IL6 promote inflammatory cell
migration by up-regulating E-selectin, P-selectin, ICAM, and
VCAM. Furthermore, macrophage recruitment has been shown
to be strongly dependent on MCP-1 secretion [46], while MIP2 is
a strong attractant for neutrophils [35]. MCP-1 deficiency does
not reduce the number of resident macrophages in peritoneal
cavity, but prevents macrophage migration in response to acute
thioglycollate induced peritonitis [46]. Lu et al. showed 3-fold
reduction in macrophage migration in 2,4-dinitro-1-fluorobenzene
induced skin hypersensitivity model while neutrophil numbers
remained unchanged. Thereafter, marked down-regulation of
MCP-1 seen in ischemic muscle could explain the observed strong
macrophage inhibition. Finally, due to reduced inflammatory
cytokine expression, we conducted further expression analyses and
found reduced expression VCAM, ICAM, E-selectin, and P-
selectin (Figure 5C). Reduced expression of common adhesion
molecules highlights the anti-migratory role of SOD3. It has been
shown that macrophage transmigration is strongly dependent on
a4b1 integrin - ICAM-1 interaction. Pre-treatment of recipient
mice before intra venous macrophage injection with monoclonal
antibodies for ICAM-1 reduced macrophage migration to
atherosclerotic plaques by 65% [62]. In addition, rolling and
attachment of P388D1 mouse monocyte cell line was inhibited by
P-selectin and VCAM antibodies in an ex vivo isolated perfused
carotid artery model [63] demonstrating the importance of these
adhesion molecules on macrophage transmigration.
In conclusion, our novel observation shows that SOD3 gene
transfer into hind limb ischemia or peritonitis results in
significantly reduced leukocyte migration due to decreased
cytokine and adhesion molecule expression. Further on, the data
suggest more pronounced anti-inflammatory effect on macro-
phages as compared to other leukocyte subtypes in the models
used in the current work. The observed anti-inflammatory effect in
SOD3 treated mice was comparable or even higher than that of
Dexamethasone, which recently has been shown to have
cardiovascular side effects [64,65]. Our previous in vivo SOD3
overexpression models have suggested non-toxicity and beneficial
effect on tissue protection and injury recovery [24–26,31]
suggesting that SOD3 overexpression by exogenous administra-
tion or through increased endogenous production in injured tissues
could provide a promising medication against excess inflammatory
cell migration.
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 2 
Abstract 
 
Reactive oxygen species, specifically hydrogen peroxide (H2O2) have a significant 
role in hormone production in thyroid tissue. Even though recent studies have 
demonstrated that Dual oxidase is responsible for H2O2 synthesis the role of 
extracellular superoxide dismutase (SOD3), which is a major H2O2 producing enzyme 
in extracellular fluids, has not been investigated in thyroid environment. In the current 
work we determined the expression of SOD3 in vitro and in vivo thyroid models 
signal transduction pathways involved in SOD3 activation, and the main 
physiological role of SOD3 in normal thyroid. According to our data SOD3 is highly 
expressed in normal thyroid, which becomes even more prominent in benign rat goiter 
model. However, we observed differentiation dependent decrease in sod3 synthesis 
during thyroid cancer development. The cellular mechanism studies showed that TSH 
signal transduction routes leading to hormone production and cell proliferation both 
increased sod3 mRNA synthesis even though the functional analysis in normal 
thyroid models indicated that the main role of SOD3 in thyroid is to regulate cell 
proliferation. Based on the correlation to the degree of thyroid cancer and sod3 
expression we suggest that SOD3 could be used as differentiation marker for thyroid 
carcinogenesis. 
 
 
 
 
 
 
 3 
Introduction 
 
The G protein-coupled receptors (GPCR), such as thyroid stimulating hormone 
receptor (TSH-R), mediate the cellular responses of various extracellular stimuli via 
two principle signal transduction pathways: cAMP pathway, which mainly mediates 
mitogen response, and phophatidylinositol pathway that is involved in calcium 
signaling in the cells (1). In thyroid TSH-R cAMP pathway is responsible for the 
thyroid cell proliferation and differentiation where as phophatidylinositol cascade 
controls thyroid hormone T3 and T4 synthesis response to thyroid stimulating 
hormone (TSH). The TSH stimulation is crucially important for normal thyroid 
function and therefore deregulation caused by e.g. TSH-R activating mutations or 
external factors affecting TSH signaling essentially disrupt the cellular homeostasis in 
thyroid (2). The low iodide uptake leads to reduced thyroid hormone T3 and T4 
production (hypothyroidism), which is compensated by increased TSH synthesis and 
subsequent activation of downstream cAMP mitogenic signaling leading to cell 
proliferation and benign thyroid enlargement known as goiter (3). Similarly toxic 
adenoma patients that have a constitutively activated TSH signaling due to mutations 
in TSH receptor with consequent permanent upregulation of cAMP pathway develop 
autonomous hyperfunctioning thyroid adenomas and non-autoimmune toxic thyroid 
hyperplasia (4).  
 
Malignant transformations of thyroid gland vary considerably in aggressiveness 
ranging from relatively common benign adenomas to differentiated papillary (PTC) 
and follicular (FTC) carcinomas, poorly differentiated (PDC) and rapidly growing 
undifferentiated carcinomas (ATC) (5). Currently known thyroid cancer 
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differentiation markers include sodium iodide symporter (NIS), thyroglobulin (Tg), 
thyroid peroxidase (TPO) and thyrotropin receptor (TSH-R), which however are not 
in diagnostic use due to inability of an individual gene to mark different 
transformation degrees (6). A larger panel of markers would offer a more reliable 
clinical diagnostic tool and therefore discovery of new differentiation makers to 
reinforce the currently known genes, would improve the diagnosis of thyroid cancer. 
 
TSH signaling has been shown to lead to increased reactive oxygen species 
production, especially to the synthesis of hydrogen peroxide (H2O2). Previously it has 
been shown that H2O2 contributes to tyrosine kinase activation, mitogen signaling, 
and consequent cell proliferation in vitro and in vivo models (7-9) by inactivating 
protein tyrosine phosphatases (10) or by phosphorylating tyrosine kinase receptors 
(11-15). We have recently demonstrated the ability of extracellular superoxide 
dismutase (SOD3), which is one of the main H2O2 producing enzymes in the 
extracellular fluids (16, 17), to promote cell proliferation in vivo by activating Ras-
Erk mitogen signaling, transcription factor upregulation and growth factor expression 
suggesting growth stimulatory role in tissues (18). Therefore, in the present work we 
studied the effect of TSH stimulation on SOD3 expression and the contribution of 
SOD3 to thyroid proliferative disorders. We identified a novel TSH-R mediated 
signal transduction pathway activating sod3 synthesis and demonstrated decreased 
sod3 expression correlating with the degree of thyroid malignancy. Therefore, SOD3 
could function as a differentiation marker in the cancer development. 
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Materials and methods 
 
Cell culture experiments. Rat PC Cl3 cells were grown in Ham’s F-12 medium, 
Coon’s modification (Sigma, St. Louis, MO) supplemented with 5% calf serum (Life 
Technologies, Inc., Paisley, PA) and 10 nM thyrotropic hormone, 10 nM 
hydrocortisone, 100 nM insulin, 5 µg/ml transferrin, 5 nM somatostatin, and 20 µg/ml 
glycyl-histidyl-lysine. HEK 293T cells were grown in DMEM 10% fetal bone serum 
(Sigma). Transfections were done with Polyfect transfection reagent (Sigma) or with 
Fugene6 (Roche Applied Science, Indianapolis, IN). Human sod3 cDNA, kindly 
provided by professor Stefan L. Marklund from the University of Umeå, Sweden, was 
cloned to pcDNA3 vector (Life Technologies, Carlsbad, CA) PC Cl3 cells were 
incubated in the presence of thyroid stimulating hormone (TSH) (Sigma), forskolin 
(Sigma), N(2-((-Bromocinnamyl)amino)ethyl)-5-isoquinolinesulfonamide (H89) 
(Calbiochem, San Diego, CA), or thapsigargin (Research Biochemicals International, 
Natick, MA). 
 
Animals. Male 4 to 5 weeks old Sprague-Dawley rats were given 0.25 % 
Propylthiouracil (PTU) (Sigma) ad libitum in drinking water for 2 weeks, sacrificed, 
and tissues were collected for expression analysis. Experimental procedures were 
done according to the European Union guidelines. 
 
PCR reactions. Messenger RNA was isolated from the pool of 4 animals or cells 
using Tri-reagent (Sigma). The first strand synthesis was done with QuantiTect 
Reverse Transcription (Qiagen, Hilden, Germany) and quantitative PCR with SYBR 
Green PCR master mix (Applied Biosystems, Foster City, CA). Primers were human 
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SOD3-for CTTCGCCTCTGCTGAAGTCT, human SOD3-rev 
GGGTGTTTCGGTACA AATGG, rat SOD3-for GACCTGGAGATCTGGATGGA, 
rat SOD3-rev GTGGTT GGAGGTGTTCTGCT, human actin-for 
TGCGTGACATTAAGGAGAAG, human actin-rev GCTCGTAGCTCTTCTCCA, 
rat actin-for TCGTGCGTGACTTAAGGAG, rat actin-rev 
GTCAGGCAGCTCGTAGCTCT. Reactions were done in 60 C annealing 
temperature. 
 
RNA interference.  Short interfering sod3 or gapdh OnTargetplus SMART pool 
oligos (Dharmacon, Lafayette, CO) were transfected into PC Cl3 cells according to 
manufactures protocol. Shortly, 20 mol/l of siSOD3 or siGAPDH control oligo were 
resuspended to total volume 100 l transfection buffer, mixed with equal volume of 
Optimem (Life Technologies, Carlsbad, CA), and incubated 5 min at room 
temperature. To prepare the transfection solution 5 l Dhermofect 4 reagent was 
added to 190 l of Optimem and incubated 5 min at room temperature. Oligo 
suspension and transfection regent were combined, incubated 20 min at room 
temperature and added to the cells for 48 h. 
 
BrdU analysis. Cells were serum starved for 16 hours and TSH stimulated 6 hours 
before addition of 10 mM bromodeoxyuridine (BrdU) (Roche) for 2 hours. 
Subsequently, cells were fixed in 3% paraformaldehyde (Sigma) and permeabilized 
with 0.2% Triton X-100 (Sigma). BrdU-positive cells were revealed with FITC–
conjugated secondary antibodies (Jackson ImmunoResearch Laboratories Inc., West 
Grove, PA). Cell nuclei were identified by Hoechst (Sigma) staining. 
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Calcium uptake assay. Intracellular Ca
2+
 concentrations were measured in PC Cl3 
cells. Briefly, cells were detached from tissue culture plates with PBS containing 0.5 
mmol/l EDTA, washed once with HEPES-buffered medium (HBM) (137 mmol/l 
NaCl, 5 mmol/l KCl, 1 mmol/l CaCl2, 0.44 mmol/l KH2PO4, 4.2 mmol/l NaHCO3, 10 
mmol/l glucose,
 
20 mmol/l HEPES, and 1.2 mmol/l MgCl2, pH 7.4) and then loaded 
with 2 µmol/l fura-2 acetoxymethyl ester for 20 min at 37 °C. After loading, the cells 
were diluted with HBM without CaCl2 to a final concentration of 0.3 mmol/l CaCl2 
and stored at room temperature until use. For fluorescence recordings an appropriate 
volume of the cell suspension was spun down, washed once in HBM, resuspended in 
HBM and placed in a thermostatted (37 °C) cuvette with magnetic stirring in a 
Hitachi F-2000 fluorescence spectrophotometer. The fluorescence was monitored at 
340 nm (excitation) and 505 nm (emission). Experiments were calibrated with 60 µg 
digitonin/ml (Fmax) and 10 mmol/l EGTA (Fmin). The intracellular [Ca
2+
] was 
calculated from the fluorescence (F) using the equation [Ca
2+] = (F−Fmin)/( Fmax−F) × 
224 nmol/l (Kd for fura-2), in which the extracellular fura-2 fluorescence was 
subtracted from F values. 
 
Western blot. Cells were homogenized in lysis buffer (50mmol/L HEPES pH 7.5, 150 
mmol/L NaCl, 10% glycerol, 1% Triton X-100, 1mmol/L EGTA, 1.5 mmol/L MgCl2, 10 
mmol/L NaF, 10 mmol/L sodium pyrophosphate, 1mmol/L Na3VO4, 10 g 
approtinin/ml, 10 g leupeptin/ml) (Sigma). Antibodies were human anti-SOD3 (Santa 
Cruz Biotechnology, Santa Cruz, CA) and anti- tubulin (Sigma). 
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Immunohistochemistry. Thyroid tissues were embedded in optimal cutting temperature 
compound, OCT (Tissue-Tek, Torrance, CA). Ten µm sections were stained with 
hematoxylin/eosin (Sigma) according to the standard protocols. 
 
Chemiluminescence assay for H2O2 detection. The H2O2 release was quantified 48 
h after cell transfection by the homovanillic acid-based fluorimetric assay (19). Cos-7 
cells were incubated in Krebs-Ringer HEPES (KRH) medium pH 7.4 containing 0.1 
µg/mL horseradish peroxidase type II, 440 µmol/l homovanillic acid and 1 µmol/l 
ionomycin during 2 h 30 min at 37°C. Fluorescence intensity of oxidized 
homovanillic acid was measured at 425 nm after excitation at 315 nm.  Results are 
reported as ng H2O2/well representing the quantity of H2O2 accumulated during 2 h 30 
min in each well (6-well plates). 
 
Chemiluminescence assay for O2
.-
 detection. Extracellular O2
.-
 release was detected 
by chemiluminescence using the superoxide dismutase–inhibitable Diogenes reagent 
(National Diagnostics, Atlanta, GA) on cells resuspended in HBSS + 10 mmol/l 
glucose. One µmol/l ionomycin was added to the cells to stimulate the Duox activity. 
Measurements were taken with 22 seconds intervals for 10 minutes in 96-well white 
plates (1.5x10
5
 cells/250 µl well) at 37 °C using a Microplate Luminometer.  
Chemiluminescence curves were analysed and peak values of the curves were 
presented in Relative Light Units (RLU)/sec. 
 
Statistical analysis. Statistical analysis was done using two-tail t-test for means. 
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Results 
 
Sod3 is abundantly expressed in rat thyroid tissue 
 
SOD3 is an extracellular H2O2 producing enzyme expressed in various tissues (16, 
20) protecting cell surface structures against deleterious effects of superoxide. The 
local viral administration of sod3 causing 2-fold increased total SOD activity in 
tissues or intravenous infusion of the native C-form of the enzyme with high affinity 
to cell surface structures results in significant attenuation of tissue damages and 
markedly increased tissue recovery (21-23) suggesting that even minor changes in 
tissue SOD3 concentration have a significant impact on the redox balance.  
 
Comparison of mRNA expression from rat tissues (Figure 1a) demonstrated thyroid 
as one of the major expression sites for sod3 showing 2.5-fold higher mRNA 
expression level in thyroid as compared to heart corresponding to previously reported 
3-fold and 5-fold differences in heart vs. thyroid protein level in rabbit and human, 
respectively (16). The expression in the rat thyroid approached the levels detected in 
the aorta, which is one of the main expression sites for SOD3 (23), indicating 
participation to ROS balance and signal transduction in thyroid tissue. 
 
Rat in vivo PTU model was used to investigate the expression status of SOD3 in 
benign thyroid enlargement caused by increased TSH secretion and compared the data 
to human clinical samples. PTU treatment is known to cause decreased T3 production 
with subsequent increase in TSH signaling, thyroid enlargement, and activated 
mitogen signal transduction (24-26). PTU treated thyroids had on average 4-fold 
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increase in wet-weight as compared to normal untreated rat thyroids suggesting a 
typical goiter formation in rats (Figure 1b), which was further supported by 
hematoxylin-eosin staining demonstrating enlarged cellular structure and the lack of 
organized vacuolar network (Figure 1c,d). The expression analysis of sod3 mRNA 
production showed 10-fold increase (p<0.01) caused by PTU-derived TSH signal 
transduction (Figure 1e) thereby confirming the in vitro data indicating the 
participation of SOD3-derived H2O2 in thyroid proliferative dysfunction. We next 
focused on the analysis of human goitrogenous tissues to compare the compatibility 
of the in vivo laboratory models to clinical patient samples. The qRT-PCR expression 
analysis from human endemic goiter and toxic adenoma patient tissues failed to 
demonstrate significant differences between patient groups (Figure 1f). The data 
therefore suggest that rat PTU model does not completely explain the regulation of in 
vivo sod3 expression, which can be affected e.g. by paracrine effect of infiltrating 
inflammatory cells in benign thyroid enlargement. 
 
SOD3 is downregulated in thyroid cancer models and patients 
 
To investigate the expression of SOD3 in malignant thyroid proliferative disorders we 
first determined the sod3 mRNA levels from rat thyroid tumor cell lines. The expression 
analysis of rat PC Cl3 derived PC PTC papillary thyroid cancer and PC E1A anaplastic 
thyroid cancer cell lines suggested differentiation dependent expression status (Figure 
2a). Papillary thyroid cancer cell model PC PTC showed 3-fold decreased sod3 mRNA 
synthesis where as more undifferentiated aggressive anaplastic PC E1A cells lacked the 
expression almost completely as compared to control PC Cl3 cells indicating differential 
regulation for SOD3 expression in benign and malignant thyroid enlargement. 
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Furthermore, the qRT-PCR and DNA array expression analysis from thyroid cancer 
patients showed significantly decreased sod3 synthesis correlating with the differentiation 
degree of the tumor samples confirming the relevance of results obtained from rat thyroid 
cancer in vitro model to clinical patient samples (Figure 2 c). The in vitro and in vivo data 
therefore suggest that SOD3 should be considered as a differentiation marker in 
malignant transformation process. 
 
TSH signal transduction increases sod3 mRNA expression 
 
Since SOD3 enzyme activity in human thyroid has been shown to be approximately 
5-fold higher than in cardiac muscle and 3-fold above the average activity of all 
human tissues (16) we therefore investigated the signal transduction routes affecting 
sod3 production in a versatile rat PC Cl3 cell line. The sod3 mRNA synthesis was 
significantly induced by TSH (3-fold increase, p<0.01) stimulation suggesting signal 
transduction either via cAMP-protein kinase A (PKA) proliferation and differentiation 
pathway or via PLC-Ca
2+
 hormone production pathway (Figure 3a). The contribution 
of cAMP pathway in sod3 mRNA production was studied by transient transfection of 
pCEF-gs and pCEF-pka into PC Cl3 cells, which resulted in 5.5-fold (p<0.01) and 6-
fold increase (p<0.001) in sod3 mRNA production, respectively. To confirm the 
transfection data we stimulated the TSH receptor signaling with forskolin incubation 
that yielded 6-fold increase (p<0.05) in mRNA production supporting the 
involvement of TSH-cAMP pathway in production of SOD3.  To further demonstrate 
that cAMP-PKA is upstream of sod3 we inhibited the PKA function with H89 PKA 
inhibitor in TSH stimulated PC Cl3 cells. Interestingly, even though TSH-H89 
incubation significantly decreased (p<0.05) sod3 production, it was not able to 
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completely diminish the messenger RNA synthesis suggesting other signaling routes 
for SOD3 stimulation (Figure 3a). In thyroid cells TSH-derived signaling is mediated 
also via Gq-PLC-Ca
2+
 signal transduction pathway, which leads to thyroid hormone 
production (27). To study the contribution of hormone synthesis pathway on sod3 
mRNA transcription PC Cl3 cells were transfected with pCEF-gq or incubated in the 
presence of thapsigargin, which increases calcium influx, and analyzed the sod3 
expression. Transfection of pCEF-gq increased relative sod3 mRNA production 3-fold 
(p<0.01) and treatment with Thapsigargin 3-fold (p<0.05) suggesting that both Gs and 
Gq signal transduction pathways are involved in SOD3 activation (Figure 3b). 
 
SOD3 has more prominent role in proliferation than in hormone production 
 
We then aimed to investigate the physiological consequences of TSH stimulated 
SOD3 production. In addition to antioxidative characteristics we have recently shown 
that extraneously administered SOD3 is able to stimulate Ras GTP loading in vitro 
and in vivo leading to activation of mitogen signaling pathway and consequent growth 
factor expression and cell proliferation indicating that SOD3-derived H2O2 has 
growth regulatory properties (18). This is further supported by numerous reports 
showing that physiological concentrations of H2O2 can activate cell membrane 
receptors and downstream signaling leading to cell proliferation in vitro and in vivo 
(10-15).  
 
The effect of SOD3 on cell proliferation was studied by RNA interference transfecting 
siSOD3 oligo into TSH stimulated PC Cl3 cells. The qRT-PCR analysis showed 95% 
interference effect (p<0.001) in sod3 mRNA production at 48-hour time point (Figure 
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4a), which simultaneously corresponded to 15% (p<0.05) decrease in TSH-derived cell 
proliferation suggesting mitogenic effect for SOD3-derived H2O2 (Figure 4b). The data is 
in line with our previous results showing that SOD3 is able to stimulated Erk1/2 mitogen 
pathway leading to increased cyclin D1 and VEGF-A expression and consequent cell 
proliferation in vivo (18). 
 
Since the sod3 expression was increased also by PLC-Ca
2+
 signal transduction pathway 
we determined the amount of SOD3-derived H2O2 in Cos-7 heterologous system to 
predict the participation of SOD3 in hormone synthesis. The data showed significant 
decrease (p<?) in extracellular superoxide concentration indicating functionality of 
SOD3 in our cell model (Figure 4c). However, according to the fluorimetric assay the 
H2O2 production was 28-fold (p<??) lower by SOD3 than by DuoxA2 suggesting dual 
oxidases as the main source of H2O2 in thyroid hormone production (Figure 4d). Even 
though SOD3-derived H2O2 could be utilized in hormone production our data suggest 
that this activity is covered by dual oxidases in thyroid tissue. Therefore, TSH-cAMP-
PKA signal cascade and consequent cell proliferation and differentiation could be 
considered to be more prominent roles for SOD3 in thyroid than the role in normal 
thyroid hormone production. 
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Discussion 
 
Thyroid tissue physiology requires continuous high concentration of H2O2 for thyroid 
hormone T3 and T4 synthesis, which is according to the recent publications produced 
mainly by dual oxidase (28-31). Another H2O2 producing enzyme, SOD3, belongs to 
superoxide dismutase isoenzyme family that is responsible for balancing the reduction-
oxidation reactions in different cellular compartments. Even though the accumulating 
data suggest that sod3 expression is tightly regulated at several levels both pre-
transcriptionally as well as post-translationally (18, 20, 32-37) the regulation of the 
expression and the physiological role of the enzyme is not completely understood. In the 
present study we analyzed the signal transduction activation and the effect of SOD3 in 
thyroid models and further compared the results obtained from in vitro and in vivo 
models to patient samples data. 
 
The expression analysis of rat tissues suggested thyroid as a major expression site for 
sod3. However, in rat thyroid the expression level compared to other rat tissues was not 
as high as reported in human thyroid samples (16), which might influence the comparison 
of the results between species (Figure 1). According to our previous studies relatively low 
concentration of SOD3 in vitro or in vivo is able to induce a physiological response in 
cells and in the surrounding extracellular environment (18, 20, 23, 38) indicating that 
even minor differences in SOD3 concentration can have an impact on cellular signaling 
and consequent biological effects. 
 
We studied the sod3 expression in benign thyroid enlargement models to determine the 
expression of the enzyme in the proliferative environment. Even though previous clinical 
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analysis have demonstrated decreased total SOD activity in the plasma of Graves’ disease 
patients (39-41) a recent paper suggested increased sod3 production in thyroid caused by 
long-term iodine deprivation in murine models (42). Since both the synthesis of 
autoantibodies against thyroid hormones in Graves’ disease and the diet iodine 
deprivation lead to increased TSH signaling and consequent hyperthyroidism we 
investigated the SOD3 expression in experimental in vivo goiter model and from 
hyperthyroid patient samples (Figure 1). Increased sod3 expression in rat goiter model 
was in line with previous murine models (42) suggesting the participation of TSH 
stimulated increased SOD3 production in thyroid cells (Figure 4c). However, analysis of 
patient samples did not support the data from the murine model (Figure 1f). The data 
suggests that the expression of SOD3 in thyroid benign enlargement depends on multiple 
factors rather than on individual action of increased TSH production. The results further 
imply that murine goiter models do not completely mimic clinical patient status, which 
should be considered in data analysis. 
 
The analysis of sod3 in thyroid cancer in vitro and in vivo showed decreased expression 
of the mRNA suggesting that SOD3 is a differentiation marker in malignant 
transformation (Figure 2). Remarkably, the expression analysis pointed to distinct 
differentiation dependent mRNA synthesis demonstrating almost complete lack of sod3 
mRNA production in anaplastic thyroid cancer, the most aggressive form of thyroid 
tumors. Interestingly, a recent paper suggested that thyroid patient survival corresponded 
to the number of Ras oncogene activation mutations; more aggressive anaplastic thyroid 
cancer harbored significantly more mutations in all three Ras genes (43). Activated Ras 
oncogene is commonly known to cause decreased expression of several genes. Even 
though the exact mechanism for Ras oncogene mediated gene silencing is not clearly 
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understood, it has been suggested to take place by epigenetic silencing mechanism (44). 
We have published previously the presence of highly methylated GpC island at the sod3 
gene and showed decreased methylation in cardiovascular proliferative disease (45). 
Therefore, Ras-mediated epigenetic gene silencing could potentially explain the 
differentiation dependent decrease in sod3 expression. 
 
Since SOD3 related signal transduction in thyroid is not characterized previously we 
focused on effect of TSH signaling, the main external factor regulating thyroid function, 
on sod3 mRNA synthesis. The effect of TSH is mediated by thyroid stimulating hormone 
receptor, a G protein-coupled receptor that activates Gs and Gq heterotrimeric G-proteins 
(46). TSH receptor stimulation, which principle intracellular signaling is channeled 
through cAMP and, to a lesser extent, by phophatidylinositol pathway, determines the 
main thyroid physiological functions. Activation of Gs leads to the stimulation of cAMP, 
a positive modulator of thyroid cell proliferation and the expression of differentiation 
markers such as sodium iodide symporter, thyroperoxidase, and thyroglobulin (1, 47). 
The Gq protein stimulation in thyroid initiates the cascade needed for Duox production 
and consequent increased in thyroid H2O2 synthesis, which is centrally important in 
thyroid hormone T3 and T4 production. Our present data describes a novel G protein-
coupled receptor mediated activation of SOD3 through cAMP and by phophatidylinositol 
pathway suggesting larger role in thyroid physiology (Figure 3). Since GPCR mediated 
signal transduction plays a significant role also in other tissues the current data could 
potentially further explain our previous observations of SOD3 mediated effects in injury 
models (23, 48).  
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Lastly, we investigated the functional effect of SOD3 in thyroid environment by sod3 
RNAi and by overexpression of sod3 in heterologous Cos7 model to study the SOD3-
derived proliferation and level of H2O2 production, respectively. The current results 
showing that sod3 RNAi knockdown is able to reduce the TSH stimulated PC Cl3 cell 
proliferation in vitro is in line with our previous data confirming the mitogen effect for 
SOD3-produced H2O2 (Figure 4). The involvement of G-protein coupled receptors, such 
as TSH receptor, on cell proliferation can be mediated through several routes; TSH 
mediated increased cAMP has been shown to activate Ras GTP loading in rat WRT cells 
and to increase Erk1/2 phosphorylation in rat FRTL-5 cells causing subsequent cell 
proliferation (49-51). It is noteworthy, that SOD3 has not been reported to have growth 
factor features and therefore the effect on cell proliferation likely sustain on H2O2 
production and subsequence activation of Erk1/2 signaling (18). The present data further 
indicates that radical production in thyroid is not solely affecting hormone production but 
has also an impact on cell proliferation.  
 
H2O2 production levels were studied by sod3 overexpression in Cos-7 heterologous 
system to determine if SOD3 could potentially contribute to thyroid hormone production. 
(Figure 4). Even though transfected sod3 reduced extracellular superoxide concentration 
the SOD3 derived H2O2 was covered by Duox produced H2O2 suggesting less 
pronounced role for SOD3-derived H2O2 in thyroid hormone production. 
 
As conclusions, we have shown a novel TSH stimulation dependent GPCR-mediated 
signal transduction pathway activating sod3 production in thyroid PC Cl3 cell line. We 
have further demonstrated differentiation dependent sod3 expression both in vitro and in 
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vivo in patient samples suggesting that SOD3 could be considered as a differentiation 
marker in thyroid cancer diagnosis. 
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Figure text 
 
Figure 1. SOD3 expression in thyroid. A. Quantitative PCR analysis for sod3 mRNA 
expression from rat tissues indicated 2.5-fold increased (p<0.05) expression in thyroid as 
compared to cardiac tissue. However, the expression level thyroid was 30% lower than in 
aorta, which showed 4-fold higher sod3 mRNA production (p<0.05) as compared to the 
heart. B. Thyroid weight measurement showed approximately 4-fold increase in wet 
weight of the PTU treated tissue indicating goitrogenous development. PTU was giving 
ad libitum in drinking water, which caused variation seen in weight development. C-D. 
Hematoxylin-eosin staining for PTU-treated rats showed hyperplasia and altered thyroid 
structure caused by the treatment. E. The sod3 mRNA expression was significantly 
(p<0.01) increased by PTU. F. Goiter patient sample sod3 mRNA expression level 
analysis insignificant differences between control, endemic goiter, and toxic adenoma 
patients.  
 
Figure 2. SOD3 is a differentiation marker. A. The sod3 mRNA analysis from rat normal 
and transformed PC Cl3 cells indicated decreased mRNA production correlating to the 
differentiation level. The sod3 synthesis decreased 60% (p<0.01) in PC PTC papillary 
thyroid cancer cell model and was almost completely diminished (p<0.001) in PC E1A 
anaplastic thyroid cancer cell model. The in vitro cell model data was in line with DNA 
array (B) and qRT-PCR (C) patient sample analysis. 
 
Figure 3. TSH activation increased sod3 mRNA production in PC Cl3 cells. A. TSH-R 
cAMP pathway increased sod3 production. The induction was analyzed from cells treated 
with TSH-R stimulants, with PKA inhibitor H89, and from cells transiently transfected 
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with pka and tsh-r gs subunit. B. The effect of TSH-R phophatidylinositol cascade on 
sod3 synthesis was studied by tsh-r gq subunit transient transfection and by calcium 
uptake analysis using thapsigargin that blocks the calcium pumps in endoplasmic 
reticulum increasing the cytosolic calcium concentration. Both treatments, transfection 
and thapsigargin administration, increased the mRNA synthesis significantly (p<0.01 and 
p<0.05, respectively). C. The intracellular calcium levels went promptly up after 100 
nmol/l thapsigargin administration and stayed above the baseline values over the follow-
up period. 
 
Figure 4. Functional role of SOD3 in thyroid models A. Quantitative PCR showed 
significant (p<0.001) sod3 downregulation caused by siSOD3 intefering oligos. B. BrdU 
analysis for proliferating nuclei suggested significantly (p<0.05) decreased cell 
proliferation caused by siSOD3 in TSH stimulated PC Cl3 cells. C-D. Cos7 heterologous 
model for radical production. 
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